Audit Information |
12 Months Ended |
---|---|
Dec. 31, 2021 | |
Auditor [Abstract] | |
Auditor Name | DELOITTE & TOUCHE LLP |
Auditor Location | Phoenix, Arizona |
Auditor Firm ID | 34 |
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Equity: | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 200,000,000 | 200,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 1,000,000,000 | 1,000,000,000 |
Common stock, shares issued (in shares) | 228,879,846 | 218,578,012 |
Common stock, shares outstanding (in shares) | 228,879,846 | 218,578,012 |
Healthcare Trust of America Holdings, LP (HTALP) | ||
Partners’ Capital: | ||
Limited partner's capital, units issued (in shares) | 4,142,408 | 3,519,545 |
Limited partner's capital, units outstanding (in shares) | 4,142,408 | 3,519,545 |
General partner's capital, units issued (in shares) | 228,879,846 | 218,578,012 |
General partner's capital, units outstanding (in shares) | 228,879,846 | 218,578,012 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Net income | $ 99,784 | $ 53,508 | $ 30,758 |
Other comprehensive income (loss) | |||
Change in unrealized gains (losses) on cash flow hedges | 10,114 | (21,876) | 4,316 |
Total other comprehensive (loss) income | 10,114 | (21,876) | 4,316 |
Total comprehensive income | 109,898 | 31,632 | 35,074 |
Comprehensive income attributable to non-controlling interests | (1,944) | (539) | (615) |
Total comprehensive income attributable to common stockholders | 107,954 | 31,093 | 34,459 |
Healthcare Trust of America Holdings, LP (HTALP) | |||
Net income | 99,784 | 53,508 | 30,758 |
Other comprehensive income (loss) | |||
Change in unrealized gains (losses) on cash flow hedges | 10,114 | (21,876) | 4,316 |
Total other comprehensive (loss) income | 10,114 | (21,876) | 4,316 |
Total comprehensive income | 109,898 | 31,632 | 35,074 |
Comprehensive income attributable to non-controlling interests | 0 | 0 | (66) |
Total comprehensive income attributable to common stockholders | $ 109,898 | $ 31,632 | $ 35,008 |
CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands |
Total |
Total Stockholders’ Equity |
Common Stock |
Additional Paid-In Capital |
Accumulated Other Comprehensive Income (Loss) |
Cumulative Dividends in Excess of Earnings |
Non-controlling Interests |
---|---|---|---|---|---|---|---|
Beginning balance (in shares) at Dec. 31, 2018 | 205,267,000 | ||||||
Beginning balance at Dec. 31, 2018 | $ 3,334,914 | $ 3,256,024 | $ 2,053 | $ 4,525,969 | $ 307 | $ (1,272,305) | $ 78,890 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of common stock in HTA (in shares) | 11,096,000 | ||||||
Issuance of common stock, net | 322,218 | 322,218 | $ 112 | 322,106 | |||
Issuance of OP Units in HTALP | 2,603 | 2,603 | |||||
Issuance of limited partner OP Units in connection with acquisitions | 2,000 | 2,000 | |||||
Share-based award transactions, net (in shares) | 319,000 | ||||||
Share-based award transactions, net | 10,127 | 10,127 | $ 3 | 10,124 | |||
Repurchase and cancellation of common stock (in shares) | (487,000) | ||||||
Repurchase and cancellation of common stock | (12,178) | (12,178) | $ (5) | (12,173) | |||
Redemption of non-controlling interest and other (in shares) | 258,000 | ||||||
Redemption of non-controlling interest and other | 1,725 | 8,018 | $ 2 | 8,016 | (6,293) | ||
Dividends declared | (265,773) | (260,593) | (260,593) | ||||
Dividends declared | (5,180) | ||||||
Net income | 30,692 | 30,154 | 30,154 | 538 | |||
Other comprehensive income | 4,316 | 4,239 | 4,239 | 77 | |||
Ending balance (in shares) at Dec. 31, 2019 | 216,453,000 | ||||||
Ending balance at Dec. 31, 2019 | 3,430,644 | 3,358,009 | $ 2,165 | 4,854,042 | 4,546 | (1,502,744) | 72,635 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of common stock in HTA (in shares) | 1,675,000 | ||||||
Issuance of common stock, net | 50,020 | 50,020 | $ 17 | 50,003 | |||
Issuance of OP Units in HTALP | 1,378 | 1,378 | |||||
Share-based award transactions, net (in shares) | 263,000 | ||||||
Share-based award transactions, net | 8,916 | 8,916 | $ 3 | 8,913 | |||
Repurchase and cancellation of common stock (in shares) | (174,000) | ||||||
Repurchase and cancellation of common stock | (5,192) | (5,192) | $ (2) | (5,190) | |||
Redemption of non-controlling interest and other (in shares) | 361,000 | ||||||
Redemption of non-controlling interest and other | 0 | 9,019 | $ 3 | 9,016 | (9,019) | ||
Dividends declared | (282,479) | (277,626) | (277,626) | ||||
Dividends declared | (4,853) | ||||||
Net income | 53,508 | 52,618 | 52,618 | 890 | |||
Other comprehensive income | $ (21,876) | (21,525) | (21,525) | (351) | |||
Ending balance (in shares) at Dec. 31, 2020 | 218,578,012 | 218,578,000 | |||||
Ending balance at Dec. 31, 2020 | $ 3,234,919 | 3,174,239 | $ 2,186 | 4,916,784 | (16,979) | (1,727,752) | 60,680 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of common stock in HTA (in shares) | 9,419,000 | ||||||
Issuance of common stock, net | 251,250 | 251,250 | $ 94 | 251,156 | |||
Issuance of OP Units in HTALP | 35,785 | 35,785 | |||||
Share-based award transactions, net (in shares) | 391,000 | ||||||
Share-based award transactions, net | 7,262 | 7,262 | $ 4 | 7,258 | |||
Repurchase and cancellation of common stock (in shares) | (125,000) | ||||||
Repurchase and cancellation of common stock | (3,414) | (3,414) | $ (1) | (3,413) | |||
Redemption of non-controlling interest and other (in shares) | 617,000 | ||||||
Redemption of non-controlling interest and other | 0 | 6,353 | $ 6 | 6,347 | (6,353) | ||
Dividends declared | (291,384) | (286,040) | (286,040) | ||||
Dividends declared | (5,344) | ||||||
Net income | 99,784 | 98,016 | 98,016 | 1,768 | |||
Other comprehensive income | $ 10,114 | 9,938 | 9,938 | 176 | |||
Ending balance (in shares) at Dec. 31, 2021 | 228,879,846 | 228,880,000 | |||||
Ending balance at Dec. 31, 2021 | $ 3,344,316 | $ 3,257,604 | $ 2,289 | $ 5,178,132 | $ (7,041) | $ (1,915,776) | $ 86,712 |
CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Statement of Stockholders' Equity [Abstract] | |||
Dividends declared (in dollars per share) | $ 1.290 | $ 1.270 | $ 1.250 |
CONSOLIDATED STATEMENTS OF CHANGES IN PARTNERS' CAPITAL - USD ($) shares in Thousands, $ in Thousands |
Total |
Healthcare Trust of America Holdings, LP (HTALP) |
Healthcare Trust of America Holdings, LP (HTALP)
General Partners’ Capital
|
Healthcare Trust of America Holdings, LP (HTALP)
Limited Partners’ Capital
|
---|---|---|---|---|
Balance as of beginning of period (in units) at Dec. 31, 2018 | 205,267 | 3,929 | ||
Balance as of beginning of period at Dec. 31, 2018 | $ 3,334,914 | $ 3,256,294 | $ 78,620 | |
Increase (Decrease) in Partners' Capital [Roll Forward] | ||||
Issuance of partner units, net (in units) | 11,096 | |||
Issuance of general partner OP Units, net | $ 2,603 | $ 322,218 | $ 2,603 | |
Issuance of limited partner OP Units in connection with acquisitions (in units) | 163 | |||
Issuance of limited partner OP Units in connection with acquisitions | 2,000 | $ 2,000 | ||
Share-based award transactions, net (in units) | 319 | |||
Share-based award transactions, net | 10,127 | $ 10,127 | ||
Redemption and cancellation of general partner units (in units) | (487) | |||
Redemption and cancellation of general partner OP Units | (12,178) | $ (12,178) | ||
Redemption of limited partner units and other (in units) | 258 | 258 | ||
Redemption of limited partner OP Units and other | 1,725 | $ 8,018 | $ (6,293) | |
Distributions declared | (265,773) | (260,593) | (5,180) | |
Net income | 30,154 | 30,692 | 30,154 | 538 |
Other comprehensive income | 4,316 | 4,316 | $ 4,239 | $ 77 |
Balance as of end of period (in units) at Dec. 31, 2019 | 216,453 | 3,834 | ||
Balance as of end of period at Dec. 31, 2019 | 3,430,644 | $ 3,358,279 | $ 72,365 | |
Increase (Decrease) in Partners' Capital [Roll Forward] | ||||
Issuance of partner units, net (in units) | 1,675 | 47 | ||
Issuance of general partner OP Units, net | 0 | 1,378 | $ 50,020 | $ 1,378 |
Share-based award transactions, net (in units) | 263 | |||
Share-based award transactions, net | 8,916 | $ 8,916 | ||
Redemption and cancellation of general partner units (in units) | (174) | |||
Redemption and cancellation of general partner OP Units | (5,192) | $ (5,192) | ||
Redemption of limited partner units and other (in units) | 361 | 361 | ||
Redemption of limited partner OP Units and other | 0 | $ 9,019 | $ (9,019) | |
Distributions declared | (282,479) | (277,626) | (4,853) | |
Net income | 52,618 | 53,508 | 52,618 | 890 |
Other comprehensive income | (21,876) | (21,876) | $ (21,525) | $ (351) |
Balance as of end of period (in units) at Dec. 31, 2020 | 218,578 | 3,520 | ||
Balance as of end of period at Dec. 31, 2020 | 3,234,919 | $ 3,174,509 | $ 60,410 | |
Increase (Decrease) in Partners' Capital [Roll Forward] | ||||
Issuance of partner units, net (in units) | 9,419 | |||
Issuance of general partner OP Units, net | 0 | $ 251,250 | ||
Issuance of limited partner OP Units in connection with acquisitions (in units) | 1,239 | |||
Issuance of limited partner OP Units in connection with acquisitions | 35,785 | $ 35,785 | ||
Share-based award transactions, net (in units) | 391 | |||
Share-based award transactions, net | 7,262 | $ 7,262 | ||
Redemption and cancellation of general partner units (in units) | (125) | |||
Redemption and cancellation of general partner OP Units | (3,414) | $ (3,414) | ||
Redemption of limited partner units and other (in units) | 617 | 617 | ||
Redemption of limited partner OP Units and other | 0 | $ 6,353 | $ (6,353) | |
Distributions declared | (291,384) | (286,040) | (5,344) | |
Net income | 98,016 | 99,784 | 98,016 | 1,768 |
Other comprehensive income | $ 10,114 | 10,114 | $ 9,938 | $ 176 |
Balance as of end of period (in units) at Dec. 31, 2021 | 228,880 | 4,142 | ||
Balance as of end of period at Dec. 31, 2021 | $ 3,344,316 | $ 3,257,874 | $ 86,442 |
CONSOLIDATED STATEMENTS OF CHANGES IN PARTNERS' CAPITAL (Parenthetical) - $ / shares |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Dividends declared (in dollars per unit) | $ 1.290 | $ 1.270 | $ 1.250 |
Healthcare Trust of America Holdings, LP (HTALP) | |||
Dividends declared (in dollars per unit) | $ 1.290 | $ 1.270 | $ 1.250 |
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Cash flows from operating activities: | |||
Net income | $ 99,784,000 | $ 53,508,000 | $ 30,758,000 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 283,300,000 | 283,039,000 | 280,969,000 |
Share-based compensation expense | 7,262,000 | 8,916,000 | 10,127,000 |
Impairment | 22,938,000 | 0 | 0 |
Income from unconsolidated joint venture | (1,604,000) | (1,612,000) | (1,882,000) |
Distributions from unconsolidated joint venture | 3,130,000 | 3,240,000 | 3,030,000 |
(Gain) loss on sale of real estate, net | (39,228,000) | (9,590,000) | 154,000 |
Loss on sale of corporate asset, net | 2,106,000 | 0 | 0 |
Loss on extinguishment of debt, net | 0 | 27,726,000 | 21,646,000 |
Changes in operating assets and liabilities: | |||
Receivables and other assets, net | (4,699,000) | (11,042,000) | (12,857,000) |
Accounts payable and accrued liabilities | 9,430,000 | 2,066,000 | (128,000) |
Prepaid rent and other liabilities | 3,197,000 | 31,711,000 | 8,577,000 |
Net cash provided by operating activities | 385,616,000 | 387,962,000 | 340,394,000 |
Cash flows from investing activities: | |||
Investments in real estate | (264,340,000) | (185,286,000) | (553,298,000) |
Development of real estate | (63,306,000) | (77,077,000) | (28,066,000) |
Proceeds from the sale of real estate | 87,628,000 | 22,939,000 | 4,880,000 |
Proceeds from the sale of corporate assets | 10,127,000 | 0 | 0 |
Capital expenditures | (97,155,000) | (74,743,000) | (91,544,000) |
Other investment | (6,000,000) | 0 | 0 |
Collection of real estate notes receivable | 15,405,000 | 907,000 | 739,000 |
Advances on real estate notes receivable | (82,214,000) | (6,000,000) | 0 |
Net cash used in investing activities | (399,855,000) | (319,260,000) | (667,289,000) |
Cash flows from financing activities: | |||
Borrowings on unsecured revolving credit facility | 310,000,000 | 1,329,862,000 | 610,000,000 |
Payments on unsecured revolving credit facility | (310,000,000) | (1,429,862,000) | (510,000,000) |
Proceeds from unsecured senior notes | 0 | 793,568,000 | 906,927,000 |
Payments on unsecured senior notes | 0 | (300,000,000) | (700,000,000) |
Payments on secured mortgage loans | 0 | (114,060,000) | (97,361,000) |
Deferred financing costs | (8,053,000) | (6,800,000) | (7,776,000) |
Debt extinguishment costs | 0 | (25,939,000) | (18,383,000) |
Proceeds from issuance of common stock | 251,250,000 | 50,020,000 | 323,393,000 |
Issuance of OP Units | 0 | 1,378,000 | 0 |
Repurchase and cancellation of common stock | (3,414,000) | (5,192,000) | (12,178,000) |
Dividends paid | (281,820,000) | (275,816,000) | (256,117,000) |
Distributions paid to non-controlling interest of limited partners | (5,420,000) | (4,712,000) | (8,758,000) |
Sale of non-controlling interest | 0 | 0 | 1,234,000 |
Net cash (used in) provided by financing activities | (47,457,000) | 12,447,000 | 230,981,000 |
Net change in cash, cash equivalents and restricted cash | (61,696,000) | 81,149,000 | (95,914,000) |
Cash, cash equivalents and restricted cash - beginning of year | 118,765,000 | 37,616,000 | 133,530,000 |
Cash, cash equivalents and restricted cash - end of year | 57,069,000 | 118,765,000 | 37,616,000 |
Healthcare Trust of America Holdings, LP (HTALP) | |||
Cash flows from operating activities: | |||
Net income | 99,784,000 | 53,508,000 | 30,758,000 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 283,300,000 | 283,039,000 | 280,969,000 |
Share-based compensation expense | 7,262,000 | 8,916,000 | 10,127,000 |
Impairment | 22,938,000 | 0 | 0 |
Income from unconsolidated joint venture | (1,604,000) | (1,612,000) | (1,882,000) |
Distributions from unconsolidated joint venture | 3,130,000 | 3,240,000 | 3,030,000 |
(Gain) loss on sale of real estate, net | (39,228,000) | (9,590,000) | 154,000 |
Loss on sale of corporate asset, net | 2,106,000 | 0 | 0 |
Loss on extinguishment of debt, net | 0 | 27,726,000 | 21,646,000 |
Changes in operating assets and liabilities: | |||
Receivables and other assets, net | (4,699,000) | (11,042,000) | (12,857,000) |
Accounts payable and accrued liabilities | 9,430,000 | 2,066,000 | (128,000) |
Prepaid rent and other liabilities | 3,197,000 | 31,711,000 | 8,577,000 |
Net cash provided by operating activities | 385,616,000 | 387,962,000 | 340,394,000 |
Cash flows from investing activities: | |||
Investments in real estate | (264,340,000) | (185,286,000) | (553,298,000) |
Development of real estate | (63,306,000) | (77,077,000) | (28,066,000) |
Proceeds from the sale of real estate | 87,628,000 | 22,939,000 | 4,880,000 |
Proceeds from the sale of corporate assets | 10,127,000 | 0 | 0 |
Capital expenditures | (97,155,000) | (74,743,000) | (91,544,000) |
Other investment | (6,000,000) | 0 | 0 |
Collection of real estate notes receivable | 15,405,000 | 907,000 | 739,000 |
Advances on real estate notes receivable | (82,214,000) | (6,000,000) | 0 |
Net cash used in investing activities | (399,855,000) | (319,260,000) | (667,289,000) |
Cash flows from financing activities: | |||
Borrowings on unsecured revolving credit facility | 310,000,000 | 1,329,862,000 | 610,000,000 |
Payments on unsecured revolving credit facility | (310,000,000) | (1,429,862,000) | (510,000,000) |
Proceeds from unsecured senior notes | 0 | 793,568,000 | 906,927,000 |
Payments on unsecured senior notes | 0 | (300,000,000) | (700,000,000) |
Payments on secured mortgage loans | 0 | (114,060,000) | (97,361,000) |
Deferred financing costs | (8,053,000) | (6,800,000) | (7,776,000) |
Debt extinguishment costs | 0 | (25,939,000) | (18,383,000) |
Proceeds from issuance of general partner OP units | 251,250,000 | 50,020,000 | 323,393,000 |
Issuance of OP Units | 0 | 1,378,000 | 0 |
Repurchase and cancellation of general partner OP units | (3,414,000) | (5,192,000) | (12,178,000) |
Distributions paid to general partner | (281,820,000) | (275,816,000) | (256,117,000) |
Distributions paid to limited partners and redeemable non-controlling interests | (5,420,000) | (4,712,000) | (8,758,000) |
Sale of non-controlling interest | 0 | 0 | 1,234,000 |
Net cash (used in) provided by financing activities | (47,457,000) | 12,447,000 | 230,981,000 |
Net change in cash, cash equivalents and restricted cash | (61,696,000) | 81,149,000 | (95,914,000) |
Cash, cash equivalents and restricted cash - beginning of year | 118,765,000 | 37,616,000 | 133,530,000 |
Cash, cash equivalents and restricted cash - end of year | $ 57,069,000 | $ 118,765,000 | $ 37,616,000 |
Organization and Description of Business |
12 Months Ended |
---|---|
Dec. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Description of Business | Organization and Description of Business HTA, a Maryland corporation, and HTALP, a Delaware limited partnership, were incorporated or formed, as applicable, on April 20, 2006. HTA operates as a REIT and is the general partner of HTALP, which is the operating partnership, in an umbrella partnership, or “UPREIT” structure. HTA has qualified and intends to continue to be taxed as a REIT for federal income tax purposes under the applicable sections of the Internal Revenue Code. We own real estate primarily consisting of MOBs located on or adjacent to hospital campuses or in off-campus, community core outpatient locations across 32 states within the U.S., and we lease space to tenants primarily consisting of health systems, research and academic institutions, and various sized physician practices. We generate substantially all of our revenues from rents and rental-related activities, such as property and facilities management and other incidental revenues related to the operation of real estate. Our primary objective is to maximize stockholder value with growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing, building services and property management oversight; (ii) target accretive acquisitions and developments of MOBs in markets with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage. Additionally, from time to time we consider, on an opportunistic basis, significant portfolio acquisitions that we believe fit our core business and we expect to enhance our existing portfolio. COVID-19 Pandemic On March 11, 2020 the novel coronavirus disease (“COVID-19”) was declared a pandemic by the World Health Organization. As the virus continued to spread throughout the United States and other countries across the world, Federal, state and local governments took various actions including the issuance of “stay-at-home” orders, social distancing guidelines and ordering the temporary closure of non-essential businesses to limit the spread of COVID-19. While many businesses have reopened and vaccinations are becoming more widely available to the general population, the economic uncertainty created by the COVID-19 pandemic continue to present risks to the Company and the future results of our operations. Although we did not experience significant disruptions from the COVID-19 pandemic during the year ended December 31, 2021, should current and planned measures, including further development and delivery of vaccines and other measures intended to reduce or eliminate the spread of COVID-19, past and/or proposed economic stimulus, and other laws, acts and orders proposed or enacted by these various governmental agencies ultimately not be successful or limited in their efficacy, our business and the broader real estate industry may experience significant adverse consequences. These consequences include loss of revenues, increased expenses, increased costs of materials, difficulty in maintaining an active workforce, and constraints on our ability to secure capital or financing, among other factors.
|
Summary of Significant Accounting Policies |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies The summary of significant accounting policies presented below is designed to assist in understanding our consolidated financial statements. Such consolidated financial statements and the accompanying notes are the representations of our management, who are responsible for their integrity and objectivity. These accounting policies conform to GAAP in all material respects and have been consistently applied in preparing our accompanying consolidated financial statements. Basis of Presentation Our accompanying consolidated financial statements include our accounts and those of our subsidiaries and any consolidated VIEs. All inter-company balances and transactions have been eliminated in the accompanying consolidated financial statements. Principles of Consolidation The consolidated financial statements include the accounts of our subsidiaries and consolidated joint venture arrangements. The portions of the HTALP operating partnership not owned by us are presented as non-controlling interests in our consolidated balance sheets and statements of operations, consolidated statements of comprehensive income or loss, consolidated statements of equity, and consolidated statements of changes in partners’ capital. The portions of other joint venture arrangements not owned by us are presented as redeemable non-controlling interests on the accompanying consolidated balance sheets. Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity on the accompanying consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of December 31, 2021, 2020 and 2019, there were approximately 4.1 million, 3.5 million and 3.8 million, respectively, of OP Units issued and outstanding. VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The HTALP operating partnership and our other joint venture arrangements are VIEs because the limited partners in those partnerships, although entitled to vote on certain matters, do not possess kick-out rights or substantive participating rights. Additionally, we determined that we are the primary beneficiary of our VIEs. Accordingly, we consolidate our interests in the HTALP operating partnership and in our other joint venture arrangements. However, because we hold what is deemed a majority voting interest in the HTALP operating partnership and our other joint venture arrangements, it qualifies for the exemption from providing certain disclosure requirements associated with investments in VIEs. We will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above. Use of Estimates The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These estimates are made and evaluated on an ongoing basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in adverse ways, and those estimates could be different under different assumptions or conditions. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents consist of all highly liquid investments with a maturity of three months or less when purchased. Restricted cash is comprised of (i) reserve accounts for property taxes, insurance, capital improvements and tenant improvements; (ii) collateral accounts for debt and interest rate swaps; and (iii) deposits for future investments. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying consolidated balance sheets to the combined amounts shown on the accompanying consolidated statements of cash flows (in thousands):
Revenue Recognition Minimum annual rental revenue is recognized on a straight-line basis over the term of the related lease (including rent holidays). Differences between rental income recognized and amounts contractually due under the lease agreements are recorded as straight-line rent receivables. If we determine that collectability of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period. Tenant reimbursement revenue, which is comprised of additional amounts recoverable from tenants for real estate taxes, common area maintenance and other certain operating expenses are recognized as revenue on a gross basis in the period in which the related recoverable expenses are incurred. We accrue revenue corresponding to these expenses on a quarterly basis to adjust recorded amounts to our best estimate of the final annual amounts to be billed. Subsequent to year-end, on a calendar year basis, we perform reconciliations on a lease-by-lease basis and bill or credit each tenant for any differences between the estimated expenses we billed and the actual expenses that were incurred. We recognize lease termination fees when there is a signed termination letter agreement, all of the conditions of the agreement have been met, and the tenant is no longer occupying the property. Rental income is reported net of amortization of inducements. Effective January 1, 2018, with the adoption of Topic 606 - Revenue from Contracts with Customers and corresponding amendments, the revenue recognition process is now based on a five-step model to account for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. Topic 606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We have identified all of our revenue streams and we have concluded that rental income from leasing arrangements represents a substantial portion of our revenue and, therefore, is specifically excluded from Topic 606 and will be governed under Topic 842 - Leases. The other revenue stream identified as impacting Topic 606 is concentrated in the recognition of real estate sales. Investments in Real Estate The majority of our investments in real estate are accounted for as asset acquisitions and the purchase price of tangible and intangible assets and liabilities are recorded based on their respective fair values. Tangible assets primarily consist of land and buildings and improvements. Additionally, the purchase price includes acquisition related expenses, above or below market leases, above or below market interests, in place leases, tenant relationships, above or below market debt assumed, interest rate swaps assumed and any contingent consideration recorded when the contingency is resolved. The determination of the fair value requires us to make certain estimates and assumptions. With the assistance of independent valuation specialists, we record the purchase price of completed investments in real estate associated with tangible and intangible assets and liabilities based on their fair values. The tangible assets (land and building and improvements) are determined based upon the value of the property as if it were to be replaced or as if it were vacant using discounted cash flow models similar to those used by market participants. Factors considered by us include an estimate of carrying costs during the expected lease-up periods considering current market conditions and costs to execute similar leases. Additionally, the purchase price of the applicable completed acquisition property is inclusive of above or below market leases, above or below market leasehold interests, in place leases, tenant relationships, above or below market debt assumed, interest rate swaps assumed, any contingent consideration and acquisition related expenses. The value of above or below market leases is determined based upon the present value (using a discount rate which reflects the risks associated with the acquired leases) of the difference between (i) the contractual amounts to be received pursuant to the lease over its remaining term and (ii) our estimate of the amounts that would be received using fair market rates over the remaining term of the lease including any bargain renewal periods. Under Topic 840, the amounts associated with above market leases are included in other intangibles, net in our accompanying consolidated balance sheets and amortized to rental income over the remaining lease term. The amounts allocated to below market leases are included in intangible liabilities, net in our accompanying consolidated balance sheets and amortized to rental income over the remaining lease term. Upon adoption of Topic 842 on January 1, 2019, the amounts associated with above market leases are included in right-of-use assets - operating leases, net in our accompanying consolidated balance sheets and amortized to rental income over the remaining lease term. The amounts allocated to below market leases are included in lease liabilities - operating leases in our accompanying consolidated balance sheets and amortized to rental income over the remaining lease term. The value associated with above or below market leasehold interests is determined based upon the present value (using a discount rate which reflects the risks associated with the acquired leases) of the difference between: (i) the contractual amounts to be paid pursuant to the lease over its remaining term; and (ii) our estimate of the amounts that would be paid using fair market rates over the remaining term of the lease including any bargain renewal periods. Under Topic 840, the amounts recorded for above market leasehold interests are included in intangible liabilities, net in our accompanying consolidated balance sheets and amortized to rental expense over the remaining lease term. The amounts allocated to below market leasehold interests are included in other intangibles, net in our accompanying consolidated balance sheets and amortized to rental expense over the remaining lease term. Upon adoption of Topic 842 on January 1, 2019, the amounts recorded for above market leasehold interests are included in lease liabilities - operating leases in our accompanying consolidated balance sheets and amortized to rental expense over the remaining lease term. The amounts allocated to below market leasehold interests are included in right-of-use assets - operating leases, net in our accompanying consolidated balance sheets and amortized to rental expense over the remaining lease term. The total amount of other intangible assets includes in place leases and tenant relationships based on our evaluation of the specific characteristics of each tenant’s lease and our overall relationship with that respective tenant. Characteristics considered by us in allocating these values include the nature and extent of the credit quality and expectations of lease renewals, among other factors. The amounts recorded for in place leases and tenant relationships are included in lease intangibles in our accompanying consolidated balance sheets and will be amortized to amortization expense over the remaining lease term. The value recorded for above or below market debt is determined based upon the present value of the difference between the cash flow stream of the assumed mortgage and the cash flow stream of a market rate mortgage. The amounts recorded for above or below market debt are included in debt in our accompanying consolidated balance sheets and are amortized to interest expense over the remaining term of the assumed debt. The value recorded for interest rate swaps is based upon a discounted cash flow analysis on the expected cash flows, taking into account interest rate curves and the remaining term. See derivative financial instruments below for further discussion. The cost of operating properties includes the cost of land and buildings and related improvements. Expenditures that increase the service life of properties are capitalized and the cost of maintenance and repairs is charged to expense as incurred. The cost of buildings is depreciated on a straight-line basis over the estimated useful lives of the buildings up to 39 years and for tenant improvements, the shorter of the lease term or useful life, typically ranging from to 10 years. Furniture, fixtures and equipment is depreciated over 5 years. Depreciation expense of buildings and improvements for the years ended December 31, 2021, 2020 and 2019, was $246.3 million, $235.8 million and $219.2 million, respectively. Leases As a lessor, we lease space in our MOBs primarily to medical enterprises for terms ranging from to seven years in length. The assets underlying these leases consist of buildings and associated land which are included as real estate investments on our accompanying consolidated balance sheets. All of our leases for which we are the lessor are classified as operating leases under Topic 842. Leases, for which we are the lessee, are classified as separate components on our accompanying consolidated balance sheets. Operating leases are included as right-of-use (“ROU”) assets - operating leases, net, with a corresponding lease liability. Financing lease assets are included in receivables and other assets, net, with a corresponding lease liability in security deposits, prepaid rent and other liabilities. A lease liability is recognized for our obligation related to the lease and an ROU asset represents our right to use the underlying asset over the lease term. Refer to Note 7 - Leases in the accompanying notes to the consolidated financial statements for more detail relating to our leases. Through the duration of the COVID-19 pandemic, changes to our leases as a result of COVID-19 have been in two categories. Leases are categorized based upon the impact of the modification on its cash flows. One category is rent deferrals for which the guidance above was utilized, which provided relief from requiring a lease by lease analysis pursuant to Topic 842. These deferrals are generally for up to three months of rent with a payback period from to twelve months once the deferral period has ended. Deferrals do not have an impact on cash flows over the lease term, rather, payments are made in different periods while the cash flows for the entirety of the lease term are the same. However, we have continued to recognize revenue and straight line revenue for amounts subject to deferral agreements in accordance with Topic 842. In 2020, which is the period that we believe constituted the majority of our COVID-19-related deferral request, we approved deferral plans totaling approximately $11.1 million, of which approximately $10.8 million have been repaid through December 31, 2021. The second category is early renewals, where the Company renewed lease arrangements prior to their contractual expirations, providing concession at the commencement of the lease in exchange for additional term, on average approximately three years. This category is treated as a modification under Topic 842, with the existing balance of cumulative difference between rental income and payment amounts (existing straight line rent receivable) being recast over the new term, factoring in any changes attributable to the new lease arrangement and for which we performed a lease by lease analysis. Cash flows are impacted over the long term as customary free rent, at an average of three months in conjunction with these agreements, and is offset by substantively more term and/or increased rental rates. During the year ended December 31, 2021, the Company has entered into minimal new deferral arrangements or early renewal leases with substantive amounts of free rent or other forms of concession at the onset of the lease. The Lease Modification Q&A had no material impact on our condensed consolidated financial statements as of and for the year ended December 31, 2021, however, its future impact to us is dependent upon the extent of lease concessions granted to tenants as a result of the COVID-19 pandemic in future periods and the elections made by us at the time of entering into any such concessions. Development We capitalize interest, direct and indirect project costs associated with the initial construction up to the time the property is substantially complete and ready for its intended use. In addition, we capitalize costs, including real estate taxes, insurance and utilities, that have been allocated to vacant space based on the square footage of the portion of the building not held available for immediate occupancy during the extended lease-up periods after construction of the building shell has been completed if costs are being incurred to ready the vacant space for its intended use. If costs and activities incurred to ready the vacant space cease, then cost capitalization is also discontinued until such activities are resumed. Once necessary work has been completed on a vacant space, project costs are no longer capitalized. We cease capitalization of all project costs on extended lease-up periods when significant activities have ceased, which does not exceed the shorter of a one-year period after the completion of the building shell or when the property attains 90% occupancy. Real Estate Held for Sale We consider properties held for sale once management commits to a plan to sell the property and has determined that the sale is probable and expected to occur within year. Upon classification as held for sale, we record the property at the lower of its carrying amount or fair value, less costs to sell, and cease depreciation and amortization. The fair value is generally based on discounted cash flow analyses, which involve management’s best estimate of market participants’ holding period, market comparables, future occupancy levels, rental rates, capitalization rates, lease-up periods and capital requirements. As of December 31, 2021, we classified a single-tenant MOB located in the greater Atlanta, Georgia market as real estate held for sale on the accompanying consolidated balance sheets. As of December 31, 2020, the Company had no properties classified as held for sale. The following table represents the major classes of assets and liabilities, and the balance sheet classification as of December 31, 2021 (in thousands):
Recoverability of Real Estate Investments Real estate investments are evaluated for potential impairment whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. Impairment indicators are assessed separately for each property and include, but are not limited to, significant decreases in real estate property net income, significant decreases in occupancy percentage, changes in management’s intent with respect to the properties and prevailing market conditions. Impairment losses are recorded when indicators of impairment are present and the carrying amount of the asset is greater than the sum of future undiscounted cash flows expected to be generated by that asset over the remaining expected holding period. We would recognize an impairment loss when the carrying amount is not recoverable to the extent the carrying amount exceeds the fair value of the property. The fair value is generally based on discounted cash flow analyses. In performing the analyses we consider executed sales agreements or management’s best estimate of market comparables, future occupancy levels, rental rates, capitalization rates, lease-up periods and capital requirements. For the year ended December 31, 2021, we recorded impairment charges of $22.9 million. During each of the years ended December 31, 2019 and 2020, we recorded no impairment charges. Real Estate Notes Receivable Real estate notes receivable consist of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower’s ownership interest in the respective real estate owner and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses. During the year ended December 31, 2021, we originated three mezzanine loans with commitments totaling $60.1 million, at an annual interest rate of 8%, maturing in 2024. Unpaid interest is capitalized, with principal and any unpaid interest due on the maturity date. As of December 31, 2021, mezzanine loans outstanding, including accrued interest totaled $54.8 million, net of unamortized loan fees. Additionally, during the year ended December 31, 2021, we originated a mortgage loan of $15.0 million, at an annual interest rate of 10%, maturing in 2022. Interest on the mortgage loan was prefunded through an interest reserve and will be recognized as interest income through maturity, with principal and any unpaid interest due on the maturity date. As of December 31, 2021, real estate notes receivable, net totaled $69.1 million. During the year ended December 31, 2021, we recognized interest income of $2.8 million related to real estate notes receivable. The following table summarizes real estate notes receivable as of December 31, 2021 (in thousands):
Pursuant to Topic 326 - Financial Instruments - Credit Losses, we adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under Topic 326. We utilize a probability of default method approach for estimating current expected credit losses and have determined that the current risk of credit loss is remote. Accordingly, we have recorded no reserve for credit loss as of December 31, 2021. Unconsolidated Joint Ventures We account for our investments in unconsolidated joint ventures using the equity method of accounting because we have the ability to exercise significant influence, but not control, over the financial and operational policy decisions of the investments. Using the equity method of accounting, the initial investment is recognized at cost and subsequently adjusted for our share of the net income and any distributions from the joint venture. As of December 31, 2021 and 2020, we had a 50% interest in one such investment with a carrying value and maximum exposure to risk of $62.8 million and $64.4 million, respectively, which is recorded in investment in unconsolidated joint venture in the accompanying consolidated balance sheets. We record our share of net income in income from unconsolidated joint venture in the accompanying consolidated statements of operations. For the years ended December 31, 2021, 2020, and 2019, we recognized income from unconsolidated joint venture of $1.6 million, $1.6 million, and $1.9 million, respectively. Derivative Financial Instruments We are exposed to the effect of interest rate changes in the normal course of business. We seek to mitigate these risks by following established risk management policies and procedures which include the occasional use of derivatives. Our primary strategy in entering into derivative contracts is to add stability to interest expense and to manage our exposure to interest rate movements. We utilize derivative instruments, including interest rate swaps, to effectively convert a portion of our variable rate debt to fixed rate debt. We do not enter into derivative instruments for speculative purposes. To qualify for hedge accounting, derivative financial instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with our related assertions. Derivatives are recognized as either assets or liabilities in our accompanying consolidated balance sheets and are measured at fair value. Changes in fair value of derivative financial instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are included as a component of interest expense in our accompanying consolidated statements of operations. As a result of our adoption of ASU 2017-12 as of January 1, 2018, the entire change in the fair value of derivatives designated and qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets and are subsequently reclassified into earnings in the period in which the hedged forecasted transaction affects earnings. Since we solely use derivatives to hedge interest rate risk, amounts paid or received pursuant to our derivative agreements are included in interest expense on the consolidated statements of operations which then flows through to operating activities on the consolidated statements of cash flows. Additionally, as a result of the adoption of ASU 2017-12, we no longer disclose the ineffective portion of the change in fair value of our derivatives financial instruments designated as hedges. The valuation of our derivative financial instruments is determined with the assistance of an independent valuation specialist using a proprietary model that utilizes widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative and observable inputs. The proprietary model reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. We incorporate credit valuation adjustments to appropriately reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees. Fair Value Measurements Fair value is a market-based measurement and is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Depending on the nature of the asset or liability, various techniques and assumptions can be used to estimate the fair value. Financial assets and liabilities are measured using inputs from three levels of the fair value hierarchy, as follows: Level 1 — Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that we have the ability to access at the measurement date. An active market is defined as a market in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 — Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active (markets with few transactions), inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates, yield curves, etc.) and inputs that are derived principally from or corroborated by observable market data correlation or other means (market corroborated inputs). Level 3 — Unobservable inputs, only used to the extent that observable inputs are not available, reflect our assumptions about the pricing of an asset or liability. We use fair value measurements to record fair value of certain assets and to estimate fair value of financial instruments not recorded at fair value but required to be disclosed at fair value. Receivables and Other Assets Deferred financing costs include amounts paid to lenders and others to obtain financing and are amortized to interest expense on a straight-line basis over the term of the unsecured revolving credit facility which approximates the effective interest method. Deferred leasing costs are amounts incurred in executing a lease, both for external broker and marketing costs, plus a portion of internal leasing related costs. Deferred leasing costs are amortized on a straight-line basis method over the term of the applicable lease. Deferred leasing costs are included in operating activities in our accompanying consolidated statements of cash flows. Share-Based Compensation We calculate the fair value of share-based awards on the date of grant. Restricted common stock is valued based on the closing price of our common stock on the NYSE. We amortize the share-based compensation expense over the period that the awards are expected to vest, net of estimated forfeitures. See Note 11 - Stockholders’ Equity and Partners’ Capital for further discussion. Non-controlling Interests HTA’s net income attributable to non-controlling interests in the accompanying consolidated statements of operations relate to non-controlling interest reflected within equity. OP Units, including LTIP awards, are accounted for as partners’ capital in HTALP’s accompanying consolidated balance sheets and as non-controlling interest reflected within equity in HTA’s accompanying consolidated balance sheets. Income Taxes HTA believes that it has qualified to be taxed as a REIT under the provisions of the Code, beginning with the taxable year ending December 31, 2007 and it intends to continue to qualify to be taxed as a REIT. To continue to qualify as a REIT for federal income tax purposes, HTA must meet certain organizational and operational requirements, including a requirement to pay dividend distributions to its stockholders of at least 90% of its annual taxable income. As a REIT, HTA is generally not subject to federal income tax on net income that it distributes to its stockholders, but it may be subject to certain state or local taxes and fees. If HTA fails to qualify as a REIT in any taxable year, it will then be subject to U.S. federal income taxes on our taxable income and will not be permitted to qualify for treatment as a REIT for U.S. federal income tax purposes for four years following the year during which qualification is lost unless the IRS grants it relief under certain statutory provisions. Such an event could have a material adverse effect on its business, financial condition, results of operations and net cash available for dividend distributions to its stockholders. HTA conducts substantially all of its operations through HTALP. As a partnership, HTALP generally is not liable for federal income taxes. The income and loss from the operations of HTALP is included in the tax returns of its partners, including HTA, who are responsible for reporting their allocable share of the partnership income and loss. Accordingly, no provision for income taxes has been made on the accompanying consolidated financial statements. We do not have any liability for uncertain tax positions that we believe should be recognized in our accompanying consolidated financial statements. The tax basis exceeded the carrying amount of the net real estate assets reported in our accompanying consolidated balance sheet by approximately $766.9 million as of December 31, 2021, primarily due to the differences in depreciation and amortization. Concentration of Credit Risk We maintain the majority of our cash and cash equivalents at major financial institutions in the U.S. and deposits with these financial institutions may exceed the amount of insurance provided on such deposits; however, we regularly monitor the financial stability of these financial institutions and believe we are not currently exposed to any significant default risk with respect to these deposits. As of December 31, 2021, we had cash balances at financial institutions of $62.5 million in excess of Federal Deposit Insurance Corporation insured limits. Segment Disclosure We have determined that we have one reportable segment, with activities related to investing in healthcare real estate assets. Our investments in healthcare real estate assets are geographically diversified and our chief operating decision maker evaluates operating performance on an individual asset level. As each of our assets has similar economic characteristics, long-term financial performance, tenants, and products and services, our assets have been aggregated into one reportable segment. Related Party Aircraft Use HTA owns an airplane that is used for business purposes. The Chief Executive Officer of the Company is permitted to use the aircraft for personal travel and, pursuant to a policy adopted by HTA relating to such personal use, the Company is reimbursed by the executive for the incremental costs of using the aircraft for personal travel. Recently Issued or Adopted Accounting Pronouncements Recently Adopted Accounting Pronouncements S-X Rule 13-01 In March 2020, the SEC adopted amendments to Rule 3-10 of Regulation S-X and created Rule 13-01 to simplify disclosure requirements related to certain registered securities. The rule became effective on January 4, 2021, at which time we adopted S-X Rule 13-01. The adoption did not have a material effect on our financial statements and related footnotes. Recently Issued Accounting Pronouncements ASU 2021-01, Reference Rate Reform (Topic 848) In January 2021, the FASB issued ASU 2021-01, which amends the scope of ASU 2020-04. The amendments of ASU 2021-01 clarify that certain optional expedients and exceptions to Topic 848 for contract modification and hedge accounting apply to derivatives that are affected by the discounting transition. For information related to the Company's current cash flow hedges, refer to Note 9 - Derivative Financial Instruments and Hedging Activities. The amendments are elective and effective immediately for contract modifications made through December 31, 2022. The Company is evaluating how the transition away from LIBOR will effect the Company and if the guidance with respect to this standard will be adopted, however, if adopted, we do not expect that this ASU will have a material impact on our financial statements. ASU 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments In July 2021, the FASB issued ASU 2021-05, which amends the lease classification requirements for lessors when classifying and accounting for a lease with variable lease payments that do not depend on a reference index or a rate. The update provides criteria, that if met, the lease would be classified and accounted for as an operating lease. The update is effective for reporting periods beginning after December 15, 2021, with early adoption permitted. At this time, the Company does not expect that the adoption of this standard will have a material impact on our financial statements.
|
Investments in Real Estate |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments in Real Estate | Investments in Real Estate For the year ended December 31, 2021, our investments had an aggregate purchase price of $308.8 million. As part of these investments, we incurred approximately $2.1 million of capitalized costs. The allocations for these investments, in which we own a controlling financial interest, are set forth below in the aggregate for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands):
Subsequent to December 31, 2021, we completed an investment with a purchase price of $19.0 million. The purchase price of this investment was subject to certain post-closing adjustments. Due to the recent timing of the acquisition of this investment, we have not completed our purchase price allocation with respect to this investment and, therefore, cannot provide disclosures at this time similar to those contained above in Note 3 - Investments in Real Estate to our consolidated financial statements. The acquired intangible assets and liabilities referenced above had weighted average lives of the following terms for the years ended December 31, 2021, 2020 and 2019, respectively (in years):
|
Dispositions and Impairment |
12 Months Ended |
---|---|
Dec. 31, 2021 | |
Disposal Group, Not Discontinued Operation, Disposal Disclosures [Abstract] | |
Dispositions and Impairment | Dispositions and Impairment Dispositions During the year ended December 31, 2021, we completed the disposition of fifteen MOBs, located in Tennessee, Virginia, Minnesota and Ohio for an aggregate gross sales price of $88.3 million, representing approximately 599,000 square feet of GLA, in addition to the sale of our interest in a land parcel in Connecticut on which the ground lessee exercised its purchase option for a gross sales price of $1.8 million, resulting in a net gain to us of approximately $39.2 million. During the year ended December 31, 2020, we completed the disposition of one MOB, located in Kansas City for an aggregate gross sales price of $24.3 million, representing approximately 69,000 square feet of GLA, and generating net gains of approximately $7.6 million. Additionally, during the year ended December 31, 2020, we sold part of our interest in undeveloped land in Miami, Florida for a gross sales price of $7.6 million which resulted in a net gain of approximately $2.0 million. During the year ended December 31, 2019, we completed the disposition of four MOBs, located in South Carolina and New Mexico for an aggregate gross sales price of $4.9 million, representing approximately 51,000 square feet of GLA, and generating net losses of $0.2 million. Subsequent to December 31, 2021, we closed a tenant purchase option transaction on a property located in Georgia for a gross sales price of $26.8 million. This property is properly classified as held for sale as of December 31, 2021. For more details, see Note 2 - Summary of Significant Accounting Policies in the “Real Estate Held for Sale” section. ImpairmentDuring the year ended December 31, 2021, we recorded impairment charges of $22.9 million on four properties, one of which was sold as of December 31, 2021. The other three properties are located in Georgia, Texas and New Mexico. During each of the years ended December 31, 2020 and 2019, we recorded no impairment charges. For more details, see Note 2 - Summary of Significant Accounting Policies in the “Recoverability of Real Estate Investments” section.
|
Intangible Assets and Liabilities |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Identified Intangibles, Net [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets and Liabilities | Intangible Assets and Liabilities Intangible assets and liabilities consisted of the following as of December 31, 2021 and 2020, respectively (in thousands, except weighted average remaining amortization terms):
The following is a summary of the net intangible amortization for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands):
As of December 31, 2021, the expected future amortization of intangible assets and liabilities is as follows (in thousands):
|
Receivables and Other Assets |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables and Other Assets [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables and Other Assets | Receivables and Other Assets Receivables and other assets consisted of the following as of December 31, 2021 and 2020, respectively (in thousands):
The following is a summary of the amortization of deferred leasing costs and financing costs for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands):
As of December 31, 2021, the expected future amortization of deferred leasing costs and financing costs is as follows (in thousands):
|
Leases |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases | Leases The majority of our lease expenses are derived from our ground leases and a few corporate leases, which are primarily for office space. We recognize lease expense for these leases on a straight-line basis over the lease term. Many of our leases contain renewal options that can extend the lease term from to ten years, or in certain cases, longer durations. The exercise of lease renewal options is at our sole discretion. Certain of our ground leases have the option to purchase the land at the end of the initial term. Our leases have one of the following payment options: (i) fixed payment throughout the term; (ii) fixed payments with periodic escalations; (iii) variable lease payments based on the Consumer Price Index (“CPI”) or another similar index; and (iv) a combination of the aforementioned. Our leases do not contain any material residual value guarantees or material restrictive covenants other than certain prohibitions as to the nature of business that can be conducted within the buildings which we own in order to limit activities that may be deemed competitive in nature to the ground lessor’s activities. As of December 31, 2021, we have no new ground leases or corporate leases that have not yet commenced. During the year ended December 31, 2021, we assumed five new ground leases as part of building acquisitions made during the year. The new ground leases were analyzed and three were classified as finance leases and two were classified as operating leases. Additionally, during the year ended December 31, 2021, nine of our in-place operating ground leases were removed as a result of property dispositions. For more details on the dispositions, refer to Note 4 - Dispositions and Impairment. Lessee - Lease Term and Discount Rates The following is the weighted average remaining lease term and the weighted average discount rate for our operating and finance leases as of December 31, 2021 (weighted average remaining lease term in years):
Lessee - Maturity of Lease Liabilities We have ground leases and other operating leases with landlords that generally require fixed annual rental payments and may also include escalation clauses and renewal options. These leases generally have terms up to 99 years, excluding extension options. The following table summarizes the future minimum lease obligations of our operating and finance leases as of December 31, 2021 under Topic 842 (in thousands):
Lessor - Lease Revenues and Maturity of Future Minimum Rents We have operating leases with tenants that expire at various dates through 2043 which generally include fixed increases or adjustment based on the consumer price index. Leases also provide for additional rents based on certain operating expenses. For the years ended December 31, 2021, 2020 and 2019, we recognized $761.7 million, $732.5 million and $686.2 million, respectively, of rental and other lease-related income related to our operating leases, of which $175.7 million, $169.1 million and $154.3 million, respectively, were variable lease payments. The following table summarizes the future minimum rent contractually due under operating leases, excluding tenant reimbursements of certain costs, as of December 31, 2021 under Topic 842 (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases | Leases The majority of our lease expenses are derived from our ground leases and a few corporate leases, which are primarily for office space. We recognize lease expense for these leases on a straight-line basis over the lease term. Many of our leases contain renewal options that can extend the lease term from to ten years, or in certain cases, longer durations. The exercise of lease renewal options is at our sole discretion. Certain of our ground leases have the option to purchase the land at the end of the initial term. Our leases have one of the following payment options: (i) fixed payment throughout the term; (ii) fixed payments with periodic escalations; (iii) variable lease payments based on the Consumer Price Index (“CPI”) or another similar index; and (iv) a combination of the aforementioned. Our leases do not contain any material residual value guarantees or material restrictive covenants other than certain prohibitions as to the nature of business that can be conducted within the buildings which we own in order to limit activities that may be deemed competitive in nature to the ground lessor’s activities. As of December 31, 2021, we have no new ground leases or corporate leases that have not yet commenced. During the year ended December 31, 2021, we assumed five new ground leases as part of building acquisitions made during the year. The new ground leases were analyzed and three were classified as finance leases and two were classified as operating leases. Additionally, during the year ended December 31, 2021, nine of our in-place operating ground leases were removed as a result of property dispositions. For more details on the dispositions, refer to Note 4 - Dispositions and Impairment. Lessee - Lease Term and Discount Rates The following is the weighted average remaining lease term and the weighted average discount rate for our operating and finance leases as of December 31, 2021 (weighted average remaining lease term in years):
Lessee - Maturity of Lease Liabilities We have ground leases and other operating leases with landlords that generally require fixed annual rental payments and may also include escalation clauses and renewal options. These leases generally have terms up to 99 years, excluding extension options. The following table summarizes the future minimum lease obligations of our operating and finance leases as of December 31, 2021 under Topic 842 (in thousands):
Lessor - Lease Revenues and Maturity of Future Minimum Rents We have operating leases with tenants that expire at various dates through 2043 which generally include fixed increases or adjustment based on the consumer price index. Leases also provide for additional rents based on certain operating expenses. For the years ended December 31, 2021, 2020 and 2019, we recognized $761.7 million, $732.5 million and $686.2 million, respectively, of rental and other lease-related income related to our operating leases, of which $175.7 million, $169.1 million and $154.3 million, respectively, were variable lease payments. The following table summarizes the future minimum rent contractually due under operating leases, excluding tenant reimbursements of certain costs, as of December 31, 2021 under Topic 842 (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases | Leases The majority of our lease expenses are derived from our ground leases and a few corporate leases, which are primarily for office space. We recognize lease expense for these leases on a straight-line basis over the lease term. Many of our leases contain renewal options that can extend the lease term from to ten years, or in certain cases, longer durations. The exercise of lease renewal options is at our sole discretion. Certain of our ground leases have the option to purchase the land at the end of the initial term. Our leases have one of the following payment options: (i) fixed payment throughout the term; (ii) fixed payments with periodic escalations; (iii) variable lease payments based on the Consumer Price Index (“CPI”) or another similar index; and (iv) a combination of the aforementioned. Our leases do not contain any material residual value guarantees or material restrictive covenants other than certain prohibitions as to the nature of business that can be conducted within the buildings which we own in order to limit activities that may be deemed competitive in nature to the ground lessor’s activities. As of December 31, 2021, we have no new ground leases or corporate leases that have not yet commenced. During the year ended December 31, 2021, we assumed five new ground leases as part of building acquisitions made during the year. The new ground leases were analyzed and three were classified as finance leases and two were classified as operating leases. Additionally, during the year ended December 31, 2021, nine of our in-place operating ground leases were removed as a result of property dispositions. For more details on the dispositions, refer to Note 4 - Dispositions and Impairment. Lessee - Lease Term and Discount Rates The following is the weighted average remaining lease term and the weighted average discount rate for our operating and finance leases as of December 31, 2021 (weighted average remaining lease term in years):
Lessee - Maturity of Lease Liabilities We have ground leases and other operating leases with landlords that generally require fixed annual rental payments and may also include escalation clauses and renewal options. These leases generally have terms up to 99 years, excluding extension options. The following table summarizes the future minimum lease obligations of our operating and finance leases as of December 31, 2021 under Topic 842 (in thousands):
Lessor - Lease Revenues and Maturity of Future Minimum Rents We have operating leases with tenants that expire at various dates through 2043 which generally include fixed increases or adjustment based on the consumer price index. Leases also provide for additional rents based on certain operating expenses. For the years ended December 31, 2021, 2020 and 2019, we recognized $761.7 million, $732.5 million and $686.2 million, respectively, of rental and other lease-related income related to our operating leases, of which $175.7 million, $169.1 million and $154.3 million, respectively, were variable lease payments. The following table summarizes the future minimum rent contractually due under operating leases, excluding tenant reimbursements of certain costs, as of December 31, 2021 under Topic 842 (in thousands):
|
Debt |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt | Debt Debt consisted of the following as of December 31, 2021 and 2020, respectively (in thousands):
Unsecured Credit Agreement Unsecured Revolving Credit Facility due 2025 On October 6, 2021, we entered into a third amended and restated revolving credit and term loan agreement (the “Credit Agreement”), which includes an unsecured revolving credit facility in an aggregate maximum principal amount of $1.0 billion (the “Revolver”) and a term loan facility in an aggregate maximum principal amount of $300.0 million (the “Term Loan”). The Credit Agreement extended the maturities of the unsecured revolving credit facility and the unsecured term loan to October 31, 2025. The maximum principal amount of the Unsecured Credit Agreement may be increased by up to $750.0 million, subject to certain conditions, for a total principal amount of $2.05 billion. Borrowings under the Revolver bears interest at a per annum rate equal to LIBOR plus a margin ranging from 0.725% to 1.40% based on our credit rating. We are also required to pay a facility fee on the aggregate commitments under the Revolver at a per annum rate ranging from 0.125% to 0.30% based on our credit rating. We incurred financing costs of $6.2 million in relation to the credit facility, which are being amortized through the maturity date. As of December 31, 2021, we had no outstanding balance under this unsecured revolving credit facility. The margin associated with our borrowings was 0.85% per annum and the facility fee was 0.20% per annum. Accrued interest under the Credit Agreement is payable quarterly and at maturity. The Credit Agreement includes customary LIBOR replacement terms and contains a sustainability-linked feature, which allows for a reduction in pricing upon our realization of certain sustainability ratings. The other terms of the Credit Agreement prior to the amendment thereof remain substantially unchanged. $300.0 Million Unsecured Term Loan due 2025 Under the Unsecured Credit Agreement as noted above, we have a $300.0 million unsecured term loan, guaranteed by HTA, with a maturity date of October 31, 2025. Borrowings under this unsecured term loan bear interest at a per annum rate equal to LIBOR, plus a margin ranging from 0.80% to 1.60% per annum based on our credit rating. The margin associated with our borrowings as of December 31, 2021 was 0.95% per annum. We incurred financing costs of $1.8 million in relation to the unsecured term loan, which are being amortized through the maturity date. We have interest rate swaps hedging the floating interest rate, which resulted in a fixed rate of 2.37% per annum, based on our current credit rating. The current hedging arrangement matures on February 1, 2023. As of December 31, 2021, we had $300.0 million under this unsecured term loan outstanding. $200.0 Million Unsecured Term Loan due 2024 In 2018, HTALP entered into a modification of our $200.0 million unsecured term loan previously due in 2023. The modification decreased pricing at our current credit rating by 65 basis points and extended the maturity date to January 15, 2024. The other material terms of the unsecured term loan prior to the modification remained substantially unchanged. Borrowings under the unsecured term loan accrue interest at a rate equal to LIBOR, plus a margin ranging from 0.75% to 1.65% per annum based on our credit rating. The margin associated with our borrowings as of December 31, 2021 was 1.00% per annum. HTALP had interest rate swaps on the balance, which resulted in a fixed interest rate at 2.32% per annum. As of December 31, 2021, HTALP had $200.0 million under this unsecured term loan outstanding. $600.0 Million Unsecured Senior Notes due 2026 In September 2019, in connection with the $650.0 million unsecured senior notes due 2030 referenced below, HTALP issued $250.0 million as additional unsecured senior notes to the $350.0 million aggregate principal of senior notes issued on July 12, 2016, all of which are guaranteed by HTA. These unsecured senior notes are registered under the Securities Act, bear interest at 3.50% per annum and are payable semi-annually. Additionally, these unsecured senior notes were offered at 103.66% and 99.72%, respectively, of the principal amount thereof, with an effective yield to maturity of 2.89% and 3.53%, respectively, per annum. As of December 31, 2021, HTALP had $600.0 million of these unsecured senior notes outstanding that mature on August 1, 2026. $500.0 Million Unsecured Senior Notes due 2027 In 2017, HTALP issued $500.0 million of unsecured senior notes that are guaranteed by HTA. These unsecured senior notes are registered under the Securities Act, bear interest at 3.75% per annum and are payable semi-annually. Additionally, these unsecured senior notes were offered at 99.49% of the principal amount thereof, with an effective yield to maturity of 3.81% per annum. As of December 31, 2021, HTALP had $500.0 million of these unsecured senior notes outstanding that mature on July 1, 2027. $650.0 Million Unsecured Senior Notes due 2030 In September 2019, in connection with the $250.0 million additional unsecured senior notes due 2026 referenced above, HTALP issued $650.0 million of unsecured senior notes that are guaranteed by HTA. These unsecured senior notes are registered under the Securities Act, bear interest at 3.10% per annum and are payable semi-annually. Additionally, these unsecured senior notes were offered at 99.66% of the principal amount thereof, with an effective yield to maturity of 3.14% per annum. As of December 31, 2021, HTALP had $650.0 million of these unsecured senior notes outstanding that mature on February 15, 2030. Proceeds from the issuance of $900.0 million of these notes were used, in part, to redeem a total of $700.0 million of unsecured senior notes. During the year ended December 31, 2019, the make-whole fees required per the terms of the indenture agreements upon our calling the notes totaling $18.3 million was recorded in loss on extinguishment of debt in the accompanying consolidated statements of operations. $800.0 Million Unsecured Senior Notes due 2031 In September 2020, HTALP issued $800.0 million of unsecured senior notes that are guaranteed by HTA. These unsecured senior notes are registered under the Securities Act, bear interest at 2.00% per annum and are payable semi-annually. Additionally, these unsecured notes were offered at 99.20% of the principal amount thereof, with an effective yield to maturity of 2.09% per annum. We incurred financing costs of $6.8 million in relation to this transaction, which are being amortized through the maturity date. As of December 31, 2021, HTALP had $800.0 million of these unsecured senior notes outstanding that mature on March 15, 2031. Proceeds from the issuance of these unsecured notes were used, in part, to redeem $300.0 million of unsecured senior notes. During the year ended December 31, 2020, the make-whole fee that was required per the terms of the indenture agreement upon our calling the notes of $24.7 million was recorded in loss on extinguishment of debt in the accompanying consolidated statements of operations. Future Debt Maturities The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of December 31, 2021 (in thousands):
Deferred Financing Costs As of December 31, 2021, the expected future amortization of our deferred financing costs is as follows (in thousands):
Debt Covenants We are required by the terms of our applicable loan agreements to meet various affirmative and negative covenants that we believe are customary for these types of facilities, such as limitations on the incurrence of debt by us and our subsidiaries that own unencumbered assets, limitations on the nature of HTALP’s business, and limitations on distributions by HTALP and its subsidiaries that own unencumbered assets. Our loan agreements also impose various financial covenants on us, such as a maximum ratio of total indebtedness to total asset value, a minimum ratio of EBITDA to fixed charges, a minimum tangible net worth covenant, a maximum ratio of unsecured indebtedness to unencumbered asset value, rent coverage ratios and a minimum ratio of unencumbered NOI to unsecured interest expense. As of December 31, 2021, we believe that we were in compliance with all such financial covenants and reporting requirements. In addition, certain of our loan agreements include events of default provisions that we believe are customary for these types of facilities, including restricting us from making dividend distributions to our stockholders in the event we are in default thereunder, except to the extent necessary for us to maintain our REIT status.
|
Derivative Financial Instruments and Hedging Activities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Financial Instruments and Hedging Activities | Derivative Financial Instruments and Hedging Activities Risk Management Objective of Using Derivative Financial Instruments We may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with our borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with our operating and financial structure as well as to hedge specific anticipated transactions. We do not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, we only enter into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which we and our affiliates may also have other financial relationships. We do not anticipate that any of the counterparties will fail to meet their obligations. We record counterparty credit risk valuation adjustments on interest rate swap derivative assets in order to properly reflect the credit quality of the counterparty. In addition, our fair value of interest rate swap derivative liabilities is adjusted to reflect the impact of our credit quality. Cash Flow Hedges of Interest Rate Risk Our objectives in using interest rate derivatives are to add stability to interest expense and to manage our exposure to interest rate movements. To accomplish this objective, we primarily use interest rate swaps and treasury locks as part of our interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable rate amounts from a counterparty in exchange for us making fixed rate payments over the life of the agreements without exchange of the underlying notional amount. A treasury lock is a synthetic forward sale of a U.S. treasury note, which is settled in cash based upon the difference between an agreed upon treasury rate and the prevailing treasury rate at settlement. Such treasury locks are entered into to effectively fix the treasury component of an upcoming debt issuance. Amounts reported in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets related to derivatives will be reclassified to interest expense as interest payments are made on our variable rate debt. During the next twelve months, we estimate that an additional $4.9 million will be reclassified from other comprehensive income (loss) in the accompanying consolidated balance sheets as an increase to interest related to derivative financial instruments in the accompanying consolidated statements of operations. As of December 31, 2021, we had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk (in thousands, except number of instruments):
The table below presents the fair value of our derivative financial instruments designated as a hedge as well as our classification in the accompanying consolidated balance sheets as of December 31, 2021 and 2020, respectively (in thousands). We had no offsetting derivatives as of December 31, 2021.
The table below presents the gain or loss recognized on our derivative financial instruments designated as hedges as well as our classification in the accompanying consolidated statements of operations for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands).
Non-Designated Hedges Derivatives not designated as hedges are not speculative and are used to manage our exposure to interest rate movements and other identified risks, but do not meet the strict hedge accounting requirements of ASC 815 - Derivatives and Hedging. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly to gain or loss on change in fair value of derivative financial instruments in the accompanying consolidated statements of operations. There were no non-designated hedges as of December 31, 2021, 2020 and 2019, respectively. Credit Risk Related Contingent Features We have agreements with each of our derivative counterparties that contain a provision that if we default on any of our indebtedness, including a default where repayment of the indebtedness has not been accelerated by the lender, then we could also be declared in default on our derivative obligations. We also have agreements with each of our derivative counterparties that incorporate provisions from our indebtedness with a lender affiliate of the derivative counterparty requiring it to maintain certain minimum financial covenant ratios on our indebtedness. Failure to comply with the covenant provisions would result in us being in default on any derivative instrument obligations covered by these agreements. As of December 31, 2021, the fair value of derivatives in a net liability position, including accrued interest, but excluding any adjustment for nonperformance risk related to these agreements, was $5.2 million. As of December 31, 2021, we have not posted any collateral related to these agreements and we were not in breach of any of the provisions of these agreements. If we had breached any of the provisions of these agreements, we could have been required to settle our obligations under these agreements.
|
Commitments and Contingencies |
12 Months Ended |
---|---|
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Litigation We engage in litigation from time to time with various parties as a routine part of our business, including tenant defaults and threatened or asserted labor matters. However, we are not presently subject to any material litigation nor, to our knowledge, is any material litigation threatened against us, which if determined unfavorably to us, would have a material effect on our consolidated financial position, results of operations or cash flows. Environmental Matters We follow the policy of monitoring our properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at our properties, we are not currently aware of any environmental liability with respect to our properties that would have a material effect on our consolidated financial position, results of operations or cash flows. Further, we are not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability at our properties that we believe would require additional disclosure or the recording of a loss contingency. Other Our other commitments and contingencies include the usual obligations of real estate owners and operators in the normal course of business. In our opinion, these matters are not expected to have a material effect on our consolidated financial position, results of operations or cash flows.
|
Stockholders' Equity and Partners' Capital |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity and Partners' Capital | Stockholders’ Equity and Partners’ Capital HTALP’s operating partnership agreement provides that it will distribute cash flow from operations and net sale proceeds to its partners in accordance with their overall ownership interests at such times and in such amounts as the general partner determines. Dividend distributions are made such that a holder of one OP Unit in HTALP will receive distributions from HTALP in an amount equal to the dividend distributions paid to the holder of one share of our common stock. In addition, for each share of common stock issued or redeemed by us, HTALP issues or redeems a corresponding number of OP Units. Common Stock Offerings In March 2021, we entered into equity distribution agreements with various sales agents with respect to our at-the-market ("ATM") offering program of common stock with an aggregate sales amount of up to $750.0 million, which replaced our prior ATM offering program that expired in February 2021. As of December 31, 2021, $750.0 million remained available for issuance by us under our current ATM. During the year ended December 31, 2021, we issued approximately 9.4 million shares of our common stock under our ATM for net proceeds of approximately $251.3 million, adjusted for costs to borrow equating to a net price to us of $26.68 per share of common stock. Refer to Note 13 - Per Share Data of HTA to these consolidated financial statements for a more detailed discussion related to our forward equity agreements. Stock Repurchase Plan In September 2020, our Board of Directors approved a stock repurchase plan authorizing us to purchase up to $300.0 million of our common stock from time to time prior to the expiration thereof on September 22, 2023. As of December 31, 2021, the remaining amount of common stock available for repurchase under the stock repurchase plan was $300.0 million. Common Stock Dividends See our accompanying consolidated statements of equity and changes in partners’ capital for the dividends declared during the years ended December 31, 2021, 2020 and 2019. As of December 31, 2021 and 2020, declared but unpaid dividends totaling $75.7 million and $71.4 million, respectively, were included in accounts payable and accrued liabilities. On February 28, 2022, our Board of Directors announced a quarterly cash dividend of $0.325 per share of common stock and per OP Unit to be paid on April 11, 2022 to stockholders and unitholders of record on April 4, 2022. Incentive Plan Our Incentive Plan permits the grant of incentive awards to our employees, officers, non-employee directors and consultants as selected by our Board of Directors. This Plan authorizes us to grant awards in any of the following forms: options; stock appreciation rights; restricted stock; restricted or deferred stock units; performance awards; dividend equivalents; other stock-based awards, including units in HTALP; and cash-based awards. Subject to adjustment as provided in the Plan, the aggregate number of awards reserved and available for issuance under the Plan is 10,000,000 shares. As of December 31, 2021, there were 9,804,333 awards available for grant under the Plan. Restricted Common Stock The weighted average fair value of restricted common stock granted during the years ended December 31, 2021, 2020 and 2019, were $28.14, $29.83 and $26.08, respectively. The fair value of restricted common stock for which the restriction lapsed during the years ended December 31, 2021, 2020 and 2019 were $8.2 million, $12.6 million and $8.9 million, respectively. We recognized compensation expense, equal to the fair market value of HTA’s stock on the grant date, over the service period which is generally to four years. For the years ended December 31, 2021, 2020 and 2019, we recognized compensation expense of $7.3 million, $8.9 million and $10.1 million respectively. Substantially all compensation expense was recorded in general and administrative expenses in the accompanying consolidated statements of operations. As of December 31, 2021, we had $6.9 million of unrecognized compensation expense, net of estimated forfeitures, which we will recognize over a remaining weighted average period of 1.6 years. The following is a summary of our restricted common stock activity as of December 31, 2021 and 2020, respectively:
|
Fair Value of Financial Instruments |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | Fair Value of Financial Instruments Financial Instruments Reported at Fair Value - Recurring The table below presents the carrying amounts and fair values of our financial instruments on a recurring basis as of December 31, 2021 and 2020 (in thousands):
The carrying amounts of cash and cash equivalents, tenant and other receivables, restricted cash, accounts payable, and accrued liabilities approximate fair value. There have been no transfers of assets or liabilities between levels. We will record any such transfers at the end of the reporting period in which a change of event occurs that results in a transfer. Although we have determined that the majority of the inputs used to value our cash flow hedges fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with these instruments utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. However, we have assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our cash flow hedge positions and have determined that the credit valuation adjustments are not significant to their overall valuation. As a result, we have determined that our cash flow hedge valuations in their entirety are classified in Level 2 of the fair value hierarchy. For further discussion of the assumptions considered, refer to Note 2 - Summary of Significant Accounting Policies. Financial Instruments Reported at Fair Value - Non-Recurring We also have assets that under certain conditions are subject to measurement at fair value on a non-recurring basis. This generally includes assets subject to impairment. We estimate fair value relating to impairment assessments based upon discounted cash flow and direct capitalization models that include all projected cash inflows and outflows over a specific holding period, or the contractual sales price, if applicable. Such projected cash flows are comprised of contractual rental revenues and forecasted rental revenues and expenses based on market conditions and expectations for growth. Capitalization rates and discount rates utilized in these models are based on a reasonable range of current market rates for each property analyzed. Based on these inputs, we determined that our valuation of properties using a discounted cash flow or a direct capitalization model were classified within Level 3 of the fair value hierarchy. For assets for which the estimated fair value was based on contractual sales prices, we determined that our valuation was classified within Level 2 of the fair value hierarchy. As of December 31, 2021, the estimated fair value for one real estate investment within Level 2 of the fair value hierarchy was based on the purchase price set forth in an executed purchase option, less estimated closing costs. The estimated fair value for two real estate investments within Level 3 of the fair value hierarchy was based on income capitalization models utilizing a capitalization rate of 7.00%. The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2021 and 2020 (in thousands):
|
Per Share Data of HTA |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Per Share Data of HTA | Per Share Data of HTA During the year ended December 31, 2021, we issued approximately 9.4 million shares of our common stock under our ATM for net proceeds of approximately $251.3 million, adjusted for costs to borrow equating to a net price to us of $26.68 per share of common stock. To account for the forward equity agreement, we considered the accounting guidance governing financial instruments and derivatives and concluded that our forward equity agreement was not a liability as it did not embody obligations to repurchase our shares of common stock nor did it embody obligations to issue a variable number of shares for which the monetary value was predominately fixed, varying with something other than the fair value of the shares, or varying inversely in relation to our shares. We also evaluated whether the agreement met the derivatives and hedging guidance scope exception to be accounted for as an equity instrument and concluded that the agreement can be classified as an equity contract based on the following assessment: (i) the agreement did not exercise contingencies were based on observable markets or indices besides those related to the market for our own stock price and operations; and (ii) none of the settlement provisions precluded the agreement from being indexed to our own common stock. In addition, we considered the potential dilution resulting from the forward equity agreement(s) on our earnings per common share calculations. We used the treasury method to determine the dilution resulting from the forward equity agreement(s) during the period of time prior to settlement. The number of weighted-average shares outstanding used in the computation of earnings per common share for the year ended December 31, 2021, included the effect from the assumed issuance of 9.4 million shares issued during 2019 and 2020, respectively, pursuant to the settlement(s) of the forward equity agreement(s) at the contractual price(s), less the assumed repurchase of our common stock at the average market price using the proceeds of approximately $251.3 million, adjusted for costs to borrow. For the year ended December 31, 2021, the impact to our weighted-average shares-diluted was approximately 916,000 weighted-average incremental shares. For the year ended December 31, 2020, 819,000 weighted-average incremental shares of our common stock were excluded from the computation of our weighted-average shares - diluted, as the impact was anti-dilutive. We include unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. Our forward equity agreement is not considered a participating security and, therefore, is not included in the computation of earnings per share using the two-class method. For the years ended December 31, 2021, 2020 and 2019, all of our earnings were distributed and the calculated earnings per share amount would be the same for all classes. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands, except per share data):
|
Per Unit Data of HTALP |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Per Unit Data of HTALP | Per Share Data of HTA During the year ended December 31, 2021, we issued approximately 9.4 million shares of our common stock under our ATM for net proceeds of approximately $251.3 million, adjusted for costs to borrow equating to a net price to us of $26.68 per share of common stock. To account for the forward equity agreement, we considered the accounting guidance governing financial instruments and derivatives and concluded that our forward equity agreement was not a liability as it did not embody obligations to repurchase our shares of common stock nor did it embody obligations to issue a variable number of shares for which the monetary value was predominately fixed, varying with something other than the fair value of the shares, or varying inversely in relation to our shares. We also evaluated whether the agreement met the derivatives and hedging guidance scope exception to be accounted for as an equity instrument and concluded that the agreement can be classified as an equity contract based on the following assessment: (i) the agreement did not exercise contingencies were based on observable markets or indices besides those related to the market for our own stock price and operations; and (ii) none of the settlement provisions precluded the agreement from being indexed to our own common stock. In addition, we considered the potential dilution resulting from the forward equity agreement(s) on our earnings per common share calculations. We used the treasury method to determine the dilution resulting from the forward equity agreement(s) during the period of time prior to settlement. The number of weighted-average shares outstanding used in the computation of earnings per common share for the year ended December 31, 2021, included the effect from the assumed issuance of 9.4 million shares issued during 2019 and 2020, respectively, pursuant to the settlement(s) of the forward equity agreement(s) at the contractual price(s), less the assumed repurchase of our common stock at the average market price using the proceeds of approximately $251.3 million, adjusted for costs to borrow. For the year ended December 31, 2021, the impact to our weighted-average shares-diluted was approximately 916,000 weighted-average incremental shares. For the year ended December 31, 2020, 819,000 weighted-average incremental shares of our common stock were excluded from the computation of our weighted-average shares - diluted, as the impact was anti-dilutive. We include unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents as “participating securities” pursuant to the two-class method. The resulting classes are our common stock and restricted stock. Our forward equity agreement is not considered a participating security and, therefore, is not included in the computation of earnings per share using the two-class method. For the years ended December 31, 2021, 2020 and 2019, all of our earnings were distributed and the calculated earnings per share amount would be the same for all classes. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands, except per share data):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Healthcare Trust of America Holdings, LP (HTALP) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Per Unit Data of HTALP | Per Unit Data of HTALP During the year ended December 31, 2021, we issued approximately 9.4 million shares of our common stock under our ATM for net proceeds of approximately $251.3 million, adjusted for costs to borrow equating to a net price to us of $26.68 per share of common stock. Refer to Note 13 - Per Share Data of HTA to our consolidated financial statements for a more detailed discussion related to our forward equity agreements. The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands, except per unit data):
|
Supplemental Cash Flow Information |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplemental Cash Flow Elements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplemental Cash Flow Information | Supplemental Cash Flow InformationThe following is the supplemental cash flow information for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands):
|
Tax Treatment of Dividends of HTA |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tax Treatment of Dividends of HTA | Treatment of Dividends of HTAThe following is the income tax treatment of dividend distributions for the years ended December 31, 2021, 2020 and 2019 (in per share):
|
Selected Quarterly Financial Data of HTA (Unaudited) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarterly Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Quarterly Financial Data of HTA (Unaudited) | Selected Quarterly Financial Data of HTA (Unaudited)The following is the selected quarterly financial data of HTA for 2021 and 2020. We believe that all necessary adjustments, consisting of only normal recurring adjustments, have been included (in thousands, except per share data).
|
Selected Quarterly Financial Data of HTALP (Unaudited) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Quarterly Financial Data [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Quarterly Financial Data of HTALP (Unaudited) | Selected Quarterly Financial Data of HTA (Unaudited)The following is the selected quarterly financial data of HTA for 2021 and 2020. We believe that all necessary adjustments, consisting of only normal recurring adjustments, have been included (in thousands, except per share data).
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Healthcare Trust of America Holdings, LP (HTALP) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Quarterly Financial Data [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Quarterly Financial Data of HTALP (Unaudited) | Selected Quarterly Financial Data of HTALP (Unaudited) The following is the selected quarterly financial data of HTALP for 2021 and 2020. We believe that all necessary adjustments, consisting of only normal recurring adjustments, have been included (in thousands, except per unit data).
|
Schedule III- Real Estate and Accumulated Depreciation |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule III - Real Estate and Accumulated Depreciation | The following schedule presents our total real estate investments and accumulated depreciation for our portfolio as of December 31, 2021 (in thousands):
(a)The cost capitalized subsequent to acquisition is net of dispositions or other write-downs and impairment. (b)The above table excludes lease intangibles; see notes (d) and (g). (c)The changes in total real estate for the years ended December 31, 2021, 2020 and 2019 are as follows (in thousands):
(d)The balances as of December 31, 2021, 2020 and 2019 exclude gross lease intangibles of $404.7 million, $628.6 million and $628.1 million, respectively. (e)The aggregate cost of our real estate for federal income tax purposes was $6.9 billion. (f)The changes in accumulated depreciation for the years ended December 31, 2021, 2020 and 2019 are as follows (in thousands):
(g)The balances as of December 31, 2021, 2020 and 2019 exclude accumulated amortization of lease intangibles of $203.0 million, $400.5 million and $362.8 million, respectively. (h)Tenant improvements are depreciated over the shorter of the lease term or useful life, ranging from to 10 years, respectively. Furniture, fixtures and equipment are depreciated over five years.
|
Schedule IV - Mortgage Loans on Real Estate Assets |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule IV - Mortgage Loans on Real Estate Assets | HEALTHCARE TRUST OF AMERICA, INC. AND HEALTHCARE TRUST OF AMERICA HOLDINGS, LP SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE ASSETS
|
Subsequent Events |
12 Months Ended |
---|---|
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events Merger with Healthcare Realty Trust Incorporated On February 28, 2022, Healthcare Trust of America, Inc. (the “Company”), a Maryland corporation, Healthcare Trust of America Holdings, LP, a Delaware limited partnership (the “Company OP”) of which the Company is the sole general partner, HR Acquisition 2, LLC, a Maryland limited liability company and a direct, wholly owned subsidiary of the Company (“Merger Sub”), and Healthcare Realty Trust Incorporated, a Maryland corporation (“HR”), entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”). Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into HR, with HR surviving the merger (the “Merger”). Prior to the effective time of the Merger (the “Effective Time”), the Company and the Company OP will take all requisite action so that, as of immediately after the Effective Time, the existing amended and restated agreement of limited partnership of the Company OP will be amended and restated to update the redemption provisions therein to account for the Merger Consideration described below. The board of directors of the Company (the “Company Board”) has unanimously approved the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement. The Merger is intended to qualify as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended. Pursuant to the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each outstanding share of Common Stock, $0.01 par value per share, of HR (“HR Common Stock”) will be converted into the right to receive 1.0 (the “Exchange Ratio”) share of Class A Common Stock, $0.01 par value per share, of the Company (“Company Common Stock” and, such consideration, the “Merger Consideration”). Subject to the closing of the Merger and the other transactions contemplated therein, the holders of shares of Company Common Stock issued and outstanding on the last business day prior to the closing date of the Merger will receive a special distribution in the amount of $4.82 in cash per share of Company Common Stock held on such date (the “Special Distribution Payment”). Once the conditions to close the Merger have been satisfied or waived, the Merger Agreement requires HR and the Company to exchange irrevocable certifications that all such closing conditions have been satisfied or waived. At such time, the Company OP will transfer or cause the transfer, on the business day before the Effective Time, to HR or its designees certain of the Company OP’s assets as specified by HR for a cash purchase price equal to the reasonably equivalent fair market value of the assets transferred. To the extent the net proceeds to the Company of the asset transfer or joint venture transactions relating to such assets are insufficient to pay the full amount of the Special Distribution Payment, the Merger Agreement requires the Company to utilize new financing to fund the balance of the Special Distribution Payment. The Company has obtained a commitment letter from JPMorgan Chase Bank, N.A. for a $1.7 billion bridge financing facility. Each option to acquire HR Common Stock that is outstanding immediately prior to the Effective Time will by virtue of the Merger be assumed by the Company with the same terms and conditions of such options immediately prior to the Effective Time, except that each HR stock option will be exercisable (or will become exercisable in accordance with its terms) for the same number of shares of Company Common Stock. Each share of restricted HR common stock and each right of any kind, contingent or accrued, to receive shares of HR Common Stock or benefits measured in whole or in part by the value of a number of shares of HR Common Stock granted by HR outstanding immediately prior to the Effective Time will become an award, on the same terms and conditions as applied to each such HR stock-based award immediately prior to the Effective Time, with respect to the number of shares of Company Common Stock that is equal to the number of shares of HR Common Stock subject to the HR stock-based award immediately prior to the Effective Time multiplied by the Exchange Ratio and rounded down to the nearest full shares. Each share of Company Common Stock subject to forfeiture conditions outstanding immediately prior to the Effective Time will vest in full as of immediately prior to the Effective Time with any Company restricted shares that were granted subject to performance-based vesting conditions treated assuming attainment of the target level of performance. Each such Company restricted share will be entitled to receive $4.82 in cash and any accrued but unpaid dividends with respect to such Company restricted share. Pursuant to the Merger Agreement, the parties have agreed that following the closing of the Merger, the Company Board will consist of 14 members, nine of whom will be the directors of HR immediately prior to the Effective Time and four of whom will be individuals designated by the Company, consisting of W. Bradley Blair II, Vicki U. Booth, Jay P. Leupp and Constance Moore. John Knox Singleton, currently Chairman of the HR board of directors, will be Chairman of the Company Board and W. Bradley Blair, II, currently Chairman of the Company Board, will be appointed Vice Chairman. Each of the Company and HR have made certain customary representations and warranties in the Merger Agreement and have agreed to customary covenants, including covenants that each party conduct its business in the ordinary course of business during the period between execution of the Merger Agreement and the Effective Time and covenants prohibiting each party from engaging in certain kinds of activities during such period without the consent of the other party. The Merger Agreement provides that, during the period from the date of the Merger Agreement until the Effective Time, subject to customary exceptions, the Company and HR will be subject to certain restrictions on (a) soliciting proposals relating to certain alternative transactions, (b) entering into discussions or negotiating or providing non-public information in connection with any proposal for an alternative transaction from a third party, (c) approving or entering into any agreements providing for any such alternative transaction, or (d) agreeing to or proposing publicly to do any of the foregoing. Notwithstanding these “no-shop” restrictions, prior to obtaining the approval of HR stockholders and approval of the Company stockholders, under specified circumstances, the Company Board and the board of directors of HR, respectively, may change their recommendations with respect to the Merger, and the Company and HR may each also terminate the Merger Agreement to accept a superior proposal upon payment of the termination fees described below. In accordance with the Merger Agreement, the Company will prepare and file with the U.S. Securities and Exchange Commission (the “SEC”) a Form S-4 registering shares of Company Common Stock issuable in the Merger, and the parties will prepare a joint proxy statement with respect to the special meeting of the Company’s stockholders to be convened for purposes of approving the issuance of shares of Company Common Shares in the Merger and the special meeting of HR’s stockholders to be convened for purposes of approving the Merger Agreement and the Merger. The joint proxy statement will be included in the Form S-4 and will contain, subject to certain exceptions, the recommendation of the Company Board that the Company’s stockholders vote in favor of the issuance of shares of Company Common Shares in the Merger and the recommendation of the HR board of directors that HR’s stockholders vote in favor of approval of the Merger Agreement and the Merger. The completion of the Merger is subject to customary conditions, including, among others: (i) approval by the Company’s stockholders and approval by HR’s stockholders, (ii) the effectiveness of the Form S-4, (iii) the absence of injunctions, restraints or government restrictions, (iv) approval by the New York Stock Exchange for listing of the shares of Company Common Stock issuable in the Merger, (v) the absence of a material adverse effect on either the Company or HR, (vi) the accuracy of each party’s representations and warranties and performance in all material respects of each party’s covenants and agreements in the Merger Agreement, (vii) the receipt of tax opinions relating to the status as a real estate investment trust (“REIT”) of each company and the tax-free nature of the transaction, and (viii) other customary conditions specified in the Merger Agreement. The Merger Agreement may be terminated under certain circumstances, including by either party (i) if the Merger has not been consummated on or before August 28, 2022, (ii) if a final and non-appealable order is entered, or other action is taken permanently restraining or prohibiting the transaction, (iii) upon a failure of either party to obtain approval of its stockholders, (iv) upon a material, uncured breach by the other party that would cause the closing conditions not to be satisfied, subject to a 30-day cure period, (v) if the other party’s board makes an adverse recommendation change with respect to the transaction, or (vi) prior to obtaining approval of its stockholders, and upon payment of the applicable termination fee, in order to enter into a definitive agreement with a third party with respect to a superior acquisition proposal. If the Merger Agreement is terminated because (i) a party’s board changes its recommendation in favor of the transactions contemplated by the Merger Agreement, (ii) a party terminates the Merger Agreement to enter into a definitive agreement with a third party with respect to a superior acquisition proposal, or (iii) a party consummates or enters into an agreement for an alternative transaction within 12 months following termination under certain circumstances, such party must pay a termination fee to the other party; provided, further, that HR must also pay the Company a termination fee (plus reimburse the Company for its actual transaction expenses up to $5,000,000) if, on the business day immediately prior to the Outside Date, the proceeds of the asset transfer, any immediate asset transfer and the financing available to the Company pursuant to the Commitment Letter or if applicable any alternative financing are insufficient to pay the aggregate Special Distribution and any unpaid cash payment obligations of HR under the Merger Agreement (so long as such termination is not in material breach of the financing, financing cooperation and sale activity provisions of the Merger Agreement). The termination fee payable by HR to the Company in such circumstances is $163 million. The termination fee payable by the Company to HR in such circumstances is $291 million. The actual amount of each termination fee described above is subject to an escrow and adjustment mechanism for REIT compliance purposes to provide for a lesser amount if necessary to be paid to the receiving party without causing such party to fail to meet its REIT requirements for such year. The Merger Agreement also provides that if the Company’s stockholders have approved the transactions contemplated by the Merger Agreement, but the Merger Agreement is terminated by the Company because HR’s stockholders vote against the transactions contemplated by the Merger Agreement, HR must pay the Company a fixed expense reimbursement base amount of $25,000,000, plus reimburse the Company for its actual transaction expenses up to $5,000,000. The Merger Agreement also provides that if HR’s stockholders have approved the transactions contemplated by the Merger Agreement, but the Merger Agreement is terminated by HR because the Company’s stockholders vote against the transactions contemplated by the Merger Agreement, the Company must pay HR a fixed expense reimbursement base amount of $25,000,000, plus reimburse the Company for its actual transaction expenses up to $5,000,000). The Merger Agreement contains customary representations, warranties and covenants by each party. The Merger is subject to certain conditions which are set forth in the Merger Agreement, including the approval of both companies’ stockholders. The boards of directors of the Company and HR have unanimously approved the Merger Agreement. The Merger is expected to close mid-2022.
|
Summary of Significant Accounting Policies (Policies) |
12 Months Ended |
---|---|
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Our accompanying consolidated financial statements include our accounts and those of our subsidiaries and any consolidated VIEs. All inter-company balances and transactions have been eliminated in the accompanying consolidated financial statements |
Principles of Consolidation | The consolidated financial statements include the accounts of our subsidiaries and consolidated joint venture arrangements. The portions of the HTALP operating partnership not owned by us are presented as non-controlling interests in our consolidated balance sheets and statements of operations, consolidated statements of comprehensive income or loss, consolidated statements of equity, and consolidated statements of changes in partners’ capital. The portions of other joint venture arrangements not owned by us are presented as redeemable non-controlling interests on the accompanying consolidated balance sheets. Holders of OP Units are considered to be non-controlling interest holders in HTALP and their ownership interests are reflected as equity on the accompanying consolidated balance sheets. Further, a portion of the earnings and losses of HTALP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of December 31, 2021, 2020 and 2019, there were approximately 4.1 million, 3.5 million and 3.8 million, respectively, of OP Units issued and outstanding. VIEs are entities where investors lack sufficient equity at risk for the entity to finance its activities without additional subordinated financial support or where equity investors, as a group, lack one of the following: (i) the power to direct the activities that most significantly impact the entity’s economic performance; (ii) the obligation to absorb the expected losses of the entity; and (iii) the right to receive the expected returns of the entity. We consolidate our investment in VIEs when we determine that we are the primary beneficiary. A primary beneficiary is one that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The HTALP operating partnership and our other joint venture arrangements are VIEs because the limited partners in those partnerships, although entitled to vote on certain matters, do not possess kick-out rights or substantive participating rights. Additionally, we determined that we are the primary beneficiary of our VIEs. Accordingly, we consolidate our interests in the HTALP operating partnership and in our other joint venture arrangements. However, because we hold what is deemed a majority voting interest in the HTALP operating partnership and our other joint venture arrangements, it qualifies for the exemption from providing certain disclosure requirements associated with investments in VIEs. We will evaluate on an ongoing basis the need to consolidate entities based on the standards set forth in GAAP as described above.
|
Use of Estimates | The preparation of our consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These estimates are made and evaluated on an ongoing basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in adverse ways, and those estimates could be different under different assumptions or conditions. |
Cash, Cash Equivalents and Restricted Cash | Cash and cash equivalents consist of all highly liquid investments with a maturity of three months or less when purchased. Restricted cash is comprised of (i) reserve accounts for property taxes, insurance, capital improvements and tenant improvements; (ii) collateral accounts for debt and interest rate swaps; and (iii) deposits for future investments. |
Revenue Recognition | Minimum annual rental revenue is recognized on a straight-line basis over the term of the related lease (including rent holidays). Differences between rental income recognized and amounts contractually due under the lease agreements are recorded as straight-line rent receivables. If we determine that collectability of future minimum lease payments is not probable, the straight-line rent receivable balance is written off and recognized as a decrease in revenue in that period. Tenant reimbursement revenue, which is comprised of additional amounts recoverable from tenants for real estate taxes, common area maintenance and other certain operating expenses are recognized as revenue on a gross basis in the period in which the related recoverable expenses are incurred. We accrue revenue corresponding to these expenses on a quarterly basis to adjust recorded amounts to our best estimate of the final annual amounts to be billed. Subsequent to year-end, on a calendar year basis, we perform reconciliations on a lease-by-lease basis and bill or credit each tenant for any differences between the estimated expenses we billed and the actual expenses that were incurred. We recognize lease termination fees when there is a signed termination letter agreement, all of the conditions of the agreement have been met, and the tenant is no longer occupying the property. Rental income is reported net of amortization of inducements. Effective January 1, 2018, with the adoption of Topic 606 - Revenue from Contracts with Customers and corresponding amendments, the revenue recognition process is now based on a five-step model to account for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. Topic 606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. We have identified all of our revenue streams and we have concluded that rental income from leasing arrangements represents a substantial portion of our revenue and, therefore, is specifically excluded from Topic 606 and will be governed under Topic 842 - Leases. The other revenue stream identified as impacting Topic 606 is concentrated in the recognition of real estate sales.
|
Investments in Real Estate | The majority of our investments in real estate are accounted for as asset acquisitions and the purchase price of tangible and intangible assets and liabilities are recorded based on their respective fair values. Tangible assets primarily consist of land and buildings and improvements. Additionally, the purchase price includes acquisition related expenses, above or below market leases, above or below market interests, in place leases, tenant relationships, above or below market debt assumed, interest rate swaps assumed and any contingent consideration recorded when the contingency is resolved. The determination of the fair value requires us to make certain estimates and assumptions. With the assistance of independent valuation specialists, we record the purchase price of completed investments in real estate associated with tangible and intangible assets and liabilities based on their fair values. The tangible assets (land and building and improvements) are determined based upon the value of the property as if it were to be replaced or as if it were vacant using discounted cash flow models similar to those used by market participants. Factors considered by us include an estimate of carrying costs during the expected lease-up periods considering current market conditions and costs to execute similar leases. Additionally, the purchase price of the applicable completed acquisition property is inclusive of above or below market leases, above or below market leasehold interests, in place leases, tenant relationships, above or below market debt assumed, interest rate swaps assumed, any contingent consideration and acquisition related expenses. The value of above or below market leases is determined based upon the present value (using a discount rate which reflects the risks associated with the acquired leases) of the difference between (i) the contractual amounts to be received pursuant to the lease over its remaining term and (ii) our estimate of the amounts that would be received using fair market rates over the remaining term of the lease including any bargain renewal periods. Under Topic 840, the amounts associated with above market leases are included in other intangibles, net in our accompanying consolidated balance sheets and amortized to rental income over the remaining lease term. The amounts allocated to below market leases are included in intangible liabilities, net in our accompanying consolidated balance sheets and amortized to rental income over the remaining lease term. Upon adoption of Topic 842 on January 1, 2019, the amounts associated with above market leases are included in right-of-use assets - operating leases, net in our accompanying consolidated balance sheets and amortized to rental income over the remaining lease term. The amounts allocated to below market leases are included in lease liabilities - operating leases in our accompanying consolidated balance sheets and amortized to rental income over the remaining lease term. The value associated with above or below market leasehold interests is determined based upon the present value (using a discount rate which reflects the risks associated with the acquired leases) of the difference between: (i) the contractual amounts to be paid pursuant to the lease over its remaining term; and (ii) our estimate of the amounts that would be paid using fair market rates over the remaining term of the lease including any bargain renewal periods. Under Topic 840, the amounts recorded for above market leasehold interests are included in intangible liabilities, net in our accompanying consolidated balance sheets and amortized to rental expense over the remaining lease term. The amounts allocated to below market leasehold interests are included in other intangibles, net in our accompanying consolidated balance sheets and amortized to rental expense over the remaining lease term. Upon adoption of Topic 842 on January 1, 2019, the amounts recorded for above market leasehold interests are included in lease liabilities - operating leases in our accompanying consolidated balance sheets and amortized to rental expense over the remaining lease term. The amounts allocated to below market leasehold interests are included in right-of-use assets - operating leases, net in our accompanying consolidated balance sheets and amortized to rental expense over the remaining lease term. The total amount of other intangible assets includes in place leases and tenant relationships based on our evaluation of the specific characteristics of each tenant’s lease and our overall relationship with that respective tenant. Characteristics considered by us in allocating these values include the nature and extent of the credit quality and expectations of lease renewals, among other factors. The amounts recorded for in place leases and tenant relationships are included in lease intangibles in our accompanying consolidated balance sheets and will be amortized to amortization expense over the remaining lease term. The value recorded for above or below market debt is determined based upon the present value of the difference between the cash flow stream of the assumed mortgage and the cash flow stream of a market rate mortgage. The amounts recorded for above or below market debt are included in debt in our accompanying consolidated balance sheets and are amortized to interest expense over the remaining term of the assumed debt. The value recorded for interest rate swaps is based upon a discounted cash flow analysis on the expected cash flows, taking into account interest rate curves and the remaining term. See derivative financial instruments below for further discussion.The cost of operating properties includes the cost of land and buildings and related improvements. Expenditures that increase the service life of properties are capitalized and the cost of maintenance and repairs is charged to expense as incurred. The cost of buildings is depreciated on a straight-line basis over the estimated useful lives of the buildings up to 39 years and for tenant improvements, the shorter of the lease term or useful life, typically ranging from to 10 years. Furniture, fixtures and equipment is depreciated over 5 years.
|
Leases | As a lessor, we lease space in our MOBs primarily to medical enterprises for terms ranging from | to seven years in length. The assets underlying these leases consist of buildings and associated land which are included as real estate investments on our accompanying consolidated balance sheets. All of our leases for which we are the lessor are classified as operating leases under Topic 842.
Leases | Leases, for which we are the lessee, are classified as separate components on our accompanying consolidated balance sheets. Operating leases are included as right-of-use (“ROU”) assets - operating leases, net, with a corresponding lease liability. Financing lease assets are included in receivables and other assets, net, with a corresponding lease liability in security deposits, prepaid rent and other liabilities. A lease liability is recognized for our obligation related to the lease and an ROU asset represents our right to use the underlying asset over the lease term. Refer to Note 7 - Leases in the accompanying notes to the consolidated financial statements for more detail relating to our leases. Through the duration of the COVID-19 pandemic, changes to our leases as a result of COVID-19 have been in two categories. Leases are categorized based upon the impact of the modification on its cash flows. One category is rent deferrals for which the guidance above was utilized, which provided relief from requiring a lease by lease analysis pursuant to Topic 842. These deferrals are generally for up to three months of rent with a payback period from to twelve months once the deferral period has ended. Deferrals do not have an impact on cash flows over the lease term, rather, payments are made in different periods while the cash flows for the entirety of the lease term are the same. However, we have continued to recognize revenue and straight line revenue for amounts subject to deferral agreements in accordance with Topic 842. In 2020, which is the period that we believe constituted the majority of our COVID-19-related deferral request, we approved deferral plans totaling approximately $11.1 million, of which approximately $10.8 million have been repaid through December 31, 2021. The second category is early renewals, where the Company renewed lease arrangements prior to their contractual expirations, providing concession at the commencement of the lease in exchange for additional term, on average approximately three years. This category is treated as a modification under Topic 842, with the existing balance of cumulative difference between rental income and payment amounts (existing straight line rent receivable) being recast over the new term, factoring in any changes attributable to the new lease arrangement and for which we performed a lease by lease analysis. Cash flows are impacted over the long term as customary free rent, at an average of three months in conjunction with these agreements, and is offset by substantively more term and/or increased rental rates. During the year ended December 31, 2021, the Company has entered into minimal new deferral arrangements or early renewal leases with substantive amounts of free rent or other forms of concession at the onset of the lease. The Lease Modification Q&A had no material impact on our condensed consolidated financial statements as of and for the year ended December 31, 2021, however, its future impact to us is dependent upon the extent of lease concessions granted to tenants as a result of the COVID-19 pandemic in future periods and the elections made by us at the time of entering into any such concessions.
|
Development and Real Estate Held for Sale | We capitalize interest, direct and indirect project costs associated with the initial construction up to the time the property is substantially complete and ready for its intended use. In addition, we capitalize costs, including real estate taxes, insurance and utilities, that have been allocated to vacant space based on the square footage of the portion of the building not held available for immediate occupancy during the extended lease-up periods after construction of the building shell has been completed if costs are being incurred to ready the vacant space for its intended use. If costs and activities incurred to ready the vacant space cease, then cost capitalization is also discontinued until such activities are resumed. Once necessary work has been completed on a vacant space, project costs are no longer capitalized. We cease capitalization of all project costs on extended lease-up periods when significant activities have ceased, which does not exceed the shorter of a one-year period after the completion of the building shell or when the property attains 90% occupancy.We consider properties held for sale once management commits to a plan to sell the property and has determined that the sale is probable and expected to occur within | year. Upon classification as held for sale, we record the property at the lower of its carrying amount or fair value, less costs to sell, and cease depreciation and amortization. The fair value is generally based on discounted cash flow analyses, which involve management’s best estimate of market participants’ holding period, market comparables, future occupancy levels, rental rates, capitalization rates, lease-up periods and capital requirements.
Recoverability of Real Estate Investments | Real estate investments are evaluated for potential impairment whenever events or changes in circumstances indicate that its carrying amount may not be recoverable. Impairment indicators are assessed separately for each property and include, but are not limited to, significant decreases in real estate property net income, significant decreases in occupancy percentage, changes in management’s intent with respect to the properties and prevailing market conditions. Impairment losses are recorded when indicators of impairment are present and the carrying amount of the asset is greater than the sum of future undiscounted cash flows expected to be generated by that asset over the remaining expected holding period. We would recognize an impairment loss when the carrying amount is not recoverable to the extent the carrying amount exceeds the fair value of the property. The fair value is generally based on discounted cash flow analyses. In performing the analyses we consider executed sales agreements or management’s best estimate of market comparables, future occupancy levels, rental rates, capitalization rates, lease-up periods and capital requirements. |
Unconsolidated Joint Ventures | We account for our investments in unconsolidated joint ventures using the equity method of accounting because we have the ability to exercise significant influence, but not control, over the financial and operational policy decisions of the investments. Using the equity method of accounting, the initial investment is recognized at cost and subsequently adjusted for our share of the net income and any distributions from the joint venture. As of December 31, 2021 and 2020, we had a 50% interest in one such investment with a carrying value and maximum exposure to risk of $62.8 million and $64.4 million, respectively, which is recorded in investment in unconsolidated joint venture in the accompanying consolidated balance sheets. We record our share of net income in income from unconsolidated joint venture in the accompanying consolidated statements of operations. |
Derivative Financial Instruments | We are exposed to the effect of interest rate changes in the normal course of business. We seek to mitigate these risks by following established risk management policies and procedures which include the occasional use of derivatives. Our primary strategy in entering into derivative contracts is to add stability to interest expense and to manage our exposure to interest rate movements. We utilize derivative instruments, including interest rate swaps, to effectively convert a portion of our variable rate debt to fixed rate debt. We do not enter into derivative instruments for speculative purposes. To qualify for hedge accounting, derivative financial instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with our related assertions. Derivatives are recognized as either assets or liabilities in our accompanying consolidated balance sheets and are measured at fair value. Changes in fair value of derivative financial instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are included as a component of interest expense in our accompanying consolidated statements of operations. As a result of our adoption of ASU 2017-12 as of January 1, 2018, the entire change in the fair value of derivatives designated and qualify as cash flow hedges are recorded in accumulated other comprehensive income (loss) in the accompanying consolidated balance sheets and are subsequently reclassified into earnings in the period in which the hedged forecasted transaction affects earnings. Since we solely use derivatives to hedge interest rate risk, amounts paid or received pursuant to our derivative agreements are included in interest expense on the consolidated statements of operations which then flows through to operating activities on the consolidated statements of cash flows. Additionally, as a result of the adoption of ASU 2017-12, we no longer disclose the ineffective portion of the change in fair value of our derivatives financial instruments designated as hedges. The valuation of our derivative financial instruments is determined with the assistance of an independent valuation specialist using a proprietary model that utilizes widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative and observable inputs. The proprietary model reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. We incorporate credit valuation adjustments to appropriately reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of our derivative contracts for the effect of nonperformance risk, we have considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees.
|
Fair Value Measurements | Fair value is a market-based measurement and is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Depending on the nature of the asset or liability, various techniques and assumptions can be used to estimate the fair value. Financial assets and liabilities are measured using inputs from three levels of the fair value hierarchy, as follows: Level 1 — Inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that we have the ability to access at the measurement date. An active market is defined as a market in which transactions for the assets or liabilities occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 — Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active (markets with few transactions), inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates, yield curves, etc.) and inputs that are derived principally from or corroborated by observable market data correlation or other means (market corroborated inputs). Level 3 — Unobservable inputs, only used to the extent that observable inputs are not available, reflect our assumptions about the pricing of an asset or liability. We use fair value measurements to record fair value of certain assets and to estimate fair value of financial instruments not recorded at fair value but required to be disclosed at fair value.
|
Receivables and Other Assets | Deferred financing costs include amounts paid to lenders and others to obtain financing and are amortized to interest expense on a straight-line basis over the term of the unsecured revolving credit facility which approximates the effective interest method. Deferred leasing costs are amounts incurred in executing a lease, both for external broker and marketing costs, plus a portion of internal leasing related costs. Deferred leasing costs are amortized on a straight-line basis method over the term of the applicable lease. Deferred leasing costs are included in operating activities in our accompanying consolidated statements of cash flows. |
Share-Based Compensation | We calculate the fair value of share-based awards on the date of grant. Restricted common stock is valued based on the closing price of our common stock on the NYSE. We amortize the share-based compensation expense over the period that the awards are expected to vest, net of estimated forfeitures. |
Noncontrolling Interests | HTA’s net income attributable to non-controlling interests in the accompanying consolidated statements of operations relate to non-controlling interest reflected within equity. OP Units, including LTIP awards, are accounted for as partners’ capital in HTALP’s accompanying consolidated balance sheets and as non-controlling interest reflected within equity in HTA’s accompanying consolidated balance sheets. |
Income Taxes | HTA believes that it has qualified to be taxed as a REIT under the provisions of the Code, beginning with the taxable year ending December 31, 2007 and it intends to continue to qualify to be taxed as a REIT. To continue to qualify as a REIT for federal income tax purposes, HTA must meet certain organizational and operational requirements, including a requirement to pay dividend distributions to its stockholders of at least 90% of its annual taxable income. As a REIT, HTA is generally not subject to federal income tax on net income that it distributes to its stockholders, but it may be subject to certain state or local taxes and fees. If HTA fails to qualify as a REIT in any taxable year, it will then be subject to U.S. federal income taxes on our taxable income and will not be permitted to qualify for treatment as a REIT for U.S. federal income tax purposes for four years following the year during which qualification is lost unless the IRS grants it relief under certain statutory provisions. Such an event could have a material adverse effect on its business, financial condition, results of operations and net cash available for dividend distributions to its stockholders. HTA conducts substantially all of its operations through HTALP. As a partnership, HTALP generally is not liable for federal income taxes. The income and loss from the operations of HTALP is included in the tax returns of its partners, including HTA, who are responsible for reporting their allocable share of the partnership income and loss. Accordingly, no provision for income taxes has been made on the accompanying consolidated financial statements. We do not have any liability for uncertain tax positions that we believe should be recognized in our accompanying consolidated financial statements.
|
Concentration of Credit Risk | We maintain the majority of our cash and cash equivalents at major financial institutions in the U.S. and deposits with these financial institutions may exceed the amount of insurance provided on such deposits; however, we regularly monitor the financial stability of these financial institutions and believe we are not currently exposed to any significant default risk with respect to these deposits. |
Segment Disclosure | We have determined that we have one reportable segment, with activities related to investing in healthcare real estate assets. Our investments in healthcare real estate assets are geographically diversified and our chief operating decision maker evaluates operating performance on an individual asset level. As each of our assets has similar economic characteristics, long-term financial performance, tenants, and products and services, our assets have been aggregated into one reportable segment. |
Related Party Aircraft Use | HTA owns an airplane that is used for business purposes. The Chief Executive Officer of the Company is permitted to use the aircraft for personal travel and, pursuant to a policy adopted by HTA relating to such personal use, the Company is reimbursed by the executive for the incremental costs of using the aircraft for personal travel. |
Recently Issued or Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements S-X Rule 13-01 In March 2020, the SEC adopted amendments to Rule 3-10 of Regulation S-X and created Rule 13-01 to simplify disclosure requirements related to certain registered securities. The rule became effective on January 4, 2021, at which time we adopted S-X Rule 13-01. The adoption did not have a material effect on our financial statements and related footnotes. Recently Issued Accounting Pronouncements ASU 2021-01, Reference Rate Reform (Topic 848) In January 2021, the FASB issued ASU 2021-01, which amends the scope of ASU 2020-04. The amendments of ASU 2021-01 clarify that certain optional expedients and exceptions to Topic 848 for contract modification and hedge accounting apply to derivatives that are affected by the discounting transition. For information related to the Company's current cash flow hedges, refer to Note 9 - Derivative Financial Instruments and Hedging Activities. The amendments are elective and effective immediately for contract modifications made through December 31, 2022. The Company is evaluating how the transition away from LIBOR will effect the Company and if the guidance with respect to this standard will be adopted, however, if adopted, we do not expect that this ASU will have a material impact on our financial statements. ASU 2021-05, Leases (Topic 842): Lessors - Certain Leases with Variable Lease Payments In July 2021, the FASB issued ASU 2021-05, which amends the lease classification requirements for lessors when classifying and accounting for a lease with variable lease payments that do not depend on a reference index or a rate. The update provides criteria, that if met, the lease would be classified and accounted for as an operating lease. The update is effective for reporting periods beginning after December 15, 2021, with early adoption permitted. At this time, the Company does not expect that the adoption of this standard will have a material impact on our financial statements.
|
Summary of Significant Accounting Policies (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash and Cash Equivalents | The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying consolidated balance sheets to the combined amounts shown on the accompanying consolidated statements of cash flows (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restricted Cash | The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying consolidated balance sheets to the combined amounts shown on the accompanying consolidated statements of cash flows (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Real Estate Held For Sale | The following table represents the major classes of assets and liabilities, and the balance sheet classification as of December 31, 2021 (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Notes Receivable | The following table summarizes real estate notes receivable as of December 31, 2021 (in thousands):
|
Investments in Real Estate (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Purchase Price Allocation | The allocations for these investments, in which we own a controlling financial interest, are set forth below in the aggregate for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Weighted Average Lives of Acquired Intangible Assets and Liabilities | The acquired intangible assets and liabilities referenced above had weighted average lives of the following terms for the years ended December 31, 2021, 2020 and 2019, respectively (in years):
|
Intangible Assets and Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Identified Intangibles, Net [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets and Liabilities | Intangible assets and liabilities consisted of the following as of December 31, 2021 and 2020, respectively (in thousands, except weighted average remaining amortization terms):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Net Intangible Amortization | The following is a summary of the net intangible amortization for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Amortization of Intangible Assets and Liabilities | As of December 31, 2021, the expected future amortization of intangible assets and liabilities is as follows (in thousands):
|
Receivables and Other Assets (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables and Other Assets [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Receivables and Other Assets | Receivables and other assets consisted of the following as of December 31, 2021 and 2020, respectively (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Amortization of Deferred Leasing Costs and Deferred Financing Costs | The following is a summary of the amortization of deferred leasing costs and financing costs for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Amortization of Deferred Leasing and Financing Costs | As of December 31, 2021, the expected future amortization of deferred leasing costs and financing costs is as follows (in thousands):
|
Leases (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lease Costs | The following is the weighted average remaining lease term and the weighted average discount rate for our operating and finance leases as of December 31, 2021 (weighted average remaining lease term in years):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Lease Repayments of Operating Lease Liabilities | The following table summarizes the future minimum lease obligations of our operating and finance leases as of December 31, 2021 under Topic 842 (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Lease Repayments of Finance Lease Liabilities | The following table summarizes the future minimum lease obligations of our operating and finance leases as of December 31, 2021 under Topic 842 (in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Future Minimum Rental Payments for Operating Leases | The following table summarizes the future minimum rent contractually due under operating leases, excluding tenant reimbursements of certain costs, as of December 31, 2021 under Topic 842 (in thousands):
|
Debt (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Debt | Debt consisted of the following as of December 31, 2021 and 2020, respectively (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Debt Maturities and Scheduled Principal Debt Repayments | The following table summarizes the debt maturities and scheduled principal repayments of our indebtedness as of December 31, 2021 (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Amortization of Deferred Financing Costs | As of December 31, 2021, the expected future amortization of our deferred financing costs is as follows (in thousands):
|
Derivative Financial Instruments and Hedging Activities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Interest Rate Derivatives | As of December 31, 2021, we had the following outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk (in thousands, except number of instruments):
The table below presents the fair value of our derivative financial instruments designated as a hedge as well as our classification in the accompanying consolidated balance sheets as of December 31, 2021 and 2020, respectively (in thousands). We had no offsetting derivatives as of December 31, 2021.
The table below presents the gain or loss recognized on our derivative financial instruments designated as hedges as well as our classification in the accompanying consolidated statements of operations for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands).
|
Stockholders' Equity and Partners' Capital (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restricted Common Stock Activity | The following is a summary of our restricted common stock activity as of December 31, 2021 and 2020, respectively:
|
Fair Value of Financial Instruments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The table below presents the carrying amounts and fair values of our financial instruments on a recurring basis as of December 31, 2021 and 2020 (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements, Nonrecurring | The table below presents our assets measured at fair value on a non-recurring basis as of December 31, 2021 and 2020 (in thousands):
|
Per Share Data of HTA (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted | The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands, except per share data):
|
Per Unit Data of HTALP (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Unit, Basic and Diluted | The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per share of HTA for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands, except per share data):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Healthcare Trust of America Holdings, LP (HTALP) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Unit, Basic and Diluted | The following is the reconciliation of the numerator and denominator used in basic and diluted earnings per unit of HTALP for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands, except per unit data):
|
Supplemental Cash Flow Information (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplemental Cash Flow Elements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Supplemental Cash Flow Information | The following is the supplemental cash flow information for the years ended December 31, 2021, 2020 and 2019, respectively (in thousands):
|
Tax Treatment of Dividends of HTA (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Tax Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Tax Treatment of Distributions | The following is the income tax treatment of dividend distributions for the years ended December 31, 2021, 2020 and 2019 (in per share):
|
Selected Quarterly Financial Data of HTA (Unaudited) (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarterly Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarterly Financial Information | The following is the selected quarterly financial data of HTA for 2021 and 2020. We believe that all necessary adjustments, consisting of only normal recurring adjustments, have been included (in thousands, except per share data).
|
Selected Quarterly Financial Data of HTALP (Unaudited) (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Quarterly Financial Data [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarterly Financial Information | The following is the selected quarterly financial data of HTA for 2021 and 2020. We believe that all necessary adjustments, consisting of only normal recurring adjustments, have been included (in thousands, except per share data).
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Healthcare Trust of America Holdings, LP (HTALP) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selected Quarterly Financial Data [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarterly Financial Information | The following is the selected quarterly financial data of HTALP for 2021 and 2020. We believe that all necessary adjustments, consisting of only normal recurring adjustments, have been included (in thousands, except per unit data).
|
Organization and Description of Business (Details) |
Dec. 31, 2021
state
|
---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of states in which the company operates | 32 |
Summary of Significant Accounting Policies - Narrative (Details) |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2021
USD ($)
segment
shares
|
Dec. 31, 2020
USD ($)
property
shares
|
Dec. 31, 2019
USD ($)
shares
|
Dec. 31, 2018
USD ($)
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] | ||||
Cash and cash equivalents | $ 52,353,000 | $ 115,407,000 | ||
Restricted cash | 4,716,000 | 3,358,000 | ||
Total cash, cash equivalents and restricted cash | $ 57,069,000 | 118,765,000 | $ 37,616,000 | $ 133,530,000 |
Leases [Abstract] | ||||
Deferred rent period | 3 months | |||
Amount of rent deferrals | $ 11,100,000 | |||
Amount of repayment of rent deferrals | $ 10,800,000 | |||
Assets Held-for-sale [Abstract] | ||||
Assets held-for-sale, period of sale | 1 year | |||
Real estate investments: | ||||
Impairment | $ 22,938,000 | $ 0 | 0 | |
Investment in unconsolidated joint ventures, ownership percentage | 50.00% | 50.00% | ||
Investment in unconsolidated joint venture | $ 62,834,000 | $ 64,360,000 | ||
Income (loss) from unconsolidated joint venture | 1,604,000 | $ 1,612,000 | 1,882,000 | |
Income Taxes [Abstract] | ||||
Tax basis in excess of carrying amount on real estate assets | 766,900,000 | |||
Concentration of Credit Risk [Abstract] | ||||
Cash balances in excess of FDIC insured limits | $ 62,500,000 | |||
Segment Reporting [Abstract] | ||||
Number of reportable segments | segment | 1 | |||
Disposal Group, Held-for-sale, Not Discontinued Operations | ||||
Assets Held-for-sale [Abstract] | ||||
Number of real estate properties | property | 0 | |||
Maximum | ||||
Leases [Abstract] | ||||
Lessor, term of contract | 7 years | |||
Deferred rent payback period | 3 months | |||
Minimum | ||||
Leases [Abstract] | ||||
Lessor, term of contract | 3 years | |||
Deferred rent payback period | 12 months | |||
Buildings | Maximum | ||||
Property, Plant and Equipment [Abstract] | ||||
Property, plant and equipment, useful life | 39 years | |||
Tenant Improvements | Maximum | ||||
Property, Plant and Equipment [Abstract] | ||||
Life on which building depreciation in income statement is computed | 10 years | |||
Tenant Improvements | Minimum | ||||
Property, Plant and Equipment [Abstract] | ||||
Life on which building depreciation in income statement is computed | 1 year | |||
Furniture, fixtures and equipment | ||||
Property, Plant and Equipment [Abstract] | ||||
Life on which building depreciation in income statement is computed | 5 years | |||
Building and Building Improvements | ||||
Property, Plant and Equipment [Abstract] | ||||
Depreciation expense | $ 246,300,000 | $ 235,800,000 | $ 219,200,000 | |
Healthcare Trust of America Holdings, LP (HTALP) | ||||
Partners' Capital Notes [Abstract] | ||||
Limited partner's capital, units issued (in shares) | shares | 4,142,408 | 3,519,545 | 3,800,000 | |
Limited partner's capital, units outstanding (in shares) | shares | 4,142,408 | 3,519,545 | 3,800,000 | |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] | ||||
Cash and cash equivalents | $ 52,353,000 | $ 115,407,000 | $ 32,713,000 | |
Restricted cash | 4,716,000 | 3,358,000 | 4,903,000 | |
Total cash, cash equivalents and restricted cash | 57,069,000 | 118,765,000 | 37,616,000 | $ 133,530,000 |
Real estate investments: | ||||
Impairment | 22,938,000 | 0 | 0 | |
Investment in unconsolidated joint venture | 62,834,000 | 64,360,000 | ||
Income (loss) from unconsolidated joint venture | $ 1,604,000 | $ 1,612,000 | $ 1,882,000 |
Summary of Significant Accounting Policies - Assets Held For Sale (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Assets held for sale, net | $ 27,070 | $ 0 |
Liabilities of assets held for sale | 262 | $ 0 |
Disposal Group, Held-for-sale, Not Discontinued Operations | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Land | 2,401 | |
Buildings and Improvements | 27,408 | |
Lease intangibles | 4,769 | |
Property, plant and equipment | 34,578 | |
Accumulated depreciation and amortization | (8,148) | |
Real estate assets held for sale, net | 26,430 | |
Receivables and other assets, net | 640 | |
Assets held for sale, net | 27,070 | |
Intangible liabilities, net | 262 | |
Liabilities of assets held for sale | $ 262 |
Summary of Significant Accounting Policies - Notes Receivable, Narrative (Details) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021
USD ($)
lease
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
|
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Number Of Mezzanine Loans Originated | lease | 3 | ||
Maximum Loan Commitment | $ 60,100,000 | ||
Stated Interest Rate | 8.00% | ||
Accrued interest receivable | $ 54,800,000 | ||
Real estate notes receivable, net | 69,114,000 | $ 0 | |
Interest income | 3,150,000 | $ 551,000 | $ 513,000 |
Reserve for credit loss | 0 | ||
Mortgage Loan - Texas | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Maximum Loan Commitment | $ 15,000,000 | ||
Stated Interest Rate | 10.00% | ||
Notes Receivable | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Interest income | $ 2,800,000 |
Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details) - USD ($) |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Stated Interest Rate | 8.00% | |
Maximum Loan Commitment | $ 60,100,000 | |
Accrued interest receivable | 54,800,000 | |
Real estate notes receivable, net | 69,114,000 | $ 0 |
Mezzanine Loans and Mortgage Loan Texas | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Real estate notes receivable, gross | 70,319,000 | |
Accrued interest receivable | 54,000 | |
Unamortized fees and costs | (526,000) | |
Unearned revenue | (733,000) | |
Real estate notes receivable, net | $ 69,114,000 | |
Mezzanine Loans - Texas | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Stated Interest Rate | 8.00% | |
Maximum Loan Commitment | $ 54,119,000 | |
Real estate notes receivable, gross | $ 49,319,000 | |
Mezzanine Loan - North Carolina | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Stated Interest Rate | 8.00% | |
Maximum Loan Commitment | $ 6,000,000 | |
Real estate notes receivable, gross | $ 6,000,000 | |
Mortgage Loan - Texas | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Stated Interest Rate | 10.00% | |
Maximum Loan Commitment | $ 15,000,000 | |
Real estate notes receivable, gross | $ 15,000,000 |
Investments in Real Estate - Acquisitions (Details) - USD ($) $ in Thousands |
2 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Feb. 28, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Investments [Abstract] | ||||
Aggregate purchase price | $ 308,764 | $ 191,718 | $ 560,456 | |
Closing costs | $ 2,100 | |||
Subsequent Event | ||||
Subsequent Event [Line Items] | ||||
Purchase price | $ 19,000 |
Investments in Real Estate - Purchase Price Allocation (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
---|---|---|---|
Asset Acquisition | |||
Land | $ 44,905 | $ 15,242 | $ 108,709 |
Building and improvements | 233,219 | 156,486 | 396,660 |
In place leases | 23,056 | 17,948 | 51,629 |
Below market leases | (4,592) | (1,132) | (5,187) |
Above market leases | 3,283 | 1,215 | 3,487 |
ROU assets | 300 | 1,527 | 0 |
Net assets acquired | 300,171 | 191,286 | 555,298 |
Other, net | 8,593 | 432 | 5,158 |
Aggregate purchase price | $ 308,764 | $ 191,718 | $ 560,456 |
Investments in Real Estate - Weighted Average Lives (Details) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Investments [Abstract] | |||
Acquired intangible assets | 6 years 6 months | 10 years 2 months 12 days | 5 years 8 months 12 days |
Acquired intangible liabilities | 8 years | 7 years 1 month 6 days | 7 years |
Dispositions and Impairment (Details) ft² in Thousands |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2021
USD ($)
ft²
property
building
|
Dec. 31, 2020
USD ($)
ft²
building
|
Dec. 31, 2019
USD ($)
ft²
building
|
Feb. 24, 2022
USD ($)
|
|
Real Estate [Line Items] | ||||
Number of assets disposed | building | 15 | |||
Gain (loss) on sale of real estate, net | $ 39,228,000 | $ 9,590,000 | $ (154,000) | |
Impairment | $ 22,938,000 | $ 0 | $ 0 | |
Number of impaired assets | property | 4 | |||
GEORGIA | Subsequent Event | ||||
Real Estate [Line Items] | ||||
Disposal consideration | $ 26,800,000 | |||
Property Portfolio in Tennessee, Virginia, Minnesota and Ohio | ||||
Real Estate [Line Items] | ||||
Proceeds from the sale of real estate | $ 88,300,000 | |||
Gross leasable area of real estate disposed (in square feet) | ft² | 599 | |||
Gain (loss) on sale of real estate, net | $ 39,200,000 | |||
Medical Office Building In Kansas City | ||||
Real Estate [Line Items] | ||||
Number of assets disposed | building | 1 | |||
Proceeds from the sale of real estate | $ 24,300,000 | |||
Gross leasable area of real estate disposed (in square feet) | ft² | 69 | |||
Gain (loss) on sale of real estate, net | $ 7,600,000 | |||
Land in Miami, FL | ||||
Real Estate [Line Items] | ||||
Proceeds from the sale of real estate | 7,600,000 | |||
Gain (loss) on sale of real estate, net | $ 2,000,000 | |||
Medical Office Building In South Carolina and New Mexico | ||||
Real Estate [Line Items] | ||||
Number of assets disposed | building | 4 | |||
Proceeds from the sale of real estate | $ 4,900,000 | |||
Gross leasable area of real estate disposed (in square feet) | ft² | 51 | |||
Gain (loss) on sale of real estate, net | $ (200,000) | |||
Land in Tennessee, Virginia and Minnesota | ||||
Real Estate [Line Items] | ||||
Proceeds from the sale of real estate | $ 1,800,000 |
Intangible Assets and Liabilities - Summary of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Assets: | ||
Gross | $ 426,251 | $ 666,497 |
Accumulated amortization | (213,801) | (427,937) |
Total | $ 212,450 | $ 238,560 |
Weighted Average Remaining Amortization in Years | 9 years 3 months 18 days | 9 years 7 months 6 days |
Liabilities: | ||
Accumulated amortization | $ (23,742) | $ (29,357) |
Total | $ 31,331 | $ 32,539 |
Weighted Average Remaining Amortization in Years | 14 years 3 months 18 days | 14 years 7 months 6 days |
Below market leases | ||
Liabilities: | ||
Gross | $ 55,073 | $ 61,896 |
Weighted Average Remaining Amortization in Years | 14 years 3 months 18 days | 14 years 7 months 6 days |
In place leases | ||
Assets: | ||
Gross | $ 349,863 | $ 483,779 |
Weighted Average Remaining Amortization in Years | 9 years 3 months 18 days | 9 years 8 months 12 days |
Tenant relationships | ||
Assets: | ||
Gross | $ 54,851 | $ 144,842 |
Weighted Average Remaining Amortization in Years | 10 years 9 months 18 days | 10 years |
Above market leases | ||
Assets: | ||
Gross | $ 21,537 | $ 37,876 |
Weighted Average Remaining Amortization in Years | 6 years 10 months 24 days | 5 years 9 months 18 days |
Intangible Assets and Liabilities - Summary of Intangible Amortization (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Amortization recorded against rental income related to above and (below) market leases | |||
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items] | |||
Amortization of intangible assets and liabilities | $ (2,638) | $ (4,056) | $ (4,422) |
Amortization expense related to in place leases and tenant relationships | |||
Schedule of Finite-Lived Intangible Assets and Liabilities [Line Items] | |||
Amortization of intangible assets and liabilities | $ 45,447 | $ 55,138 | $ 60,363 |
Intangible Assets and Liabilities - Future Amortization of Intangibles (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Assets | ||
2022 | $ 40,676 | |
2023 | 33,161 | |
2024 | 27,345 | |
2025 | 23,136 | |
2026 | 19,437 | |
Thereafter | 68,695 | |
Total | 212,450 | $ 238,560 |
Liabilities | ||
2022 | 5,254 | |
2023 | 4,408 | |
2024 | 3,798 | |
2025 | 3,161 | |
2026 | 2,686 | |
Thereafter | 12,024 | |
Total | $ 31,331 | $ 32,539 |
Receivables and Other Assets - Schedule of Receivables and Other Assets (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Receivables and Other Assets [Abstract] | ||
Tenant receivables, net | $ 10,477 | $ 17,717 |
Other receivables, net | 6,098 | 6,243 |
Deferred financing costs, net | 7,055 | 2,586 |
Deferred leasing costs, net | 45,008 | 43,234 |
Straight-line rent receivables, net | 142,604 | 128,070 |
Prepaid expenses, deposits, equipment and other, net | 38,301 | 46,114 |
Real estate notes receivable, net | 69,114 | 0 |
Finance ROU asset, net | 16,284 | 7,764 |
Total | $ 334,941 | $ 251,728 |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Total | Total |
Receivables and Other Assets - Amortization (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Receivables and Other Assets [Abstract] | |||
Amortization expense related to deferred leasing costs | $ 8,831 | $ 8,755 | $ 7,976 |
Interest expense related to amortization of deferred financing costs | $ 1,753 | $ 1,724 | $ 1,724 |
Receivables and Other Assets - Amortization of Deferred Leasing and Financing Costs (Details) (Details) $ in Thousands |
Dec. 31, 2021
USD ($)
|
---|---|
Receivables and Other Assets [Abstract] | |
2022 | $ 10,287 |
2023 | 9,263 |
2024 | 8,203 |
2025 | 6,939 |
2026 | 4,560 |
Thereafter | 12,811 |
Total | $ 52,063 |
Leases - Narrative (Details) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021
USD ($)
lease
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
|
Lessee, Lease, Description [Line Items] | |||
Number of ground leases commenced | 5 | ||
Number of ground leases commenced classified as finance leases | 9 | ||
Rental and other revenues from operating lease payments | $ | $ 761.7 | $ 732.5 | $ 686.2 |
Variable lease payments | $ | $ 175.7 | $ 169.1 | $ 154.3 |
Finance Lease | |||
Lessee, Lease, Description [Line Items] | |||
Number of ground leases commenced | 3 | ||
Operating Lease | |||
Lessee, Lease, Description [Line Items] | |||
Number of ground leases commenced | 2 | ||
Minimum | |||
Lessee, Lease, Description [Line Items] | |||
Extended lease term | 1 year | ||
Maximum | |||
Lessee, Lease, Description [Line Items] | |||
Extended lease term | 10 years | ||
Term of lease contracts | 99 years |
Leases - Lease Costs (Details) |
Dec. 31, 2021 |
---|---|
Operating leases: | |
Weighted-average remaining lease term | 46 years 6 months |
Weighted-average discount rate | 5.30% |
Finance leases: | |
Weighted-average remaining lease term | 48 years 1 month 6 days |
Weighted-average discount rate | 3.80% |
Leases - Maturity of Lease Liabilities (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Operating leases | ||
2022 | $ 10,568 | |
2023 | 10,758 | |
2024 | 10,370 | |
2025 | 9,857 | |
2026 | 9,869 | |
Thereafter | 599,954 | |
Total | 651,376 | |
Less: Interest | (455,090) | |
Present value of lease liabilities | 196,286 | $ 198,367 |
Finance leases | ||
2022 | 630 | |
2023 | 635 | |
2024 | 640 | |
2025 | 645 | |
2026 | 656 | |
Thereafter | 37,524 | |
Total undiscounted lease payments | 40,730 | |
Less: Interest | (23,826) | |
Present value of lease liabilities | $ 16,904 | |
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Security deposits, prepaid rent and other liabilities | Security deposits, prepaid rent and other liabilities |
Leases - Lease Revenues and Maturity of Future Minimum Rents (Details) $ in Thousands |
Dec. 31, 2021
USD ($)
|
---|---|
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract] | |
2022 | $ 569,363 |
2023 | 524,166 |
2024 | 466,821 |
2025 | 407,880 |
2026 | 360,766 |
Thereafter | 1,322,375 |
Total | $ 3,651,371 |
Debt - Schedule of Debt (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt Instrument | ||
Total debt, gross | $ 3,050,000 | $ 3,050,000 |
Deferred financing costs, net | (17,975) | (19,157) |
Net premium (discount) | (3,903) | (3,844) |
Total | 3,028,122 | 3,026,999 |
Unsecured term loans | ||
Debt Instrument | ||
Total debt, gross | 500,000 | 500,000 |
Unsecured senior notes | ||
Debt Instrument | ||
Total debt, gross | 2,550,000 | 2,550,000 |
Fixed rate mortgages | ||
Debt Instrument | ||
Total debt, gross | 0 | 0 |
Unsecured revolving credit facility | ||
Debt Instrument | ||
Unsecured revolving credit facility | $ 0 | $ 0 |
Debt - Narrative (Details) - USD ($) |
1 Months Ended | 12 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Oct. 06, 2021 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Jul. 12, 2016 |
|
Debt Instrument | |||||||||
Outstanding amount | $ 3,050,000,000 | $ 3,050,000,000 | |||||||
Loss on extinguishment of debt, net | 0 | 27,726,000 | $ 21,646,000 | ||||||
Payments of financing costs | 8,053,000 | 6,800,000 | 7,776,000 | ||||||
Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Loss on extinguishment of debt, net | 0 | 27,726,000 | 21,646,000 | ||||||
Payments of financing costs | 8,053,000 | 6,800,000 | 7,776,000 | ||||||
Unsecured term loans | |||||||||
Debt Instrument | |||||||||
Line of credit facility, borrowing capacity | $ 300,000,000 | ||||||||
Outstanding amount | $ 500,000,000 | 500,000,000 | |||||||
Unsecured term loans | $300.0 Million Unsecured Term Loan due 2022 and 2023 | |||||||||
Debt Instrument | |||||||||
Basis spread on variable rate (as a percent) | 0.95% | ||||||||
Financing costs | $ 1,800,000 | ||||||||
Outstanding amount | $ 300,000,000 | $ 300,000,000.0 | |||||||
Weighted average interest rate with interest rate swap impact | 2.37% | ||||||||
Unsecured term loans | $300.0 Million Unsecured Term Loan due 2022 and 2023 | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Outstanding amount | $ 300,000,000 | ||||||||
Unsecured term loans | $300.0 Million Unsecured Term Loan due 2022 and 2023 | LIBOR | Minimum | |||||||||
Debt Instrument | |||||||||
Basis spread on variable rate (as a percent) | 0.80% | ||||||||
Unsecured term loans | $300.0 Million Unsecured Term Loan due 2022 and 2023 | LIBOR | Maximum | |||||||||
Debt Instrument | |||||||||
Basis spread on variable rate (as a percent) | 1.60% | ||||||||
Unsecured term loans | $200.0 Million Unsecured Term Loan due 2024 | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Basis spread on variable rate (as a percent) | 1.00% | 65.00% | |||||||
Outstanding amount | $ 200,000,000 | ||||||||
Weighted average interest rate with interest rate swap impact | 2.32% | ||||||||
Debt instrument, face amount | $ 200,000,000.0 | $ 200,000,000 | |||||||
Unsecured term loans | $200.0 Million Unsecured Term Loan due 2024 | LIBOR | Minimum | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Basis spread on variable rate (as a percent) | 0.75% | ||||||||
Unsecured term loans | $200.0 Million Unsecured Term Loan due 2024 | LIBOR | Maximum | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Basis spread on variable rate (as a percent) | 1.65% | ||||||||
Unsecured senior notes | |||||||||
Debt Instrument | |||||||||
Outstanding amount | $ 2,550,000,000 | 2,550,000,000 | |||||||
Loss on extinguishment of debt, net | $ 18,300,000 | ||||||||
Extinguishment of debt | 700,000,000 | ||||||||
Unsecured senior notes | $600.0 Million Unsecured Senior Notes due 2026 | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Outstanding amount | 600,000,000 | ||||||||
Debt instrument, face amount | $ 600,000,000.0 | ||||||||
Debt instrument, stated interest rate | 3.50% | ||||||||
Debt instrument, percentage of principal amount received | 103.66% | ||||||||
Debt instrument, effective interest rate | 2.89% | ||||||||
Unsecured senior notes | Unsecured Senior Notes, $650.0 Million | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Outstanding amount | 650,000,000 | ||||||||
Debt instrument, face amount | $ 650,000,000 | ||||||||
Debt instrument, stated interest rate | 3.10% | ||||||||
Debt instrument, percentage of principal amount received | 99.66% | ||||||||
Debt instrument, effective interest rate | 3.14% | ||||||||
Proceeds from issuance of debt | 900,000,000 | ||||||||
Unsecured senior notes | Unsecured Senior Notes $250.0 Million | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Debt instrument, percentage of principal amount received | 99.72% | ||||||||
Debt instrument, effective interest rate | 3.53% | ||||||||
Payments on unsecured senior notes | $ 250,000,000 | ||||||||
Unsecured senior notes | Unsecured Senior Notes $350.0 Million | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Debt instrument, face amount | $ 350,000,000 | ||||||||
Unsecured senior notes | Unsecured Senior Notes $500.0 Million | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Outstanding amount | 500,000,000 | ||||||||
Debt instrument, face amount | $ 500,000,000.0 | ||||||||
Debt instrument, stated interest rate | 3.75% | ||||||||
Debt instrument, percentage of principal amount received | 99.49% | ||||||||
Debt instrument, effective interest rate | 3.81% | ||||||||
Unsecured senior notes | Unsecured Senior Notes, $800.0 Million | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Debt instrument, face amount | 800,000,000.0 | ||||||||
Loss on extinguishment of debt, net | 24,700,000 | ||||||||
Debt instrument, stated interest rate | 2.00% | ||||||||
Debt instrument, percentage of principal amount received | 99.20% | ||||||||
Debt instrument, effective interest rate | 2.09% | ||||||||
Payments on unsecured senior notes | $ 800,000,000 | ||||||||
Payments of financing costs | $ 6,800,000 | ||||||||
Extinguishment of debt | 300,000,000 | ||||||||
Fixed rate mortgages | |||||||||
Debt Instrument | |||||||||
Outstanding amount | 0 | 0 | |||||||
Unsecured revolving credit facility | |||||||||
Debt Instrument | |||||||||
Unsecured revolving credit facility | 0 | $ 0 | |||||||
Unsecured revolving credit facility | Healthcare Trust of America Holdings, LP (HTALP) | |||||||||
Debt Instrument | |||||||||
Maximum borrowing capacity, conditional increase | 750,000,000 | ||||||||
Conditional maximum borrowing capacity | $ 2,050,000,000.00 | ||||||||
Basis spread on variable rate (as a percent) | 0.85% | ||||||||
Line of credit facility, commitment fee (as a percent) | 0.20% | ||||||||
Financing costs | $ 6,200,000 | ||||||||
Unsecured revolving credit facility | $ 0 | ||||||||
Unsecured revolving credit facility | Line of Credit | |||||||||
Debt Instrument | |||||||||
Line of credit facility, borrowing capacity | $ 1,000,000,000 | ||||||||
Unsecured revolving credit facility | Line of Credit | Minimum | |||||||||
Debt Instrument | |||||||||
Line of credit facility, commitment fee (as a percent) | 0.125% | ||||||||
Unsecured revolving credit facility | Line of Credit | Maximum | |||||||||
Debt Instrument | |||||||||
Line of credit facility, commitment fee (as a percent) | 0.30% | ||||||||
Unsecured revolving credit facility | Line of Credit | LIBOR | Minimum | |||||||||
Debt Instrument | |||||||||
Basis spread on variable rate (as a percent) | 0.725% | ||||||||
Unsecured revolving credit facility | Line of Credit | LIBOR | Maximum | |||||||||
Debt Instrument | |||||||||
Basis spread on variable rate (as a percent) | 1.40% |
Debt - Principal Maturity Schedule (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt Disclosure [Abstract] | ||
2022 | $ 0 | |
2023 | 0 | |
2024 | 200,000 | |
2025 | 300,000 | |
2026 | 600,000 | |
Thereafter | 1,950,000 | |
Total | $ 3,050,000 | $ 3,050,000 |
Debt - Amortization of Deferred Financing Costs (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt Disclosure [Abstract] | ||
2022 | $ 3,106 | |
2023 | 3,106 | |
2024 | 2,724 | |
2025 | 2,603 | |
2026 | 1,839 | |
Thereafter | 4,597 | |
Total | $ 17,975 | $ 19,157 |
Derivative Financial Instruments and Hedging Activities - Table of Derivative Financial Instruments (Details) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021
USD ($)
derivative
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
|
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||
Derivatives expected to be reclassified in the next 12 months | $ 4,900,000 | ||
Derivative | |||
Gain on change in fair value of derivative financial instruments, net | $ 0 | $ 0 | $ 0 |
Cash Flow Hedging | Designated as Hedging Instrument | Interest rate swaps | |||
Derivative | |||
Number of instruments | derivative | 7 | ||
Notional amount | $ 500,000,000 |
Derivative Financial Instruments and Hedging Activities - Derivative Instruments Fair Value Table (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Derivatives, Fair Value | |||
Liability Derivatives | $ 5,069 | $ 14,957 | |
Designated as Hedging Instrument | Cash Flow Hedging | Interest rate swaps | |||
Derivatives, Fair Value | |||
(Loss) gain recognized in OCI | 3,393 | (25,773) | $ 5,910 |
(Loss) gain reclassified from accumulated OCI into income | (6,721) | (3,897) | $ 1,594 |
Designated as Hedging Instrument | Cash Flow Hedging | Interest rate swaps | Receivables and other assets | |||
Derivatives, Fair Value | |||
Asset Derivatives | 0 | 0 | |
Designated as Hedging Instrument | Cash Flow Hedging | Interest rate swaps | Derivative financial instruments | |||
Derivatives, Fair Value | |||
Liability Derivatives | $ 5,069 | $ 14,957 |
Derivative Financial Instruments and Hedging Activities - Narrative (Details) - USD ($) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||
Derivatives expected to be reclassified in the next 12 months | $ 4,900,000 | ||
Gain on change in fair value of derivative financial instruments, net | 0 | $ 0 | $ 0 |
Fair value of derivatives in net liability position, including accrued interest, excluding nonperformance risk adjustment | $ 5,200,000 |
Stockholders' Equity and Partners' Capital - Narrative (Details) |
12 Months Ended | |||||
---|---|---|---|---|---|---|
Feb. 28, 2022
$ / shares
|
Dec. 31, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2019
USD ($)
$ / shares
shares
|
Jun. 30, 2021
USD ($)
|
Sep. 30, 2020
USD ($)
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
ATM, authorized amount | $ 300,000,000 | |||||
Remaining amount of common stock available for repurchase | $ 300,000,000 | |||||
Common Stock Dividends | ||||||
Dividend distributions declared, but not paid | $ 75,723,000 | $ 71,423,000 | $ 69,468,000 | |||
Subsequent Event | ||||||
Incentive Plan | ||||||
Common Stock, Dividends, Per Share, Declared | $ / shares | $ 0.325 | |||||
Common Stock | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Amount remaining available for issuance under the ATM | $ 750,000,000 | |||||
Issuance of common stock in HTA (in shares) | shares | 9,419,000 | 1,675,000 | 11,096,000 | |||
Restricted Common Stock | ||||||
Incentive Plan | ||||||
Granted (in dollars per share) | $ / shares | $ 28.14 | $ 29.83 | $ 26.08 | |||
Fair value of restriction lapsed common stock | $ 8,200,000 | $ 12,600,000 | $ 8,900,000 | |||
Nonvested awards, total compensation cost not yet recognized | $ 6,900,000 | |||||
Period for recognition (in years) | 1 year 7 months 6 days | |||||
Restricted Common Stock | General and Administrative Expense | ||||||
Incentive Plan | ||||||
Compensation expense | $ 7,300,000 | $ 8,900,000 | $ 10,100,000 | |||
Restricted Common Stock | Minimum | ||||||
Incentive Plan | ||||||
Award vesting period (in years) | 3 years | |||||
Restricted Common Stock | Maximum | ||||||
Incentive Plan | ||||||
Award vesting period (in years) | 4 years | |||||
ATM Offering Program | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Amount remaining available for issuance under the ATM | $ 750,000,000 | |||||
Issuance of common stock in HTA (in shares) | shares | 9,400,000 | |||||
Stock issued, value, issued on a forward basis | $ 251,300,000 | |||||
Shares issued (in dollars per share) | $ / shares | $ 26.68 | |||||
2006 Incentive Plan | ||||||
Incentive Plan | ||||||
Number of shares authorized (in shares) | shares | 10,000,000 | |||||
Number of shares available for grant (in shares) | shares | 9,804,333 | |||||
Healthcare Trust of America Holdings, LP (HTALP) | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Dividend distribution ratio | 1 | |||||
Healthcare Trust of America Holdings, LP (HTALP) | Subsequent Event | ||||||
Incentive Plan | ||||||
Common Stock, Dividends, Per Share, Declared | $ / shares | $ 0.325 |
Stockholders' Equity and Partners' Capital - Restricted Common Stock Activity (Details) - Restricted Common Stock - $ / shares |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Restricted Common Stock | |||
Balance as of beginning of period (in shares) | 436,399 | 600,987 | |
Granted (in shares) | 552,989 | 273,503 | |
Vested (in shares) | (297,555) | (426,693) | |
Forfeited (in shares) | (161,971) | (11,398) | |
Balance as of end of period (in shares) | 529,862 | 436,399 | 600,987 |
Weighted Average Grant Date Fair Value | |||
Balance as of beginning of period (in dollars per share) | $ 28.27 | $ 28.04 | |
Granted (in dollars per share) | 28.14 | 29.83 | $ 26.08 |
Vested (in dollars per share) | 27.47 | 28.93 | |
Forfeited (in dollars per share) | 27.47 | 28.88 | |
Balance as of end of period (in dollars per share) | $ 28.83 | $ 28.27 | $ 28.04 |
Fair Value of Financial Instruments - Assets and Liabilities at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Liabilities: | ||
Debt | $ 3,028,122 | $ 3,026,999 |
Fair Value, Measurements, Recurring | Carrying Amount | Fair Value, Inputs, Level 2 | ||
Assets: | ||
Real estate notes receivable, net | 69,114 | 0 |
Liabilities: | ||
Derivative financial instrument, liability | 5,069 | 14,957 |
Debt | 3,028,122 | 3,026,999 |
Fair Value, Measurements, Recurring | Fair Value | Fair Value, Inputs, Level 2 | ||
Assets: | ||
Real estate notes receivable, net | 68,476 | 0 |
Liabilities: | ||
Derivative financial instrument, liability | 5,069 | 14,957 |
Debt | $ 3,117,602 | $ 3,258,573 |
Fair Value of Financial Instruments - Assets Measured on Non-Recurring Basis (Details) $ in Thousands |
Dec. 31, 2021
USD ($)
property
|
Dec. 31, 2020
USD ($)
|
---|---|---|
Fair Value, Inputs, Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Number of real estate properties | property | 1 | |
Fair Value, Inputs, Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Number of real estate properties | property | 2 | |
Fair Value, Inputs, Level 3 | Measurement Input, Cap Rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Real estate measurement input | 0.0700 | |
Fair Value, Nonrecurring | Fair Value, Inputs, Level 2 | Fair Value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Real estate investments | $ | $ 26,768 | $ 0 |
Fair Value, Nonrecurring | Fair Value, Inputs, Level 3 | Fair Value | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Real estate investments | $ | $ 4,970 | $ 0 |
Per Share Data of HTA (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|||
Earnings Per Share | |||||
Antidilutive effect of forward equity sales agreement (in shares) | 916 | 819 | |||
Numerator: | |||||
Net income | $ 99,784 | $ 53,508 | $ 30,758 | ||
Net income attributable to non-controlling interests | [1] | (1,768) | (890) | (604) | |
Net income (loss) attributable to common stockholders/unitholders | $ 98,016 | $ 52,618 | $ 30,154 | ||
Denominator: | |||||
Weighted average shares/units outstanding - basic (in shares) | 219,439 | 218,078 | 205,720 | ||
Dilutive shares - OP Unit convertible into common stock (in shares) | 3,860 | 3,588 | 3,885 | ||
Dilutive effect of forward equity sales agreement (in shares) | 916 | 0 | 0 | ||
Adjusted weighted average number of shares/units outstanding — diluted (in shares) | 224,215 | 221,666 | 209,605 | ||
Earnings per common share - basic | |||||
Net income attributable to common stockholders/unitholders (in dollars per share) | $ 0.45 | $ 0.24 | $ 0.15 | ||
Earnings per common share - diluted | |||||
Net income attributable to common stockholders/unitholders (in dollars per share) | $ 0.44 | $ 0.24 | $ 0.14 | ||
ATM Offering Program | |||||
Earnings Per Share | |||||
Issuance of common stock in HTA (in shares) | 9,400 | ||||
Stock issued, value, issued on a forward basis | $ 251,300 | ||||
Shares issued (in dollars per share) | $ 26.68 | ||||
|
Per Unit Data of HTALP (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
Sep. 30, 2020 |
Jun. 30, 2020 |
Mar. 31, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|||
Numerator: | |||||||||||||
Net income | $ 99,784 | $ 53,508 | $ 30,758 | ||||||||||
Net income attributable to non-controlling interests | [1] | (1,768) | (890) | (604) | |||||||||
Net income (loss) attributable to common stockholders/unitholders | $ 98,016 | $ 52,618 | $ 30,154 | ||||||||||
Denominator: | |||||||||||||
Weighted average shares/units outstanding - basic (in shares) | 219,439 | 218,078 | 205,720 | ||||||||||
Dilutive shares - OP Unit convertible into common stock (in shares) | 3,860 | 3,588 | 3,885 | ||||||||||
Dilutive effect of forward equity sales agreement (in shares) | 916 | 0 | 0 | ||||||||||
Adjusted weighted average number of shares/units outstanding — diluted (in shares) | 224,215 | 221,666 | 209,605 | ||||||||||
Earnings per common unit - basic: | |||||||||||||
Net income attributable to common stockholders/unitholders (in dollars per share) | $ 0.45 | $ 0.24 | $ 0.15 | ||||||||||
Earnings per common unit - diluted: | |||||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.44 | $ 0.24 | $ 0.14 | ||||||||||
Healthcare Trust of America Holdings, LP (HTALP) | |||||||||||||
Numerator: | |||||||||||||
Net income | $ 16,610 | $ 22,042 | $ 38,739 | $ 22,393 | $ 28,507 | $ (6,932) | $ 13,725 | $ 18,208 | $ 99,784 | $ 53,508 | $ 30,758 | ||
Net income attributable to non-controlling interests | 0 | 0 | (66) | ||||||||||
Net income (loss) attributable to common stockholders/unitholders | $ 16,610 | $ 22,042 | $ 38,739 | $ 22,393 | $ 28,507 | $ (6,932) | $ 13,725 | $ 18,208 | $ 99,784 | $ 53,508 | $ 30,692 | ||
Denominator: | |||||||||||||
Weighted average shares/units outstanding - basic (in shares) | 223,299 | 221,666 | 209,605 | ||||||||||
Dilutive shares - OP Unit convertible into common stock (in shares) | 0 | 0 | 0 | ||||||||||
Dilutive effect of forward equity sales agreement (in shares) | 916 | 0 | 0 | ||||||||||
Adjusted weighted average number of shares/units outstanding — diluted (in shares) | 224,215 | 221,666 | 209,605 | ||||||||||
Earnings per common unit - basic: | |||||||||||||
Net income attributable to common stockholders/unitholders (in dollars per share) | $ 0.07 | $ 0.10 | $ 0.17 | $ 0.10 | $ 0.13 | $ (0.03) | $ 0.06 | $ 0.08 | $ 0.45 | $ 0.24 | $ 0.15 | ||
Earnings per common unit - diluted: | |||||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | 0.07 | $ 0.10 | $ 0.17 | $ 0.10 | $ 0.13 | $ (0.03) | $ 0.06 | $ 0.08 | $ 0.45 | $ 0.24 | $ 0.15 | ||
ATM Offering Program | |||||||||||||
Subsidiary of Limited Liability Company or Limited Partnership [Line Items] | |||||||||||||
Issuance of common stock (in shares) | 9,400 | ||||||||||||
Stock issued, value, issued on a forward basis | $ 251,300 | ||||||||||||
Shares issued (in dollars per share) | $ 26.68 | $ 26.68 | |||||||||||
|
Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Supplemental Disclosure of Cash Flow Information: | |||
Interest paid, net of capitalized interest | $ 80,367 | $ 83,375 | $ 94,668 |
Cash paid for operating leases | 15,108 | 12,465 | 11,842 |
Supplemental Disclosure of Noncash Investing and Financing Activities: | |||
Accrued capital and development expenditures | 12,696 | 31,807 | 6,381 |
Conversion of notes receivable to investments in real estate | 1,142 | 0 | 0 |
Extinguishment of finance ground lease from land acquisition | 0 | 1,710 | 0 |
Dividend distributions declared, but not paid | 75,723 | 71,423 | 69,468 |
Issuance of OP Units in HTALP | 0 | 0 | 2,603 |
Issuance of OP Units in HTALP in connection with an acquisition | 35,785 | 0 | 2,000 |
Note receivable retired in connection with an acquisition | 0 | 6,000 | 0 |
Redemption of non-controlling interest | 6,354 | 9,019 | 7,527 |
ROU assets obtained in exchange for lease obligations | $ 8,798 | $ 4,373 | $ 200,879 |
Tax Treatment of Dividends of HTA (Details) - $ / shares |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Income Tax Disclosure [Abstract] | |||
Ordinary income | $ 0.7920 | $ 0.6976 | $ 0.6405 |
Return of capital | 0.4930 | 0.5582 | 0.6045 |
Capital gain | 0.0000 | 0.0092 | 0.0000 |
Total | $ 1.2850 | $ 1.2650 | $ 1.2450 |
Selected Quarterly Financial Data of HTA (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
Sep. 30, 2020 |
Jun. 30, 2020 |
Mar. 31, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Selected Quarterly Financial Data [Line Items] | |||||||||||
Revenues | $ 767,073 | $ 738,965 | $ 692,040 | ||||||||
Net income (loss) | 99,784 | 53,508 | 30,758 | ||||||||
Net income (loss) attributable to common stockholders | $ 98,016 | $ 52,618 | $ 30,154 | ||||||||
Earnings per common share - basic | |||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.45 | $ 0.24 | $ 0.15 | ||||||||
Earnings per common share - diluted | |||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.44 | $ 0.24 | $ 0.14 | ||||||||
HTA, Inc. | |||||||||||
Selected Quarterly Financial Data [Line Items] | |||||||||||
Revenues | $ 195,703 | $ 191,262 | $ 188,615 | $ 191,493 | $ 187,018 | $ 187,326 | $ 178,845 | $ 185,776 | |||
Net income (loss) | 16,610 | 22,042 | 38,739 | 22,393 | 28,507 | (6,932) | 13,725 | 18,208 | |||
Net income (loss) attributable to common stockholders | $ 16,303 | $ 21,672 | $ 38,011 | $ 22,030 | $ 28,055 | $ (6,827) | $ 13,489 | $ 17,901 | |||
Earnings per common share - basic | |||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.07 | $ 0.10 | $ 0.17 | $ 0.10 | $ 0.13 | $ (0.03) | $ 0.06 | $ 0.08 | |||
Earnings per common share - diluted | |||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.07 | $ 0.10 | $ 0.17 | $ 0.10 | $ 0.13 | $ (0.03) | $ 0.06 | $ 0.08 |
Selected Quarterly Financial Data of HTALP (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Dec. 31, 2020 |
Sep. 30, 2020 |
Jun. 30, 2020 |
Mar. 31, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Selected Quarterly Financial Data [Line Items] | |||||||||||
Revenues | $ 767,073 | $ 738,965 | $ 692,040 | ||||||||
Net income (loss) | 99,784 | 53,508 | 30,758 | ||||||||
Net income (loss) attributable to common stockholders | $ 98,016 | $ 52,618 | $ 30,154 | ||||||||
Earnings per common share/unit - basic: | |||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.45 | $ 0.24 | $ 0.15 | ||||||||
Earnings per common share/unit - diluted: | |||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.44 | $ 0.24 | $ 0.14 | ||||||||
Healthcare Trust of America Holdings, LP (HTALP) | |||||||||||
Selected Quarterly Financial Data [Line Items] | |||||||||||
Revenues | $ 195,703 | $ 191,262 | $ 188,615 | $ 191,493 | $ 187,018 | $ 187,326 | $ 178,845 | $ 185,776 | $ 767,073 | $ 738,965 | $ 692,040 |
Net income (loss) | 16,610 | 22,042 | 38,739 | 22,393 | 28,507 | (6,932) | 13,725 | 18,208 | 99,784 | 53,508 | 30,758 |
Net income (loss) attributable to common stockholders | $ 16,610 | $ 22,042 | $ 38,739 | $ 22,393 | $ 28,507 | $ (6,932) | $ 13,725 | $ 18,208 | $ 99,784 | $ 53,508 | $ 30,692 |
Earnings per common share/unit - basic: | |||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.07 | $ 0.10 | $ 0.17 | $ 0.10 | $ 0.13 | $ (0.03) | $ 0.06 | $ 0.08 | $ 0.45 | $ 0.24 | $ 0.15 |
Earnings per common share/unit - diluted: | |||||||||||
Net income (loss) attributable to common stockholders/unitholders (in dollars per share) | $ 0.07 | $ 0.10 | $ 0.17 | $ 0.10 | $ 0.13 | $ (0.03) | $ 0.06 | $ 0.08 | $ 0.45 | $ 0.24 | $ 0.15 |
Schedule III- Real Estate and Accumulated Depreciation Schedule III - Real Estate and Accumulated Depreciation - Real Estate Investments and Accumulated Depreciation (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 633,514 | |||
Buildings, Improvements and Fixtures | 6,116,214 | |||
Cost Capitalized Subsequent to Acquisition | 579,168 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 640,382 | |||
Buildings, Improvements and Fixtures | 6,688,516 | |||
Total | 7,328,898 | $ 7,104,085 | $ 6,837,400 | $ 6,269,023 |
Accumulated Depreciation | (1,395,479) | $ (1,302,204) | $ (1,085,048) | $ (882,488) |
Disposal Group, Held-for-sale, Not Discontinued Operations | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 2,401 | |||
Buildings, Improvements and Fixtures | 39,693 | |||
Cost Capitalized Subsequent to Acquisition | (12,285) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,401 | |||
Buildings, Improvements and Fixtures | 27,408 | |||
Total | 29,809 | |||
Accumulated Depreciation | $ (6,263) | |||
Dignity Phoenix MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 20 years | |||
Dignity Phoenix MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 39 years | |||
Dignity Northridge MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 30 years | |||
Dignity Northridge MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 35 years | |||
Dignity Marian MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 17 years | |||
Dignity Marian MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 38 years | |||
Harbin Clinic MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 30 years | |||
Harbin Clinic MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 39 years | |||
Chicago MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 38 years | |||
Chicago MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 39 years | |||
Memorial Hermann MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 25 years | |||
Memorial Hermann MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 39 years | |||
Houston Methodist MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 35 years | |||
Houston Methodist MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 39 years | |||
Longview Regional MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 36 years | |||
Longview Regional MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 39 years | |||
North Cypress MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 35 years | |||
North Cypress MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 39 years | |||
Columbia St. Mary's MOBs | Minimum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 35 years | |||
Columbia St. Mary's MOBs | Maximum | ||||
Gross Amount at Which Carried at Close of Period | ||||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 612,952 | |||
Buildings, Improvements and Fixtures | 6,155,907 | |||
Cost Capitalized Subsequent to Acquisition | 566,865 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 619,820 | |||
Buildings, Improvements and Fixtures | 6,715,906 | |||
Total | 7,335,726 | |||
Accumulated Depreciation | (1,401,742) | |||
Operating Properties | Shelby MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 25,095 | |||
Cost Capitalized Subsequent to Acquisition | 2,686 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 27,781 | |||
Total | 27,781 | |||
Accumulated Depreciation | $ (5,390) | |||
Life on which building depreciation in income statement is computed | 36 years | |||
Operating Properties | Simon Williamson Clinic | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 25,689 | |||
Cost Capitalized Subsequent to Acquisition | (156) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 25,533 | |||
Total | 25,533 | |||
Accumulated Depreciation | $ (4,489) | |||
Life on which building depreciation in income statement is computed | 36 years | |||
Operating Properties | Jasper | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 5,973 | |||
Cost Capitalized Subsequent to Acquisition | 325 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,298 | |||
Total | 6,298 | |||
Accumulated Depreciation | $ (1,563) | |||
Life on which building depreciation in income statement is computed | 25 years | |||
Operating Properties | Phoenix Med Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 453 | |||
Buildings, Improvements and Fixtures | 2,768 | |||
Cost Capitalized Subsequent to Acquisition | 841 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 453 | |||
Buildings, Improvements and Fixtures | 3,609 | |||
Total | 4,062 | |||
Accumulated Depreciation | $ (1,311) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Thunderbird MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,842 | |||
Buildings, Improvements and Fixtures | 19,679 | |||
Cost Capitalized Subsequent to Acquisition | 2,198 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,842 | |||
Buildings, Improvements and Fixtures | 21,877 | |||
Total | 25,719 | |||
Accumulated Depreciation | $ (9,597) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Peoria MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 605 | |||
Buildings, Improvements and Fixtures | 4,394 | |||
Cost Capitalized Subsequent to Acquisition | 2,248 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 605 | |||
Buildings, Improvements and Fixtures | 6,642 | |||
Total | 7,247 | |||
Accumulated Depreciation | $ (2,115) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Baptist MC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 12,637 | |||
Cost Capitalized Subsequent to Acquisition | 3,661 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 16,298 | |||
Total | 16,298 | |||
Accumulated Depreciation | $ (6,113) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Desert Ridge MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 27,738 | |||
Cost Capitalized Subsequent to Acquisition | 2,690 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 30,428 | |||
Total | 30,428 | |||
Accumulated Depreciation | $ (9,779) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Dignity Phoenix MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 66,106 | |||
Cost Capitalized Subsequent to Acquisition | 1,342 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 67,448 | |||
Total | 67,448 | |||
Accumulated Depreciation | (10,483) | |||
Operating Properties | Estrella Med Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 24,703 | |||
Cost Capitalized Subsequent to Acquisition | 2,142 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 26,845 | |||
Total | 26,845 | |||
Accumulated Depreciation | $ (9,240) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Sun City Boswell MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 12,642 | |||
Cost Capitalized Subsequent to Acquisition | 4,464 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 17,106 | |||
Total | 17,106 | |||
Accumulated Depreciation | $ (6,672) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Sun City Boswell West | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,610 | |||
Cost Capitalized Subsequent to Acquisition | 1,913 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 8,523 | |||
Total | 8,523 | |||
Accumulated Depreciation | $ (3,354) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Sun City Webb MP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 16,188 | |||
Cost Capitalized Subsequent to Acquisition | 4,021 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 20,209 | |||
Total | 20,209 | |||
Accumulated Depreciation | $ (7,808) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Sun City West MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 744 | |||
Buildings, Improvements and Fixtures | 13,466 | |||
Cost Capitalized Subsequent to Acquisition | 4,160 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 744 | |||
Buildings, Improvements and Fixtures | 17,626 | |||
Total | 18,370 | |||
Accumulated Depreciation | $ (6,936) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Gateway Med Plaza | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 14,005 | |||
Cost Capitalized Subsequent to Acquisition | 565 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 14,570 | |||
Total | 14,570 | |||
Accumulated Depreciation | $ (4,629) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Tucson Academy MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,193 | |||
Buildings, Improvements and Fixtures | 6,107 | |||
Cost Capitalized Subsequent to Acquisition | 1,396 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,193 | |||
Buildings, Improvements and Fixtures | 7,503 | |||
Total | 8,696 | |||
Accumulated Depreciation | $ (3,071) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Tucson Desert Life MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,309 | |||
Buildings, Improvements and Fixtures | 17,572 | |||
Cost Capitalized Subsequent to Acquisition | 6,466 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,309 | |||
Buildings, Improvements and Fixtures | 24,038 | |||
Total | 25,347 | |||
Accumulated Depreciation | $ (10,468) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Bakersfield Medical Office Building | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 0 | |||
Cost Capitalized Subsequent to Acquisition | 28,695 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 28,695 | |||
Total | 28,695 | |||
Accumulated Depreciation | $ (293) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Dignity Mercy MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 15,207 | |||
Cost Capitalized Subsequent to Acquisition | (240) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 14,967 | |||
Total | 14,967 | |||
Accumulated Depreciation | $ (2,144) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | 5995 Plaza Drive | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 5,109 | |||
Buildings, Improvements and Fixtures | 17,961 | |||
Cost Capitalized Subsequent to Acquisition | 2,703 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 5,109 | |||
Buildings, Improvements and Fixtures | 20,664 | |||
Total | 25,773 | |||
Accumulated Depreciation | $ (7,860) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Dignity Glendale MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 7,244 | |||
Cost Capitalized Subsequent to Acquisition | 257 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 7,501 | |||
Total | 7,501 | |||
Accumulated Depreciation | $ (1,530) | |||
Life on which building depreciation in income statement is computed | 30 years | |||
Operating Properties | 3rd Street MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 10,603 | |||
Buildings, Improvements and Fixtures | 63,419 | |||
Cost Capitalized Subsequent to Acquisition | 2,070 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 10,603 | |||
Buildings, Improvements and Fixtures | 65,489 | |||
Total | 76,092 | |||
Accumulated Depreciation | $ (5,750) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Mission Medical Center MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 21,911 | |||
Buildings, Improvements and Fixtures | 117,672 | |||
Cost Capitalized Subsequent to Acquisition | 7,416 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 21,911 | |||
Buildings, Improvements and Fixtures | 125,088 | |||
Total | 146,999 | |||
Accumulated Depreciation | $ (18,184) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Dignity Northridge MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 21,467 | |||
Cost Capitalized Subsequent to Acquisition | 1,250 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 22,717 | |||
Total | 22,717 | |||
Accumulated Depreciation | (3,657) | |||
Operating Properties | San Luis Obispo MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 11,900 | |||
Cost Capitalized Subsequent to Acquisition | 985 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 12,885 | |||
Total | 12,885 | |||
Accumulated Depreciation | $ (4,169) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Facey MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 6,452 | |||
Buildings, Improvements and Fixtures | 5,586 | |||
Cost Capitalized Subsequent to Acquisition | 19,641 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 6,452 | |||
Buildings, Improvements and Fixtures | 25,227 | |||
Total | 31,679 | |||
Accumulated Depreciation | $ (3,447) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Dignity Marian MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 13,646 | |||
Cost Capitalized Subsequent to Acquisition | 726 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 14,372 | |||
Total | 14,372 | |||
Accumulated Depreciation | (2,940) | |||
Operating Properties | Premier Health Plaza | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 1,672 | |||
Buildings, Improvements and Fixtures | 10,954 | |||
Cost Capitalized Subsequent to Acquisition | 113 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,668 | |||
Buildings, Improvements and Fixtures | 11,071 | |||
Total | 12,739 | |||
Accumulated Depreciation | $ (307) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Rampart MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,794 | |||
Buildings, Improvements and Fixtures | 13,077 | |||
Cost Capitalized Subsequent to Acquisition | 434 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,794 | |||
Buildings, Improvements and Fixtures | 13,511 | |||
Total | 17,305 | |||
Accumulated Depreciation | $ (1,017) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | SCL Health MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 11,652 | |||
Buildings, Improvements and Fixtures | 104,327 | |||
Cost Capitalized Subsequent to Acquisition | 10,372 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 11,652 | |||
Buildings, Improvements and Fixtures | 114,699 | |||
Total | 126,351 | |||
Accumulated Depreciation | $ (14,592) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Hampden Place MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,032 | |||
Buildings, Improvements and Fixtures | 12,553 | |||
Cost Capitalized Subsequent to Acquisition | 475 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,032 | |||
Buildings, Improvements and Fixtures | 13,028 | |||
Total | 16,060 | |||
Accumulated Depreciation | $ (4,095) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Highlands Ranch MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,240 | |||
Buildings, Improvements and Fixtures | 10,426 | |||
Cost Capitalized Subsequent to Acquisition | 8,385 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,240 | |||
Buildings, Improvements and Fixtures | 18,811 | |||
Total | 21,051 | |||
Accumulated Depreciation | $ (8,692) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Lone Tree Medical Office Buildings | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,736 | |||
Buildings, Improvements and Fixtures | 29,546 | |||
Cost Capitalized Subsequent to Acquisition | 2,313 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,736 | |||
Buildings, Improvements and Fixtures | 31,859 | |||
Total | 35,595 | |||
Accumulated Depreciation | $ (7,115) | |||
Life on which building depreciation in income statement is computed | 38 years | |||
Operating Properties | Lincoln Medical Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 5,142 | |||
Buildings, Improvements and Fixtures | 28,638 | |||
Cost Capitalized Subsequent to Acquisition | 1,682 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 5,142 | |||
Buildings, Improvements and Fixtures | 30,320 | |||
Total | 35,462 | |||
Accumulated Depreciation | $ (7,894) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | 80 Fisher | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 5,094 | |||
Cost Capitalized Subsequent to Acquisition | 1 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 5,095 | |||
Total | 5,095 | |||
Accumulated Depreciation | $ (1,414) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | 533 Cottage - Northwestern | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 726 | |||
Buildings, Improvements and Fixtures | 3,964 | |||
Cost Capitalized Subsequent to Acquisition | (527) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 726 | |||
Buildings, Improvements and Fixtures | 3,437 | |||
Total | 4,163 | |||
Accumulated Depreciation | $ (749) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | Northwestern MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,369 | |||
Buildings, Improvements and Fixtures | 6,287 | |||
Cost Capitalized Subsequent to Acquisition | 732 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,369 | |||
Buildings, Improvements and Fixtures | 7,019 | |||
Total | 8,388 | |||
Accumulated Depreciation | $ (1,865) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | 406 Farmington | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 379 | |||
Buildings, Improvements and Fixtures | 3,509 | |||
Cost Capitalized Subsequent to Acquisition | 3 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 379 | |||
Buildings, Improvements and Fixtures | 3,512 | |||
Total | 3,891 | |||
Accumulated Depreciation | $ (692) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | 704 Hebron | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,223 | |||
Buildings, Improvements and Fixtures | 6,544 | |||
Cost Capitalized Subsequent to Acquisition | 20 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,223 | |||
Buildings, Improvements and Fixtures | 6,564 | |||
Total | 8,787 | |||
Accumulated Depreciation | $ (1,575) | |||
Life on which building depreciation in income statement is computed | 37 years | |||
Operating Properties | Gateway MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 11,328 | |||
Buildings, Improvements and Fixtures | 41,320 | |||
Cost Capitalized Subsequent to Acquisition | 10,291 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 13,448 | |||
Buildings, Improvements and Fixtures | 49,491 | |||
Total | 62,939 | |||
Accumulated Depreciation | $ (10,190) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Hamden MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,925 | |||
Buildings, Improvements and Fixtures | 36,835 | |||
Cost Capitalized Subsequent to Acquisition | 69 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,925 | |||
Buildings, Improvements and Fixtures | 36,904 | |||
Total | 41,829 | |||
Accumulated Depreciation | $ (2,356) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Haynes MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,100 | |||
Buildings, Improvements and Fixtures | 14,620 | |||
Cost Capitalized Subsequent to Acquisition | 6 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,100 | |||
Buildings, Improvements and Fixtures | 14,626 | |||
Total | 15,726 | |||
Accumulated Depreciation | $ (2,681) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Pomeroy MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,774 | |||
Buildings, Improvements and Fixtures | 10,078 | |||
Cost Capitalized Subsequent to Acquisition | (48) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,774 | |||
Buildings, Improvements and Fixtures | 10,030 | |||
Total | 11,804 | |||
Accumulated Depreciation | $ (2,412) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Saybrook MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 10,314 | |||
Cost Capitalized Subsequent to Acquisition | 887 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 11,201 | |||
Total | 11,201 | |||
Accumulated Depreciation | $ (2,711) | |||
Life on which building depreciation in income statement is computed | 28 years | |||
Operating Properties | Yale Long Wharf | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 9,367 | |||
Buildings, Improvements and Fixtures | 58,691 | |||
Cost Capitalized Subsequent to Acquisition | 7,707 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 7,791 | |||
Buildings, Improvements and Fixtures | 67,974 | |||
Total | 75,765 | |||
Accumulated Depreciation | $ (17,824) | |||
Life on which building depreciation in income statement is computed | 30 years | |||
Operating Properties | Devine MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,606 | |||
Buildings, Improvements and Fixtures | 27,278 | |||
Cost Capitalized Subsequent to Acquisition | 1,708 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,606 | |||
Buildings, Improvements and Fixtures | 28,986 | |||
Total | 32,592 | |||
Accumulated Depreciation | $ (5,301) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | Evergreen MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 5,565 | |||
Buildings, Improvements and Fixtures | 25,839 | |||
Cost Capitalized Subsequent to Acquisition | (81) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 5,833 | |||
Buildings, Improvements and Fixtures | 25,490 | |||
Total | 31,323 | |||
Accumulated Depreciation | $ (4,845) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Westport Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,311 | |||
Buildings, Improvements and Fixtures | 13,296 | |||
Cost Capitalized Subsequent to Acquisition | 843 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,311 | |||
Buildings, Improvements and Fixtures | 14,139 | |||
Total | 17,450 | |||
Accumulated Depreciation | $ (1,364) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Day Hill MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,980 | |||
Buildings, Improvements and Fixtures | 7,055 | |||
Cost Capitalized Subsequent to Acquisition | 34 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,980 | |||
Buildings, Improvements and Fixtures | 7,089 | |||
Total | 11,069 | |||
Accumulated Depreciation | $ (2,166) | |||
Life on which building depreciation in income statement is computed | 30 years | |||
Operating Properties | Clint Moore Medical Facility | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 20,051 | |||
Buildings, Improvements and Fixtures | 27,157 | |||
Cost Capitalized Subsequent to Acquisition | 64 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 20,072 | |||
Buildings, Improvements and Fixtures | 27,200 | |||
Total | 47,272 | |||
Accumulated Depreciation | $ (384) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Riverside MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,230 | |||
Buildings, Improvements and Fixtures | 7,689 | |||
Cost Capitalized Subsequent to Acquisition | 354 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,230 | |||
Buildings, Improvements and Fixtures | 8,043 | |||
Total | 10,273 | |||
Accumulated Depreciation | $ (1,886) | |||
Life on which building depreciation in income statement is computed | 25 years | |||
Operating Properties | Brandon MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 901 | |||
Buildings, Improvements and Fixtures | 6,946 | |||
Cost Capitalized Subsequent to Acquisition | 867 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 901 | |||
Buildings, Improvements and Fixtures | 7,813 | |||
Total | 8,714 | |||
Accumulated Depreciation | $ (2,807) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | McMullen MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,470 | |||
Buildings, Improvements and Fixtures | 12,621 | |||
Cost Capitalized Subsequent to Acquisition | (613) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,470 | |||
Buildings, Improvements and Fixtures | 12,008 | |||
Total | 15,478 | |||
Accumulated Depreciation | $ (2,907) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Orlando Rehab Hospital | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,600 | |||
Buildings, Improvements and Fixtures | 20,256 | |||
Cost Capitalized Subsequent to Acquisition | 3,000 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,600 | |||
Buildings, Improvements and Fixtures | 23,256 | |||
Total | 25,856 | |||
Accumulated Depreciation | $ (8,425) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Palmetto MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 15,512 | |||
Cost Capitalized Subsequent to Acquisition | 5,487 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 20,999 | |||
Total | 20,999 | |||
Accumulated Depreciation | $ (7,775) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Palmetto II | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 51,480 | |||
Cost Capitalized Subsequent to Acquisition | 75 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 51,555 | |||
Total | 51,555 | |||
Accumulated Depreciation | $ (1,673) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | East FL Senior Jacksonville | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,291 | |||
Buildings, Improvements and Fixtures | 9,220 | |||
Cost Capitalized Subsequent to Acquisition | (736) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,291 | |||
Buildings, Improvements and Fixtures | 8,484 | |||
Total | 12,775 | |||
Accumulated Depreciation | $ (3,647) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | King Street MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 7,232 | |||
Cost Capitalized Subsequent to Acquisition | 86 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 7,318 | |||
Total | 7,318 | |||
Accumulated Depreciation | $ (2,445) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Jupiter MP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,204 | |||
Buildings, Improvements and Fixtures | 11,778 | |||
Cost Capitalized Subsequent to Acquisition | 1,283 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,204 | |||
Buildings, Improvements and Fixtures | 13,061 | |||
Total | 14,265 | |||
Accumulated Depreciation | $ (3,336) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Central FL SC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 768 | |||
Buildings, Improvements and Fixtures | 3,002 | |||
Cost Capitalized Subsequent to Acquisition | 511 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 768 | |||
Buildings, Improvements and Fixtures | 3,513 | |||
Total | 4,281 | |||
Accumulated Depreciation | $ (1,549) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Vista Pro Center MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,082 | |||
Buildings, Improvements and Fixtures | 3,587 | |||
Cost Capitalized Subsequent to Acquisition | 569 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,082 | |||
Buildings, Improvements and Fixtures | 4,156 | |||
Total | 5,238 | |||
Accumulated Depreciation | $ (1,582) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Largo Medical Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 51,045 | |||
Cost Capitalized Subsequent to Acquisition | 660 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 51,705 | |||
Total | 51,705 | |||
Accumulated Depreciation | $ (11,897) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Largo MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 729 | |||
Buildings, Improvements and Fixtures | 8,908 | |||
Cost Capitalized Subsequent to Acquisition | 1,496 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 729 | |||
Buildings, Improvements and Fixtures | 10,404 | |||
Total | 11,133 | |||
Accumulated Depreciation | $ (4,234) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | FL Family Medical Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 4,257 | |||
Cost Capitalized Subsequent to Acquisition | 1,271 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 5,528 | |||
Total | 5,528 | |||
Accumulated Depreciation | $ (2,519) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Northwest Medical Park | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,525 | |||
Cost Capitalized Subsequent to Acquisition | (297) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 5 | |||
Buildings, Improvements and Fixtures | 9,223 | |||
Total | 9,228 | |||
Accumulated Depreciation | $ (2,138) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Coral Reef | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,160 | |||
Buildings, Improvements and Fixtures | 0 | |||
Cost Capitalized Subsequent to Acquisition | 18,454 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,160 | |||
Buildings, Improvements and Fixtures | 18,454 | |||
Total | 19,614 | |||
Accumulated Depreciation | $ (343) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | North Shore MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 4,942 | |||
Cost Capitalized Subsequent to Acquisition | 1,592 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,534 | |||
Total | 6,534 | |||
Accumulated Depreciation | $ (2,889) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Sunset Professional and Kendall MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 11,855 | |||
Buildings, Improvements and Fixtures | 13,633 | |||
Cost Capitalized Subsequent to Acquisition | 6,679 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 11,855 | |||
Buildings, Improvements and Fixtures | 20,312 | |||
Total | 32,167 | |||
Accumulated Depreciation | $ (7,506) | |||
Life on which building depreciation in income statement is computed | 27 years | |||
Operating Properties | Commons V MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,173 | |||
Buildings, Improvements and Fixtures | 9,070 | |||
Cost Capitalized Subsequent to Acquisition | 2,788 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,173 | |||
Buildings, Improvements and Fixtures | 11,858 | |||
Total | 16,031 | |||
Accumulated Depreciation | $ (4,642) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Orlando Lake Underhill MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 8,515 | |||
Cost Capitalized Subsequent to Acquisition | 428 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 8,943 | |||
Total | 8,943 | |||
Accumulated Depreciation | $ (2,837) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Florida Hospital MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 151,647 | |||
Cost Capitalized Subsequent to Acquisition | 3,185 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 154,832 | |||
Total | 154,832 | |||
Accumulated Depreciation | $ (21,818) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Orlando Oviedo MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 5,711 | |||
Cost Capitalized Subsequent to Acquisition | 926 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,637 | |||
Total | 6,637 | |||
Accumulated Depreciation | $ (2,364) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Heart & Family Health MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 686 | |||
Buildings, Improvements and Fixtures | 8,102 | |||
Cost Capitalized Subsequent to Acquisition | 15 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 686 | |||
Buildings, Improvements and Fixtures | 8,117 | |||
Total | 8,803 | |||
Accumulated Depreciation | $ (2,248) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | St. Lucie MC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,127 | |||
Cost Capitalized Subsequent to Acquisition | (41) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,086 | |||
Total | 6,086 | |||
Accumulated Depreciation | $ (1,473) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | East FL Senior Sunrise | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,947 | |||
Buildings, Improvements and Fixtures | 12,825 | |||
Cost Capitalized Subsequent to Acquisition | (1,006) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,947 | |||
Buildings, Improvements and Fixtures | 11,819 | |||
Total | 14,766 | |||
Accumulated Depreciation | $ (4,641) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Tallahassee Rehab Hospital | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 7,142 | |||
Buildings, Improvements and Fixtures | 18,691 | |||
Cost Capitalized Subsequent to Acquisition | 2,400 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 7,142 | |||
Buildings, Improvements and Fixtures | 21,091 | |||
Total | 28,233 | |||
Accumulated Depreciation | $ (7,903) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Optimal MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,002 | |||
Buildings, Improvements and Fixtures | 69,824 | |||
Cost Capitalized Subsequent to Acquisition | 552 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,002 | |||
Buildings, Improvements and Fixtures | 70,376 | |||
Total | 74,378 | |||
Accumulated Depreciation | $ (10,921) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Tampa Medical Village MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,627 | |||
Buildings, Improvements and Fixtures | 14,806 | |||
Cost Capitalized Subsequent to Acquisition | 1,295 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,627 | |||
Buildings, Improvements and Fixtures | 16,101 | |||
Total | 19,728 | |||
Accumulated Depreciation | $ (2,906) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | VA MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 17,802 | |||
Buildings, Improvements and Fixtures | 80,154 | |||
Cost Capitalized Subsequent to Acquisition | 732 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 17,802 | |||
Buildings, Improvements and Fixtures | 80,886 | |||
Total | 98,688 | |||
Accumulated Depreciation | $ (11,226) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | FL Ortho Institute | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,923 | |||
Buildings, Improvements and Fixtures | 17,647 | |||
Cost Capitalized Subsequent to Acquisition | (1) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,923 | |||
Buildings, Improvements and Fixtures | 17,646 | |||
Total | 20,569 | |||
Accumulated Depreciation | $ (6,021) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Wellington MAP III | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 10,511 | |||
Cost Capitalized Subsequent to Acquisition | 31 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 10,542 | |||
Total | 10,542 | |||
Accumulated Depreciation | $ (3,288) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Victor Farris MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 23,052 | |||
Cost Capitalized Subsequent to Acquisition | 11,965 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 35,017 | |||
Total | 35,017 | |||
Accumulated Depreciation | $ (9,022) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | East FL Senior Winter Park | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,840 | |||
Buildings, Improvements and Fixtures | 12,825 | |||
Cost Capitalized Subsequent to Acquisition | (1,023) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,840 | |||
Buildings, Improvements and Fixtures | 11,802 | |||
Total | 14,642 | |||
Accumulated Depreciation | $ (4,872) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Camp Creek Med Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,961 | |||
Buildings, Improvements and Fixtures | 19,688 | |||
Cost Capitalized Subsequent to Acquisition | 1,371 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,961 | |||
Buildings, Improvements and Fixtures | 21,059 | |||
Total | 24,020 | |||
Accumulated Depreciation | $ (7,593) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Camp Creek MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 328 | |||
Buildings, Improvements and Fixtures | 12,539 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 328 | |||
Buildings, Improvements and Fixtures | 12,539 | |||
Total | 12,867 | |||
Accumulated Depreciation | $ (875) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | North Atlanta MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 41,836 | |||
Cost Capitalized Subsequent to Acquisition | 1,621 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 43,457 | |||
Total | 43,457 | |||
Accumulated Depreciation | $ (6,249) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Paces Pavilion | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,670 | |||
Buildings, Improvements and Fixtures | 16,328 | |||
Cost Capitalized Subsequent to Acquisition | 27 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,670 | |||
Buildings, Improvements and Fixtures | 16,355 | |||
Total | 20,025 | |||
Accumulated Depreciation | $ 0 | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Augusta Rehab Hospital | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,059 | |||
Buildings, Improvements and Fixtures | 20,899 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,059 | |||
Buildings, Improvements and Fixtures | 20,899 | |||
Total | 21,958 | |||
Accumulated Depreciation | $ (6,779) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Austell Medical Park | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 432 | |||
Buildings, Improvements and Fixtures | 4,057 | |||
Cost Capitalized Subsequent to Acquisition | (160) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 432 | |||
Buildings, Improvements and Fixtures | 3,897 | |||
Total | 4,329 | |||
Accumulated Depreciation | $ (1,113) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Harbin Clinic MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 7,097 | |||
Buildings, Improvements and Fixtures | 112,155 | |||
Cost Capitalized Subsequent to Acquisition | (11,230) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 7,097 | |||
Buildings, Improvements and Fixtures | 100,925 | |||
Total | 108,022 | |||
Accumulated Depreciation | (17,790) | |||
Operating Properties | Decatur MP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 3,166 | |||
Buildings, Improvements and Fixtures | 6,862 | |||
Cost Capitalized Subsequent to Acquisition | 1,303 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,166 | |||
Buildings, Improvements and Fixtures | 8,165 | |||
Total | 11,331 | |||
Accumulated Depreciation | $ (2,954) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Yorktown MC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,802 | |||
Buildings, Improvements and Fixtures | 12,502 | |||
Cost Capitalized Subsequent to Acquisition | 3,967 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,802 | |||
Buildings, Improvements and Fixtures | 16,469 | |||
Total | 19,271 | |||
Accumulated Depreciation | $ (6,766) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Gwinett MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,290 | |||
Buildings, Improvements and Fixtures | 7,246 | |||
Cost Capitalized Subsequent to Acquisition | 4,525 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,290 | |||
Buildings, Improvements and Fixtures | 11,771 | |||
Total | 13,061 | |||
Accumulated Depreciation | $ (5,467) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Marietta Health Park | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,276 | |||
Buildings, Improvements and Fixtures | 12,197 | |||
Cost Capitalized Subsequent to Acquisition | 3,198 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,276 | |||
Buildings, Improvements and Fixtures | 15,395 | |||
Total | 16,671 | |||
Accumulated Depreciation | $ (5,436) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | WellStar Tower MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 748 | |||
Buildings, Improvements and Fixtures | 13,528 | |||
Cost Capitalized Subsequent to Acquisition | 321 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 748 | |||
Buildings, Improvements and Fixtures | 13,849 | |||
Total | 14,597 | |||
Accumulated Depreciation | $ (2,962) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Shakerag MC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 743 | |||
Buildings, Improvements and Fixtures | 3,290 | |||
Cost Capitalized Subsequent to Acquisition | 1,130 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 743 | |||
Buildings, Improvements and Fixtures | 4,420 | |||
Total | 5,163 | |||
Accumulated Depreciation | $ (2,307) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Overlook at Eagle's Landing | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 638 | |||
Buildings, Improvements and Fixtures | 6,685 | |||
Cost Capitalized Subsequent to Acquisition | 581 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 638 | |||
Buildings, Improvements and Fixtures | 7,266 | |||
Total | 7,904 | |||
Accumulated Depreciation | $ (2,653) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | SouthCrest MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,260 | |||
Buildings, Improvements and Fixtures | 14,636 | |||
Cost Capitalized Subsequent to Acquisition | 2,257 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,260 | |||
Buildings, Improvements and Fixtures | 16,893 | |||
Total | 21,153 | |||
Accumulated Depreciation | $ (7,061) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Cherokee Medical Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 16,558 | |||
Cost Capitalized Subsequent to Acquisition | 990 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 17,548 | |||
Total | 17,548 | |||
Accumulated Depreciation | $ (4,262) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | Honolulu MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 27,336 | |||
Cost Capitalized Subsequent to Acquisition | 3,132 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 30,468 | |||
Total | 30,468 | |||
Accumulated Depreciation | $ (6,595) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | Kapolei Medical Park | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 16,253 | |||
Cost Capitalized Subsequent to Acquisition | 643 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 16,896 | |||
Total | 16,896 | |||
Accumulated Depreciation | $ (4,237) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | North Curtis Road | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 382 | |||
Buildings, Improvements and Fixtures | 5,995 | |||
Cost Capitalized Subsequent to Acquisition | 12 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 382 | |||
Buildings, Improvements and Fixtures | 6,007 | |||
Total | 6,389 | |||
Accumulated Depreciation | $ (462) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Eagle Road MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 666 | |||
Buildings, Improvements and Fixtures | 9,636 | |||
Cost Capitalized Subsequent to Acquisition | (146) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 666 | |||
Buildings, Improvements and Fixtures | 9,490 | |||
Total | 10,156 | |||
Accumulated Depreciation | $ (1,004) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Chicago MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 7,723 | |||
Buildings, Improvements and Fixtures | 129,520 | |||
Cost Capitalized Subsequent to Acquisition | 1,151 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 7,723 | |||
Buildings, Improvements and Fixtures | 130,671 | |||
Total | 138,394 | |||
Accumulated Depreciation | (16,824) | |||
Operating Properties | Streeterville Center MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 4,223 | |||
Buildings, Improvements and Fixtures | 35,008 | |||
Cost Capitalized Subsequent to Acquisition | 139 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,223 | |||
Buildings, Improvements and Fixtures | 35,147 | |||
Total | 39,370 | |||
Accumulated Depreciation | $ (2,554) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Rush Oak Park MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,096 | |||
Buildings, Improvements and Fixtures | 38,550 | |||
Cost Capitalized Subsequent to Acquisition | (2,667) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,096 | |||
Buildings, Improvements and Fixtures | 35,883 | |||
Total | 36,979 | |||
Accumulated Depreciation | $ (8,975) | |||
Life on which building depreciation in income statement is computed | 38 years | |||
Operating Properties | Brownsburg MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 431 | |||
Buildings, Improvements and Fixtures | 639 | |||
Cost Capitalized Subsequent to Acquisition | 641 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 431 | |||
Buildings, Improvements and Fixtures | 1,280 | |||
Total | 1,711 | |||
Accumulated Depreciation | $ (531) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Athens SC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 381 | |||
Buildings, Improvements and Fixtures | 3,575 | |||
Cost Capitalized Subsequent to Acquisition | 417 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 381 | |||
Buildings, Improvements and Fixtures | 3,992 | |||
Total | 4,373 | |||
Accumulated Depreciation | $ (1,670) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Crawfordsville MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 318 | |||
Buildings, Improvements and Fixtures | 1,899 | |||
Cost Capitalized Subsequent to Acquisition | 260 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 318 | |||
Buildings, Improvements and Fixtures | 2,159 | |||
Total | 2,477 | |||
Accumulated Depreciation | $ (907) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Deaconess Clinic Downtown | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,748 | |||
Buildings, Improvements and Fixtures | 21,963 | |||
Cost Capitalized Subsequent to Acquisition | 77 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,748 | |||
Buildings, Improvements and Fixtures | 22,040 | |||
Total | 23,788 | |||
Accumulated Depreciation | $ (8,675) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Deaconess Clinic Westside | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 360 | |||
Buildings, Improvements and Fixtures | 3,265 | |||
Cost Capitalized Subsequent to Acquisition | 356 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 360 | |||
Buildings, Improvements and Fixtures | 3,621 | |||
Total | 3,981 | |||
Accumulated Depreciation | $ (1,413) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Dupont MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 8,246 | |||
Cost Capitalized Subsequent to Acquisition | 1,412 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,658 | |||
Total | 9,658 | |||
Accumulated Depreciation | $ (2,209) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Ft. Wayne MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,579 | |||
Cost Capitalized Subsequent to Acquisition | (243) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,336 | |||
Total | 6,336 | |||
Accumulated Depreciation | $ (1,940) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Community MP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 560 | |||
Buildings, Improvements and Fixtures | 3,581 | |||
Cost Capitalized Subsequent to Acquisition | 821 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 560 | |||
Buildings, Improvements and Fixtures | 4,402 | |||
Total | 4,962 | |||
Accumulated Depreciation | $ (1,719) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Eagle Highlands MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,216 | |||
Buildings, Improvements and Fixtures | 11,154 | |||
Cost Capitalized Subsequent to Acquisition | 8,269 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,216 | |||
Buildings, Improvements and Fixtures | 19,423 | |||
Total | 21,639 | |||
Accumulated Depreciation | $ (10,226) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Epler Parke MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,556 | |||
Buildings, Improvements and Fixtures | 6,928 | |||
Cost Capitalized Subsequent to Acquisition | 2,095 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,556 | |||
Buildings, Improvements and Fixtures | 9,023 | |||
Total | 10,579 | |||
Accumulated Depreciation | $ (3,807) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Glendale Professional Plaza | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 570 | |||
Buildings, Improvements and Fixtures | 2,739 | |||
Cost Capitalized Subsequent to Acquisition | 1,697 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 570 | |||
Buildings, Improvements and Fixtures | 4,436 | |||
Total | 5,006 | |||
Accumulated Depreciation | $ (2,332) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | MMP Eagle Highlands | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,044 | |||
Buildings, Improvements and Fixtures | 13,548 | |||
Cost Capitalized Subsequent to Acquisition | 3,914 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,044 | |||
Buildings, Improvements and Fixtures | 17,462 | |||
Total | 18,506 | |||
Accumulated Depreciation | $ (6,969) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | MMP East | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,236 | |||
Buildings, Improvements and Fixtures | 9,840 | |||
Cost Capitalized Subsequent to Acquisition | 3,374 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,236 | |||
Buildings, Improvements and Fixtures | 13,214 | |||
Total | 14,450 | |||
Accumulated Depreciation | $ (6,364) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | MMP North | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,518 | |||
Buildings, Improvements and Fixtures | 15,460 | |||
Cost Capitalized Subsequent to Acquisition | 6,210 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,427 | |||
Buildings, Improvements and Fixtures | 21,761 | |||
Total | 23,188 | |||
Accumulated Depreciation | $ (9,521) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | MMP South | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,127 | |||
Buildings, Improvements and Fixtures | 10,414 | |||
Cost Capitalized Subsequent to Acquisition | 2,333 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,127 | |||
Buildings, Improvements and Fixtures | 12,747 | |||
Total | 13,874 | |||
Accumulated Depreciation | $ (5,430) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Southpointe MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,190 | |||
Buildings, Improvements and Fixtures | 7,548 | |||
Cost Capitalized Subsequent to Acquisition | 1,529 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,190 | |||
Buildings, Improvements and Fixtures | 9,077 | |||
Total | 11,267 | |||
Accumulated Depreciation | $ (4,016) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | St. Vincent MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,964 | |||
Buildings, Improvements and Fixtures | 23,352 | |||
Cost Capitalized Subsequent to Acquisition | 49 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,964 | |||
Buildings, Improvements and Fixtures | 23,401 | |||
Total | 26,365 | |||
Accumulated Depreciation | $ (3,773) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | Kokomo MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,779 | |||
Buildings, Improvements and Fixtures | 9,614 | |||
Cost Capitalized Subsequent to Acquisition | 2,450 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,779 | |||
Buildings, Improvements and Fixtures | 12,064 | |||
Total | 13,843 | |||
Accumulated Depreciation | $ (5,260) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Deaconess Clinic Gateway | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 10,952 | |||
Cost Capitalized Subsequent to Acquisition | 26 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 10,978 | |||
Total | 10,978 | |||
Accumulated Depreciation | $ (3,844) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Community Health Pavilion | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 5,560 | |||
Buildings, Improvements and Fixtures | 28,988 | |||
Cost Capitalized Subsequent to Acquisition | 1,658 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 5,560 | |||
Buildings, Improvements and Fixtures | 30,646 | |||
Total | 36,206 | |||
Accumulated Depreciation | $ (8,124) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Zionsville MC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 655 | |||
Buildings, Improvements and Fixtures | 2,877 | |||
Cost Capitalized Subsequent to Acquisition | 1,152 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 664 | |||
Buildings, Improvements and Fixtures | 4,020 | |||
Total | 4,684 | |||
Accumulated Depreciation | $ (1,825) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Nashoba Valley Med Center MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 5,529 | |||
Cost Capitalized Subsequent to Acquisition | 313 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 299 | |||
Buildings, Improvements and Fixtures | 5,543 | |||
Total | 5,842 | |||
Accumulated Depreciation | $ (1,888) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | 670 Albany | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 104,365 | |||
Cost Capitalized Subsequent to Acquisition | (1,795) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 102,570 | |||
Total | 102,570 | |||
Accumulated Depreciation | $ (17,428) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Tufts Medical Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 32,514 | |||
Buildings, Improvements and Fixtures | 109,180 | |||
Cost Capitalized Subsequent to Acquisition | 9,778 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 32,514 | |||
Buildings, Improvements and Fixtures | 118,958 | |||
Total | 151,472 | |||
Accumulated Depreciation | $ (32,158) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | St. Elizabeth's Med Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 20,929 | |||
Cost Capitalized Subsequent to Acquisition | 3,627 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,379 | |||
Buildings, Improvements and Fixtures | 23,177 | |||
Total | 24,556 | |||
Accumulated Depreciation | $ (7,529) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | Good Samaritan MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 15,887 | |||
Cost Capitalized Subsequent to Acquisition | 2,127 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 144 | |||
Buildings, Improvements and Fixtures | 17,870 | |||
Total | 18,014 | |||
Accumulated Depreciation | $ (5,477) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | Pearl Street MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,714 | |||
Buildings, Improvements and Fixtures | 18,193 | |||
Cost Capitalized Subsequent to Acquisition | 1,465 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,714 | |||
Buildings, Improvements and Fixtures | 19,658 | |||
Total | 24,372 | |||
Accumulated Depreciation | $ (4,266) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Carney Hospital MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 7,250 | |||
Cost Capitalized Subsequent to Acquisition | 813 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 530 | |||
Buildings, Improvements and Fixtures | 7,533 | |||
Total | 8,063 | |||
Accumulated Depreciation | $ (2,450) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | St. Anne's Hospital MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,304 | |||
Cost Capitalized Subsequent to Acquisition | 130 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 40 | |||
Buildings, Improvements and Fixtures | 9,394 | |||
Total | 9,434 | |||
Accumulated Depreciation | $ (2,381) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | Norwood Hospital MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,489 | |||
Cost Capitalized Subsequent to Acquisition | 536 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,295 | |||
Buildings, Improvements and Fixtures | 7,730 | |||
Total | 10,025 | |||
Accumulated Depreciation | $ (2,751) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | Holy Family Hospital MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 4,502 | |||
Cost Capitalized Subsequent to Acquisition | 304 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 168 | |||
Buildings, Improvements and Fixtures | 4,638 | |||
Total | 4,806 | |||
Accumulated Depreciation | $ (1,872) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | Morton Hospital MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 15,317 | |||
Cost Capitalized Subsequent to Acquisition | 1,910 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 502 | |||
Buildings, Improvements and Fixtures | 16,725 | |||
Total | 17,227 | |||
Accumulated Depreciation | $ (8,222) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | Stetson MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,362 | |||
Buildings, Improvements and Fixtures | 15,555 | |||
Cost Capitalized Subsequent to Acquisition | 3,681 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,362 | |||
Buildings, Improvements and Fixtures | 19,236 | |||
Total | 22,598 | |||
Accumulated Depreciation | $ (6,409) | |||
Life on which building depreciation in income statement is computed | 20 years | |||
Operating Properties | Johnston Professional Building | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 21,481 | |||
Cost Capitalized Subsequent to Acquisition | 423 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 21,904 | |||
Total | 21,904 | |||
Accumulated Depreciation | $ (5,208) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | Triad Tech Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 26,548 | |||
Cost Capitalized Subsequent to Acquisition | 25 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 26,573 | |||
Total | 26,573 | |||
Accumulated Depreciation | $ (8,499) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | St. John Providence MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 42,371 | |||
Cost Capitalized Subsequent to Acquisition | (195) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 42,176 | |||
Total | 42,176 | |||
Accumulated Depreciation | $ (12,659) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Fort Road MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,571 | |||
Buildings, Improvements and Fixtures | 5,786 | |||
Cost Capitalized Subsequent to Acquisition | 1,468 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,571 | |||
Buildings, Improvements and Fixtures | 7,254 | |||
Total | 8,825 | |||
Accumulated Depreciation | $ (3,319) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Chesterfield Rehab Hospital | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,213 | |||
Buildings, Improvements and Fixtures | 27,898 | |||
Cost Capitalized Subsequent to Acquisition | 774 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,313 | |||
Buildings, Improvements and Fixtures | 28,574 | |||
Total | 32,887 | |||
Accumulated Depreciation | $ (11,410) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | BJC West County MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,242 | |||
Buildings, Improvements and Fixtures | 13,130 | |||
Cost Capitalized Subsequent to Acquisition | 994 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,242 | |||
Buildings, Improvements and Fixtures | 14,124 | |||
Total | 16,366 | |||
Accumulated Depreciation | $ (5,494) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Winghaven MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,455 | |||
Buildings, Improvements and Fixtures | 9,708 | |||
Cost Capitalized Subsequent to Acquisition | 1,645 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,455 | |||
Buildings, Improvements and Fixtures | 11,353 | |||
Total | 12,808 | |||
Accumulated Depreciation | $ (4,479) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | BJC MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 304 | |||
Buildings, Improvements and Fixtures | 1,554 | |||
Cost Capitalized Subsequent to Acquisition | (891) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 304 | |||
Buildings, Improvements and Fixtures | 663 | |||
Total | 967 | |||
Accumulated Depreciation | $ (512) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Des Peres MAP II | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 11,386 | |||
Cost Capitalized Subsequent to Acquisition | 36 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 11,422 | |||
Total | 11,422 | |||
Accumulated Depreciation | $ (3,793) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Baptist Memorial MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 26,263 | |||
Cost Capitalized Subsequent to Acquisition | 7,570 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 33,833 | |||
Total | 33,833 | |||
Accumulated Depreciation | $ (3,759) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Medical Park of Cary | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,931 | |||
Buildings, Improvements and Fixtures | 20,305 | |||
Cost Capitalized Subsequent to Acquisition | 38,308 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,931 | |||
Buildings, Improvements and Fixtures | 58,613 | |||
Total | 61,544 | |||
Accumulated Depreciation | $ (9,072) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Rex Cary MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,449 | |||
Buildings, Improvements and Fixtures | 18,226 | |||
Cost Capitalized Subsequent to Acquisition | 472 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,449 | |||
Buildings, Improvements and Fixtures | 18,698 | |||
Total | 20,147 | |||
Accumulated Depreciation | $ (3,696) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Tryon Office Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,200 | |||
Buildings, Improvements and Fixtures | 14,956 | |||
Cost Capitalized Subsequent to Acquisition | 1,053 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,200 | |||
Buildings, Improvements and Fixtures | 16,009 | |||
Total | 18,209 | |||
Accumulated Depreciation | $ (3,659) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Carolinas Health MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 75,198 | |||
Cost Capitalized Subsequent to Acquisition | (1,072) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 74,126 | |||
Total | 74,126 | |||
Accumulated Depreciation | $ (8,851) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Davidson MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,188 | |||
Buildings, Improvements and Fixtures | 8,556 | |||
Cost Capitalized Subsequent to Acquisition | 98 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,188 | |||
Buildings, Improvements and Fixtures | 8,654 | |||
Total | 9,842 | |||
Accumulated Depreciation | $ (685) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Duke Fertility Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 596 | |||
Buildings, Improvements and Fixtures | 3,882 | |||
Cost Capitalized Subsequent to Acquisition | (106) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 596 | |||
Buildings, Improvements and Fixtures | 3,776 | |||
Total | 4,372 | |||
Accumulated Depreciation | $ (569) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Duke Medical Plaza | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,093 | |||
Buildings, Improvements and Fixtures | 11,836 | |||
Cost Capitalized Subsequent to Acquisition | 1,521 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,093 | |||
Buildings, Improvements and Fixtures | 13,357 | |||
Total | 14,450 | |||
Accumulated Depreciation | $ (261) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Hock Plaza II | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 680 | |||
Buildings, Improvements and Fixtures | 27,044 | |||
Cost Capitalized Subsequent to Acquisition | 643 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 680 | |||
Buildings, Improvements and Fixtures | 27,687 | |||
Total | 28,367 | |||
Accumulated Depreciation | $ (4,569) | |||
Life on which building depreciation in income statement is computed | 36 years | |||
Operating Properties | UNC Rex Holly Springs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 27,591 | |||
Cost Capitalized Subsequent to Acquisition | 11,082 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 38,673 | |||
Total | 38,673 | |||
Accumulated Depreciation | $ (4,347) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Huntersville Office Park | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 5,376 | |||
Buildings, Improvements and Fixtures | 67,125 | |||
Cost Capitalized Subsequent to Acquisition | 2,331 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 5,376 | |||
Buildings, Improvements and Fixtures | 69,456 | |||
Total | 74,832 | |||
Accumulated Depreciation | $ (5,614) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Rosedale MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,281 | |||
Buildings, Improvements and Fixtures | 7,738 | |||
Cost Capitalized Subsequent to Acquisition | 58 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,281 | |||
Buildings, Improvements and Fixtures | 7,796 | |||
Total | 9,077 | |||
Accumulated Depreciation | $ (698) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Medical Park MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,771 | |||
Buildings, Improvements and Fixtures | 13,266 | |||
Cost Capitalized Subsequent to Acquisition | 9,982 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,141 | |||
Buildings, Improvements and Fixtures | 22,878 | |||
Total | 25,019 | |||
Accumulated Depreciation | $ (4,724) | |||
Life on which building depreciation in income statement is computed | 23 years | |||
Operating Properties | 3100 Blue Ridge | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,732 | |||
Buildings, Improvements and Fixtures | 8,891 | |||
Cost Capitalized Subsequent to Acquisition | 714 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,732 | |||
Buildings, Improvements and Fixtures | 9,605 | |||
Total | 11,337 | |||
Accumulated Depreciation | $ (3,016) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | Raleigh Medical Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,381 | |||
Buildings, Improvements and Fixtures | 15,630 | |||
Cost Capitalized Subsequent to Acquisition | 5,955 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,381 | |||
Buildings, Improvements and Fixtures | 21,585 | |||
Total | 23,966 | |||
Accumulated Depreciation | $ (8,311) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Sandy Forks MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 652 | |||
Buildings, Improvements and Fixtures | 7,263 | |||
Cost Capitalized Subsequent to Acquisition | 15 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 652 | |||
Buildings, Improvements and Fixtures | 7,278 | |||
Total | 7,930 | |||
Accumulated Depreciation | $ (950) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Sunset Ridge MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 811 | |||
Buildings, Improvements and Fixtures | 3,926 | |||
Cost Capitalized Subsequent to Acquisition | 710 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 811 | |||
Buildings, Improvements and Fixtures | 4,636 | |||
Total | 5,447 | |||
Accumulated Depreciation | $ (585) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Piedmont MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,024 | |||
Buildings, Improvements and Fixtures | 13,911 | |||
Cost Capitalized Subsequent to Acquisition | 41 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,024 | |||
Buildings, Improvements and Fixtures | 13,952 | |||
Total | 14,976 | |||
Accumulated Depreciation | $ (1,307) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | NorthPark MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,098 | |||
Buildings, Improvements and Fixtures | 13,921 | |||
Cost Capitalized Subsequent to Acquisition | 2 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,098 | |||
Buildings, Improvements and Fixtures | 13,923 | |||
Total | 16,021 | |||
Accumulated Depreciation | $ (57) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Hackensack MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 31,658 | |||
Cost Capitalized Subsequent to Acquisition | 608 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 32,266 | |||
Total | 32,266 | |||
Accumulated Depreciation | $ (4,003) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Mountain View MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 41,553 | |||
Cost Capitalized Subsequent to Acquisition | 2,802 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 44,355 | |||
Total | 44,355 | |||
Accumulated Depreciation | $ (6,064) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Santa Fe 440 MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 842 | |||
Buildings, Improvements and Fixtures | 7,448 | |||
Cost Capitalized Subsequent to Acquisition | (3,205) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 842 | |||
Buildings, Improvements and Fixtures | 4,243 | |||
Total | 5,085 | |||
Accumulated Depreciation | $ (2,267) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | San Martin MAP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 14,777 | |||
Cost Capitalized Subsequent to Acquisition | 4,801 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 19,578 | |||
Total | 19,578 | |||
Accumulated Depreciation | $ (7,882) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Madison Ave MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 83 | |||
Buildings, Improvements and Fixtures | 2,759 | |||
Cost Capitalized Subsequent to Acquisition | 151 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 83 | |||
Buildings, Improvements and Fixtures | 2,910 | |||
Total | 2,993 | |||
Accumulated Depreciation | $ (1,097) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Patroon Creek HQ | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,870 | |||
Buildings, Improvements and Fixtures | 29,453 | |||
Cost Capitalized Subsequent to Acquisition | 4,896 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,870 | |||
Buildings, Improvements and Fixtures | 34,349 | |||
Total | 36,219 | |||
Accumulated Depreciation | $ (12,451) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Patroon Creek MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,439 | |||
Buildings, Improvements and Fixtures | 27,639 | |||
Cost Capitalized Subsequent to Acquisition | 186 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,439 | |||
Buildings, Improvements and Fixtures | 27,825 | |||
Total | 29,264 | |||
Accumulated Depreciation | $ (9,013) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Washington Ave MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,699 | |||
Buildings, Improvements and Fixtures | 18,440 | |||
Cost Capitalized Subsequent to Acquisition | 1,023 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,699 | |||
Buildings, Improvements and Fixtures | 19,463 | |||
Total | 21,162 | |||
Accumulated Depreciation | $ (6,569) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Putnam MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 24,216 | |||
Cost Capitalized Subsequent to Acquisition | 326 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 24,542 | |||
Total | 24,542 | |||
Accumulated Depreciation | $ (7,482) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Capital Region Health Park | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,305 | |||
Buildings, Improvements and Fixtures | 37,494 | |||
Cost Capitalized Subsequent to Acquisition | 3,565 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,305 | |||
Buildings, Improvements and Fixtures | 41,059 | |||
Total | 43,364 | |||
Accumulated Depreciation | $ (14,672) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | ACP MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 53,265 | |||
Buildings, Improvements and Fixtures | 62,873 | |||
Cost Capitalized Subsequent to Acquisition | 505 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 53,265 | |||
Buildings, Improvements and Fixtures | 63,378 | |||
Total | 116,643 | |||
Accumulated Depreciation | $ (4,085) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | 210 Westchester MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 8,628 | |||
Buildings, Improvements and Fixtures | 18,408 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 8,628 | |||
Buildings, Improvements and Fixtures | 18,408 | |||
Total | 27,036 | |||
Accumulated Depreciation | $ (5,225) | |||
Life on which building depreciation in income statement is computed | 31 years | |||
Operating Properties | Westchester MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 17,274 | |||
Buildings, Improvements and Fixtures | 41,865 | |||
Cost Capitalized Subsequent to Acquisition | 11,930 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 17,274 | |||
Buildings, Improvements and Fixtures | 53,795 | |||
Total | 71,069 | |||
Accumulated Depreciation | $ (15,027) | |||
Life on which building depreciation in income statement is computed | 29 years | |||
Operating Properties | Kindred MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,238 | |||
Buildings, Improvements and Fixtures | 118,778 | |||
Cost Capitalized Subsequent to Acquisition | (101) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,238 | |||
Buildings, Improvements and Fixtures | 118,677 | |||
Total | 122,915 | |||
Accumulated Depreciation | $ (16,338) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Diley Ridge MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,811 | |||
Cost Capitalized Subsequent to Acquisition | 67 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,878 | |||
Total | 9,878 | |||
Accumulated Depreciation | $ (2,128) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Good Sam MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,825 | |||
Buildings, Improvements and Fixtures | 9,966 | |||
Cost Capitalized Subsequent to Acquisition | (178) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,825 | |||
Buildings, Improvements and Fixtures | 9,788 | |||
Total | 11,613 | |||
Accumulated Depreciation | $ (1,372) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | TriHealth | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 34,894 | |||
Cost Capitalized Subsequent to Acquisition | 313 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 35,207 | |||
Total | 35,207 | |||
Accumulated Depreciation | $ (4,484) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Market Exchange MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,326 | |||
Buildings, Improvements and Fixtures | 17,207 | |||
Cost Capitalized Subsequent to Acquisition | 4,011 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,326 | |||
Buildings, Improvements and Fixtures | 21,218 | |||
Total | 23,544 | |||
Accumulated Depreciation | $ (8,424) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Mt. Carmel East | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 14,983 | |||
Cost Capitalized Subsequent to Acquisition | 409 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 15,392 | |||
Total | 15,392 | |||
Accumulated Depreciation | $ (570) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Olentangy | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,247 | |||
Buildings, Improvements and Fixtures | 9,830 | |||
Cost Capitalized Subsequent to Acquisition | 1,001 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,247 | |||
Buildings, Improvements and Fixtures | 10,831 | |||
Total | 12,078 | |||
Accumulated Depreciation | $ (1,425) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Polaris MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,447 | |||
Buildings, Improvements and Fixtures | 12,192 | |||
Cost Capitalized Subsequent to Acquisition | 66 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,447 | |||
Buildings, Improvements and Fixtures | 12,258 | |||
Total | 13,705 | |||
Accumulated Depreciation | $ (2,315) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Gahanna MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,078 | |||
Buildings, Improvements and Fixtures | 5,674 | |||
Cost Capitalized Subsequent to Acquisition | 59 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,078 | |||
Buildings, Improvements and Fixtures | 5,733 | |||
Total | 6,811 | |||
Accumulated Depreciation | $ (1,322) | |||
Life on which building depreciation in income statement is computed | 30 years | |||
Operating Properties | Hilliard II MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 959 | |||
Buildings, Improvements and Fixtures | 7,260 | |||
Cost Capitalized Subsequent to Acquisition | 288 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 959 | |||
Buildings, Improvements and Fixtures | 7,548 | |||
Total | 8,507 | |||
Accumulated Depreciation | $ (1,553) | |||
Life on which building depreciation in income statement is computed | 38 years | |||
Operating Properties | Hilliard MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 946 | |||
Buildings, Improvements and Fixtures | 11,174 | |||
Cost Capitalized Subsequent to Acquisition | 743 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 946 | |||
Buildings, Improvements and Fixtures | 11,917 | |||
Total | 12,863 | |||
Accumulated Depreciation | $ (2,965) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Park Place MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,987 | |||
Buildings, Improvements and Fixtures | 11,341 | |||
Cost Capitalized Subsequent to Acquisition | 5,411 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,987 | |||
Buildings, Improvements and Fixtures | 16,752 | |||
Total | 18,739 | |||
Accumulated Depreciation | $ (7,385) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Liberty Falls MP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 842 | |||
Buildings, Improvements and Fixtures | 5,640 | |||
Cost Capitalized Subsequent to Acquisition | 836 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 842 | |||
Buildings, Improvements and Fixtures | 6,476 | |||
Total | 7,318 | |||
Accumulated Depreciation | $ (2,695) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Parma Ridge MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 372 | |||
Buildings, Improvements and Fixtures | 3,636 | |||
Cost Capitalized Subsequent to Acquisition | 1,006 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 372 | |||
Buildings, Improvements and Fixtures | 4,642 | |||
Total | 5,014 | |||
Accumulated Depreciation | $ (2,005) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | St. Ann's MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 16,978 | |||
Cost Capitalized Subsequent to Acquisition | 8 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 16,986 | |||
Total | 16,986 | |||
Accumulated Depreciation | $ (793) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Deaconess MOP | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 25,975 | |||
Cost Capitalized Subsequent to Acquisition | 2,938 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 28,913 | |||
Total | 28,913 | |||
Accumulated Depreciation | $ (10,795) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Silverton Health MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 953 | |||
Buildings, Improvements and Fixtures | 6,164 | |||
Cost Capitalized Subsequent to Acquisition | (27) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 953 | |||
Buildings, Improvements and Fixtures | 6,137 | |||
Total | 7,090 | |||
Accumulated Depreciation | $ (1,150) | |||
Life on which building depreciation in income statement is computed | 35 years | |||
Operating Properties | Monroeville MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,264 | |||
Buildings, Improvements and Fixtures | 7,038 | |||
Cost Capitalized Subsequent to Acquisition | 1,453 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,264 | |||
Buildings, Improvements and Fixtures | 8,491 | |||
Total | 11,755 | |||
Accumulated Depreciation | $ (2,994) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | 2750 Monroe MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,323 | |||
Buildings, Improvements and Fixtures | 22,631 | |||
Cost Capitalized Subsequent to Acquisition | 5,423 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,323 | |||
Buildings, Improvements and Fixtures | 28,054 | |||
Total | 30,377 | |||
Accumulated Depreciation | $ (12,984) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | 1740 South MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,855 | |||
Buildings, Improvements and Fixtures | 7,735 | |||
Cost Capitalized Subsequent to Acquisition | 241 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,855 | |||
Buildings, Improvements and Fixtures | 7,976 | |||
Total | 9,831 | |||
Accumulated Depreciation | $ (726) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Main Line Bryn Mawr MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 46,967 | |||
Cost Capitalized Subsequent to Acquisition | 5,095 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 52,062 | |||
Total | 52,062 | |||
Accumulated Depreciation | $ (6,077) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Phoenixville MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 60,287 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 60,287 | |||
Total | 60,287 | |||
Accumulated Depreciation | $ (295) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Federal North MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,489 | |||
Buildings, Improvements and Fixtures | 30,268 | |||
Cost Capitalized Subsequent to Acquisition | 4,463 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,489 | |||
Buildings, Improvements and Fixtures | 34,731 | |||
Total | 37,220 | |||
Accumulated Depreciation | $ (10,290) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Highmark Penn Ave | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,774 | |||
Buildings, Improvements and Fixtures | 38,921 | |||
Cost Capitalized Subsequent to Acquisition | 865 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,774 | |||
Buildings, Improvements and Fixtures | 39,786 | |||
Total | 41,560 | |||
Accumulated Depreciation | $ (11,141) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | WP Allegheny HQ MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,514 | |||
Buildings, Improvements and Fixtures | 32,368 | |||
Cost Capitalized Subsequent to Acquisition | 3,669 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,514 | |||
Buildings, Improvements and Fixtures | 36,037 | |||
Total | 37,551 | |||
Accumulated Depreciation | $ (11,020) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | 39 Broad Street | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,180 | |||
Buildings, Improvements and Fixtures | 1,970 | |||
Cost Capitalized Subsequent to Acquisition | 3,161 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,480 | |||
Buildings, Improvements and Fixtures | 4,831 | |||
Total | 8,311 | |||
Accumulated Depreciation | $ (1,249) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Cannon Park Place | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 425 | |||
Buildings, Improvements and Fixtures | 8,651 | |||
Cost Capitalized Subsequent to Acquisition | 942 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 425 | |||
Buildings, Improvements and Fixtures | 9,593 | |||
Total | 10,018 | |||
Accumulated Depreciation | $ (3,284) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | MUSC Elm MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,172 | |||
Buildings, Improvements and Fixtures | 4,361 | |||
Cost Capitalized Subsequent to Acquisition | 178 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,172 | |||
Buildings, Improvements and Fixtures | 4,539 | |||
Total | 5,711 | |||
Accumulated Depreciation | $ (978) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Tides Medical Arts Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,763 | |||
Buildings, Improvements and Fixtures | 19,787 | |||
Cost Capitalized Subsequent to Acquisition | 411 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,763 | |||
Buildings, Improvements and Fixtures | 20,198 | |||
Total | 23,961 | |||
Accumulated Depreciation | $ (4,347) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Bowman Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,896 | |||
Buildings, Improvements and Fixtures | 6,874 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,896 | |||
Buildings, Improvements and Fixtures | 6,874 | |||
Total | 10,770 | |||
Accumulated Depreciation | $ (67) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | East Cooper Medical Arts Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,470 | |||
Buildings, Improvements and Fixtures | 6,289 | |||
Cost Capitalized Subsequent to Acquisition | (290) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,470 | |||
Buildings, Improvements and Fixtures | 5,999 | |||
Total | 8,469 | |||
Accumulated Depreciation | $ (1,630) | |||
Life on which building depreciation in income statement is computed | 32 years | |||
Operating Properties | East Cooper Medical Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,073 | |||
Buildings, Improvements and Fixtures | 5,939 | |||
Cost Capitalized Subsequent to Acquisition | 2,594 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,073 | |||
Buildings, Improvements and Fixtures | 8,533 | |||
Total | 10,606 | |||
Accumulated Depreciation | $ (2,904) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | The Mullis Building | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 18,810 | |||
Cost Capitalized Subsequent to Acquisition | 48 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 18,858 | |||
Total | 18,858 | |||
Accumulated Depreciation | $ (401) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | MUSC University MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,524 | |||
Buildings, Improvements and Fixtures | 9,627 | |||
Cost Capitalized Subsequent to Acquisition | (882) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,524 | |||
Buildings, Improvements and Fixtures | 8,745 | |||
Total | 10,269 | |||
Accumulated Depreciation | $ (1,615) | |||
Life on which building depreciation in income statement is computed | 36 years | |||
Operating Properties | St. Thomas DePaul MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 55,040 | |||
Cost Capitalized Subsequent to Acquisition | 1,003 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 56,043 | |||
Total | 56,043 | |||
Accumulated Depreciation | $ (7,320) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Amarillo Hospital | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,110 | |||
Buildings, Improvements and Fixtures | 17,688 | |||
Cost Capitalized Subsequent to Acquisition | 605 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,110 | |||
Buildings, Improvements and Fixtures | 18,293 | |||
Total | 19,403 | |||
Accumulated Depreciation | $ (6,618) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Austin Heart MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 15,172 | |||
Cost Capitalized Subsequent to Acquisition | 612 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 15,784 | |||
Total | 15,784 | |||
Accumulated Depreciation | $ (4,138) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | BS&W MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 300,952 | |||
Cost Capitalized Subsequent to Acquisition | 1,657 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 302,609 | |||
Total | 302,609 | |||
Accumulated Depreciation | $ (39,353) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Post Oak North MC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 887 | |||
Buildings, Improvements and Fixtures | 7,011 | |||
Cost Capitalized Subsequent to Acquisition | (221) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 887 | |||
Buildings, Improvements and Fixtures | 6,790 | |||
Total | 7,677 | |||
Accumulated Depreciation | $ (1,585) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | MatureWell MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,307 | |||
Buildings, Improvements and Fixtures | 11,078 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,307 | |||
Buildings, Improvements and Fixtures | 11,078 | |||
Total | 12,385 | |||
Accumulated Depreciation | $ (1,858) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Texas A&M Health Science Center | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 32,494 | |||
Cost Capitalized Subsequent to Acquisition | (2,009) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 30,485 | |||
Total | 30,485 | |||
Accumulated Depreciation | $ (7,374) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Dallas Rehab Hospital | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,919 | |||
Buildings, Improvements and Fixtures | 16,341 | |||
Cost Capitalized Subsequent to Acquisition | (505) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,919 | |||
Buildings, Improvements and Fixtures | 15,836 | |||
Total | 17,755 | |||
Accumulated Depreciation | $ (5,067) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Cedar Hill MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 778 | |||
Buildings, Improvements and Fixtures | 4,830 | |||
Cost Capitalized Subsequent to Acquisition | 1,898 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 778 | |||
Buildings, Improvements and Fixtures | 6,728 | |||
Total | 7,506 | |||
Accumulated Depreciation | $ (2,243) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Cedar Park MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 30,338 | |||
Cost Capitalized Subsequent to Acquisition | 1,268 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 31,606 | |||
Total | 31,606 | |||
Accumulated Depreciation | $ (4,212) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Corsicana MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 6,781 | |||
Cost Capitalized Subsequent to Acquisition | 233 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 7,014 | |||
Total | 7,014 | |||
Accumulated Depreciation | $ (2,593) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Dallas LTAC Hospital | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,301 | |||
Buildings, Improvements and Fixtures | 20,627 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,301 | |||
Buildings, Improvements and Fixtures | 20,627 | |||
Total | 22,928 | |||
Accumulated Depreciation | $ (6,996) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Forest Park Pavilion | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 9,670 | |||
Buildings, Improvements and Fixtures | 11,152 | |||
Cost Capitalized Subsequent to Acquisition | 48,094 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 9,670 | |||
Buildings, Improvements and Fixtures | 59,246 | |||
Total | 68,916 | |||
Accumulated Depreciation | $ (3,732) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Forest Park Tower | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,340 | |||
Buildings, Improvements and Fixtures | 35,071 | |||
Cost Capitalized Subsequent to Acquisition | 5,841 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,340 | |||
Buildings, Improvements and Fixtures | 40,912 | |||
Total | 44,252 | |||
Accumulated Depreciation | $ (10,289) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Northpoint Medical | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,388 | |||
Buildings, Improvements and Fixtures | 14,621 | |||
Cost Capitalized Subsequent to Acquisition | 1,629 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,388 | |||
Buildings, Improvements and Fixtures | 16,250 | |||
Total | 18,638 | |||
Accumulated Depreciation | $ (3,496) | |||
Life on which building depreciation in income statement is computed | 20 years | |||
Operating Properties | Baylor MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 9,956 | |||
Buildings, Improvements and Fixtures | 122,852 | |||
Cost Capitalized Subsequent to Acquisition | 6,737 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 9,956 | |||
Buildings, Improvements and Fixtures | 129,589 | |||
Total | 139,545 | |||
Accumulated Depreciation | $ (16,761) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Denton Med Rehab Hospital | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,000 | |||
Buildings, Improvements and Fixtures | 11,704 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,000 | |||
Buildings, Improvements and Fixtures | 11,704 | |||
Total | 13,704 | |||
Accumulated Depreciation | $ (4,444) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Denton MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 7,543 | |||
Cost Capitalized Subsequent to Acquisition | 733 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 8,276 | |||
Total | 8,276 | |||
Accumulated Depreciation | $ (2,567) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Cliff Medical Plaza MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,064 | |||
Buildings, Improvements and Fixtures | 1,972 | |||
Cost Capitalized Subsequent to Acquisition | 4,157 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,064 | |||
Buildings, Improvements and Fixtures | 6,129 | |||
Total | 7,193 | |||
Accumulated Depreciation | $ (3,023) | |||
Life on which building depreciation in income statement is computed | 8 years | |||
Operating Properties | El Paso MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,075 | |||
Buildings, Improvements and Fixtures | 14,902 | |||
Cost Capitalized Subsequent to Acquisition | (233) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,075 | |||
Buildings, Improvements and Fixtures | 14,669 | |||
Total | 16,744 | |||
Accumulated Depreciation | $ (1,207) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Providence Medical Plaza | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 5,396 | |||
Cost Capitalized Subsequent to Acquisition | 4,080 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,476 | |||
Total | 9,476 | |||
Accumulated Depreciation | $ (2,906) | |||
Life on which building depreciation in income statement is computed | 20 years | |||
Operating Properties | Sierra Medical | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 2,998 | |||
Cost Capitalized Subsequent to Acquisition | 1,011 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 4,009 | |||
Total | 4,009 | |||
Accumulated Depreciation | $ (1,616) | |||
Life on which building depreciation in income statement is computed | 15 years | |||
Operating Properties | Texas Tech MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 42,419 | |||
Cost Capitalized Subsequent to Acquisition | 2,040 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 44,459 | |||
Total | 44,459 | |||
Accumulated Depreciation | $ (1,178) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Texas Health MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 38,429 | |||
Cost Capitalized Subsequent to Acquisition | 165 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 38,594 | |||
Total | 38,594 | |||
Accumulated Depreciation | $ (5,282) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Forest Park Frisco MC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,238 | |||
Buildings, Improvements and Fixtures | 19,979 | |||
Cost Capitalized Subsequent to Acquisition | 9,038 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,238 | |||
Buildings, Improvements and Fixtures | 29,017 | |||
Total | 30,255 | |||
Accumulated Depreciation | $ (9,851) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | T-Mobile Building | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,807 | |||
Buildings, Improvements and Fixtures | 67,076 | |||
Cost Capitalized Subsequent to Acquisition | (3,139) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,807 | |||
Buildings, Improvements and Fixtures | 63,937 | |||
Total | 68,744 | |||
Accumulated Depreciation | $ (7,827) | |||
Life on which building depreciation in income statement is computed | 38 years | |||
Operating Properties | Greenville MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 616 | |||
Buildings, Improvements and Fixtures | 10,822 | |||
Cost Capitalized Subsequent to Acquisition | 633 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 616 | |||
Buildings, Improvements and Fixtures | 11,455 | |||
Total | 12,071 | |||
Accumulated Depreciation | $ (4,172) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | 7900 Fannin MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 34,764 | |||
Cost Capitalized Subsequent to Acquisition | 2,767 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 37,531 | |||
Total | 37,531 | |||
Accumulated Depreciation | $ (11,942) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Cypress Medical Building MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 4,678 | |||
Cost Capitalized Subsequent to Acquisition | 203 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 4,881 | |||
Total | 4,881 | |||
Accumulated Depreciation | $ (1,273) | |||
Life on which building depreciation in income statement is computed | 30 years | |||
Operating Properties | Cypress Station MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,345 | |||
Buildings, Improvements and Fixtures | 8,312 | |||
Cost Capitalized Subsequent to Acquisition | (4,237) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,345 | |||
Buildings, Improvements and Fixtures | 4,075 | |||
Total | 5,420 | |||
Accumulated Depreciation | $ (3,644) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Gemini MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,619 | |||
Buildings, Improvements and Fixtures | 17,450 | |||
Cost Capitalized Subsequent to Acquisition | 153 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,619 | |||
Buildings, Improvements and Fixtures | 17,603 | |||
Total | 22,222 | |||
Accumulated Depreciation | $ (1,410) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Houston Medical Plaza | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,107 | |||
Buildings, Improvements and Fixtures | 35,560 | |||
Cost Capitalized Subsequent to Acquisition | 36 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,110 | |||
Buildings, Improvements and Fixtures | 35,593 | |||
Total | 39,703 | |||
Accumulated Depreciation | $ (363) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Park Plaza MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 5,719 | |||
Buildings, Improvements and Fixtures | 50,054 | |||
Cost Capitalized Subsequent to Acquisition | 8,389 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 5,719 | |||
Buildings, Improvements and Fixtures | 58,443 | |||
Total | 64,162 | |||
Accumulated Depreciation | $ (15,664) | |||
Life on which building depreciation in income statement is computed | 24 years | |||
Operating Properties | T-Mobile Tower | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 8,314 | |||
Buildings, Improvements and Fixtures | 15,335 | |||
Cost Capitalized Subsequent to Acquisition | 35 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 8,314 | |||
Buildings, Improvements and Fixtures | 15,370 | |||
Total | 23,684 | |||
Accumulated Depreciation | $ (419) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Triumph Hospital NW | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,377 | |||
Buildings, Improvements and Fixtures | 14,531 | |||
Cost Capitalized Subsequent to Acquisition | 164 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,377 | |||
Buildings, Improvements and Fixtures | 14,695 | |||
Total | 16,072 | |||
Accumulated Depreciation | $ (5,819) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Memorial Hermann MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,479 | |||
Cost Capitalized Subsequent to Acquisition | 13,361 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 22,840 | |||
Total | 22,840 | |||
Accumulated Depreciation | (3,130) | |||
Operating Properties | Jourdanton MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 17,804 | |||
Cost Capitalized Subsequent to Acquisition | 2 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 17,806 | |||
Total | 17,806 | |||
Accumulated Depreciation | $ (2,384) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Houston Methodist MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 43,078 | |||
Cost Capitalized Subsequent to Acquisition | 7,760 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 50,838 | |||
Total | 50,838 | |||
Accumulated Depreciation | (5,641) | |||
Operating Properties | Lone Star Endoscopy MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 622 | |||
Buildings, Improvements and Fixtures | 3,502 | |||
Cost Capitalized Subsequent to Acquisition | 36 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 622 | |||
Buildings, Improvements and Fixtures | 3,538 | |||
Total | 4,160 | |||
Accumulated Depreciation | $ (1,330) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Seton Medical MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 30,102 | |||
Cost Capitalized Subsequent to Acquisition | 2,617 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 32,719 | |||
Total | 32,719 | |||
Accumulated Depreciation | $ (4,470) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Lewisville MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 452 | |||
Buildings, Improvements and Fixtures | 3,841 | |||
Cost Capitalized Subsequent to Acquisition | (133) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 452 | |||
Buildings, Improvements and Fixtures | 3,708 | |||
Total | 4,160 | |||
Accumulated Depreciation | $ (1,219) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Longview Regional MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 59,258 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 59,258 | |||
Total | 59,258 | |||
Accumulated Depreciation | (8,209) | |||
Operating Properties | Terrace Medical Building | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 179 | |||
Cost Capitalized Subsequent to Acquisition | 121 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 300 | |||
Total | 300 | |||
Accumulated Depreciation | $ (154) | |||
Life on which building depreciation in income statement is computed | 5 years | |||
Operating Properties | Towers Medical Plaza | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 786 | |||
Cost Capitalized Subsequent to Acquisition | 236 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 1,022 | |||
Total | 1,022 | |||
Accumulated Depreciation | $ (617) | |||
Life on which building depreciation in income statement is computed | 10 years | |||
Operating Properties | North Cypress MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 7,841 | |||
Buildings, Improvements and Fixtures | 121,215 | |||
Cost Capitalized Subsequent to Acquisition | 1,687 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 7,841 | |||
Buildings, Improvements and Fixtures | 122,902 | |||
Total | 130,743 | |||
Accumulated Depreciation | (16,639) | |||
Operating Properties | Pearland MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 912 | |||
Buildings, Improvements and Fixtures | 4,628 | |||
Cost Capitalized Subsequent to Acquisition | 314 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 912 | |||
Buildings, Improvements and Fixtures | 4,942 | |||
Total | 5,854 | |||
Accumulated Depreciation | $ (1,732) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Independence Medical Village | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 4,229 | |||
Buildings, Improvements and Fixtures | 17,874 | |||
Cost Capitalized Subsequent to Acquisition | (132) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 4,229 | |||
Buildings, Improvements and Fixtures | 17,742 | |||
Total | 21,971 | |||
Accumulated Depreciation | $ (3,347) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | San Angelo MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 3,907 | |||
Cost Capitalized Subsequent to Acquisition | (237) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 3,670 | |||
Total | 3,670 | |||
Accumulated Depreciation | $ (1,331) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Mtn Plains Pecan Valley | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 416 | |||
Buildings, Improvements and Fixtures | 13,690 | |||
Cost Capitalized Subsequent to Acquisition | 512 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 416 | |||
Buildings, Improvements and Fixtures | 14,202 | |||
Total | 14,618 | |||
Accumulated Depreciation | $ (5,091) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Sugar Land II MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,648 | |||
Cost Capitalized Subsequent to Acquisition | 79 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 9,727 | |||
Total | 9,727 | |||
Accumulated Depreciation | $ (3,198) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Triumph Hospital SW | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,670 | |||
Buildings, Improvements and Fixtures | 14,018 | |||
Cost Capitalized Subsequent to Acquisition | (670) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,656 | |||
Buildings, Improvements and Fixtures | 13,362 | |||
Total | 15,018 | |||
Accumulated Depreciation | $ (5,625) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Mtn Plains Clear Lake | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 832 | |||
Buildings, Improvements and Fixtures | 21,168 | |||
Cost Capitalized Subsequent to Acquisition | 5,761 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 832 | |||
Buildings, Improvements and Fixtures | 26,929 | |||
Total | 27,761 | |||
Accumulated Depreciation | $ (8,382) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | N. Texas Neurology MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 736 | |||
Buildings, Improvements and Fixtures | 5,611 | |||
Cost Capitalized Subsequent to Acquisition | (1,957) | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 736 | |||
Buildings, Improvements and Fixtures | 3,654 | |||
Total | 4,390 | |||
Accumulated Depreciation | $ (1,838) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Wylie Medical Plaza | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,412 | |||
Buildings, Improvements and Fixtures | 15,353 | |||
Cost Capitalized Subsequent to Acquisition | 272 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,412 | |||
Buildings, Improvements and Fixtures | 15,625 | |||
Total | 17,037 | |||
Accumulated Depreciation | $ (1,205) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Renaissance MC | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 3,701 | |||
Buildings, Improvements and Fixtures | 24,442 | |||
Cost Capitalized Subsequent to Acquisition | 442 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 3,701 | |||
Buildings, Improvements and Fixtures | 24,884 | |||
Total | 28,585 | |||
Accumulated Depreciation | $ (8,850) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Salt Lake Regional Medical Building | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 10,351 | |||
Cost Capitalized Subsequent to Acquisition | 110 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 10,461 | |||
Total | 10,461 | |||
Accumulated Depreciation | $ (670) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Fairfax MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 2,404 | |||
Buildings, Improvements and Fixtures | 14,074 | |||
Cost Capitalized Subsequent to Acquisition | 193 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 2,404 | |||
Buildings, Improvements and Fixtures | 14,267 | |||
Total | 16,671 | |||
Accumulated Depreciation | $ (1,379) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Fair Oaks MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 47,616 | |||
Cost Capitalized Subsequent to Acquisition | 562 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 48,178 | |||
Total | 48,178 | |||
Accumulated Depreciation | $ (5,876) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Aurora - Menomonee | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 1,055 | |||
Buildings, Improvements and Fixtures | 14,998 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 1,055 | |||
Buildings, Improvements and Fixtures | 14,998 | |||
Total | 16,053 | |||
Accumulated Depreciation | $ (6,816) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Aurora - Milwaukee | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 350 | |||
Buildings, Improvements and Fixtures | 5,508 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 350 | |||
Buildings, Improvements and Fixtures | 5,508 | |||
Total | 5,858 | |||
Accumulated Depreciation | $ (2,508) | |||
Life on which building depreciation in income statement is computed | 39 years | |||
Operating Properties | Columbia St. Mary's MOBs | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | $ 0 | |||
Initial Cost to Company | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 87,825 | |||
Cost Capitalized Subsequent to Acquisition | 1,144 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 0 | |||
Buildings, Improvements and Fixtures | 88,969 | |||
Total | 88,969 | |||
Accumulated Depreciation | (10,921) | |||
Undeveloped Land | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 22,963 | |||
Buildings, Improvements and Fixtures | 0 | |||
Cost Capitalized Subsequent to Acquisition | 18 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 22,963 | |||
Buildings, Improvements and Fixtures | 18 | |||
Total | 22,981 | |||
Accumulated Depreciation | 0 | |||
Undeveloped Land | Macon Pond MOB | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 5,504 | |||
Buildings, Improvements and Fixtures | 0 | |||
Cost Capitalized Subsequent to Acquisition | 13 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 5,504 | |||
Buildings, Improvements and Fixtures | 13 | |||
Total | 5,517 | |||
Accumulated Depreciation | 0 | |||
Undeveloped Land | Forest Park Pavilion IV | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 7,014 | |||
Buildings, Improvements and Fixtures | 0 | |||
Cost Capitalized Subsequent to Acquisition | 0 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 7,014 | |||
Buildings, Improvements and Fixtures | 0 | |||
Total | 7,014 | |||
Accumulated Depreciation | 0 | |||
Undeveloped Land | Houston Heights | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | ||||
Encumbrances | 0 | |||
Initial Cost to Company | ||||
Land | 10,445 | |||
Buildings, Improvements and Fixtures | 0 | |||
Cost Capitalized Subsequent to Acquisition | 5 | |||
Gross Amount at Which Carried at Close of Period | ||||
Land | 10,445 | |||
Buildings, Improvements and Fixtures | 5 | |||
Total | 10,450 | |||
Accumulated Depreciation | $ 0 |
Schedule III- Real Estate and Accumulated Depreciation Schedule III - Real Estate and Accumulated Depreciation - Rollforward of Carrying Amount of Real Estate Assets (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate [Roll Forward] | |||
Balance as of the beginning of the year | $ 7,104,085 | $ 6,837,400 | $ 6,269,023 |
Acquisitions | 278,124 | 171,728 | 505,424 |
Additions | 188,592 | 121,777 | 90,859 |
Dispositions and other | (189,156) | (26,820) | (27,906) |
Impairment | (22,938) | 0 | 0 |
Held for sale | (29,809) | 0 | 0 |
Balance as of the end of the year | 7,328,898 | 7,104,085 | 6,837,400 |
Lease intangibles | 404,714 | $ 628,621 | $ 628,100 |
Federal income tax basis | $ 6,900,000 |
Schedule III- Real Estate and Accumulated Depreciation Schedule III - Real Estate and Accumulated Depreciation - Rollforward of Accumulated Depreciation (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation [Roll Forward] | |||
Balance as of the beginning of the year | $ 1,302,204 | $ 1,085,048 | $ 882,488 |
Additions | 246,417 | 236,271 | 217,566 |
Dispositions and other | (146,879) | (19,115) | (15,006) |
Held for sale | (6,263) | 0 | 0 |
Balance as of the end of the year | 1,395,479 | 1,302,204 | 1,085,048 |
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | |||
Accumulated depreciation lease intangibles | $ 203,000 | $ 400,500 | $ 362,800 |
Tenant Improvements | Minimum | |||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | |||
Estimated useful life | 1 year | ||
Tenant Improvements | Maximum | |||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | |||
Estimated useful life | 10 years | ||
Furniture, fixtures and equipment | |||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items] | |||
Estimated useful life | 5 years |
Schedule IV - Mortgage Loans on Real Estate Assets (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | |||
Prior Liens | $ 0 | ||
Face Amount | 70,319 | ||
Carrying Amount | 69,072 | ||
Accrued interest receivable | 42 | ||
Carrying Amount, Net | 69,114 | ||
Principal Amount of Loans Subject to Delinquent Principal or Interest | 0 | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward] | |||
Balance as of the beginning of the year | 555 | $ 1,332 | $ 2,070 |
Additions: | |||
New real estate notes | 67,032 | 6,000 | 0 |
Capitalized interest | 1,841 | 0 | 0 |
Accretion of fees and other items | 932 | 0 | 0 |
Deductions: | |||
Mortgage loan retired in connection with an acquisition | 0 | (6,000) | 0 |
Collection of real estate loans | (555) | (777) | (738) |
Deferred fees and other items | (691) | 0 | 0 |
Balance as of the end of the year | $ 69,114 | $ 555 | $ 1,332 |
TEXAS | Medical Real Estate in Texas Maturing in July 2022 | |||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | |||
Interest Rate | 10.00% | ||
Prior Liens | $ 0 | ||
Face Amount | 15,000 | ||
Carrying Amount | 14,267 | ||
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 0 | ||
TEXAS | Property 1 | |||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | |||
Interest Rate | 8.00% | ||
Prior Liens | $ 0 | ||
Face Amount | 49,319 | ||
Carrying Amount | 48,793 | ||
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 0 | ||
NORTH CAROLINA | Property 2 | |||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | |||
Interest Rate | 8.00% | ||
Prior Liens | $ 0 | ||
Face Amount | 6,000 | ||
Carrying Amount | 6,012 | ||
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 0 |
Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions |
Feb. 28, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
---|---|---|---|
Subsequent Event [Line Items] | |||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |
Subsequent Event | Merger Agreement with Healthcare Realty Trust Incorporated | |||
Subsequent Event [Line Items] | |||
Common stock, par value (in dollars per share) | $ 0.01 | ||
Special distribution payment (in dollars per share) | $ 4.82 | ||
Merger agreement conversion ratio | 1.0 | ||
Financing termination fee payable | $ 291 | ||
Fixed expense reimbursement amount | 25 | ||
Subsequent Event | Merger Agreement with Healthcare Realty Trust Incorporated | Bridge Financing Facility | |||
Subsequent Event [Line Items] | |||
Amount of financing facility amount | $ 1,700 | ||
Subsequent Event | Healthcare Realty Trust Incorporated | Merger Agreement with Healthcare Realty Trust Incorporated | |||
Subsequent Event [Line Items] | |||
Common stock, par value (in dollars per share) | $ 0.01 | ||
Merger agreement covenants termination fee | $ 5 | ||
Financing termination fee payable | 163 | ||
Fixed expense reimbursement amount | $ 25 |